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ABSTRACT 
Ti tl e of Thes i s :  POSTMORTEM STAB I L ITY O F  DRUGS I N  BLOOD AND T I SSUES 
Ba rry Steven Levi ne , B . S .  
Med i ca l  Col l ege o f  V i rg i n i a-V i rg i n i a  Commonwea l th Un i vers i ty ,  1982 
Maj o r  D i rectors : D r .  Robert V .  B l anke 
Dr. J ames C.  Val entour 
viii 
The del ay that occurs between s pec imen acqui s i ti on and ana l y s i s  i n  
c l i n i ca l  and foren s i c toxi cology requ i res the establ i s hment that n o  changes  
in  dru g  concentrati on have occurred during  th i s  t imed interva l . In th i s  
research , severa l groups  of common drugs were exami ned for stab i l i ty i n  
serum , b l ood and t i ssues  a t  room temperature and a t  4° C .  S pec i fi ca l l y ,  
benzodi azepines , barbi tu rates , l i doca i ne , proca i nami de and nortrypty l i ne 
were stud i ed .  Decrea ses  were found i n  the fol l owi ng  drugs : 
ch l ordi azepox i de ,  norch l ordi azepox i de ,  demoxepam , and n i trazepam . No  
changes were found i n  the other  drugs . More deta i l ed work wa s performed on 
ch l ordi azepox i de ( COP) . Two breakdown products , demoxepam and nordi azepam 
( NO) were i denti fied  and quanti tated . A seri es  of experi ments at  var i ous  
pH's in the presence and  ab sence of fl uori de/ oxa l ate ( F-/ C20� ) were 
undertaken to exami ne chemi cal  and mi croorgan i sm effects on COP b rea kdown 
in b l ood and buffe r .  At pH5 , the rate of COP breakdown wa s the s ame i n  
bl ood and buffer and n o  nord i azepam wa s formed i n  e i ther medi um .  Thi s was 
determined by comparing  the s l opes of I n ( CDP) vs . t ime for each condi t i on ;  
the s l opes were about -.06 for each . Al l s l opes a re i n  ( days)- l . At pH 
6 . 5  and pH 8 ,  i n  the absence of F-/ C204 , COP  wa s l es s  stab l e i n  b l ood than 
buffer ( s l opes of - . 13 and - . 27 vers u s  - . 036 and - . 039 ) and NO wa s fo rmed 
i n  the b l ood . At these pH ' s ,  F-/ C204 stab i l i zed COP i n  b l ood such  that  i t  
was more stab l e than buffer ( s l opes of - . 0047 and - . 0066 vers u s  - . 038 and  
- . 036 ) . 
i x  
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I NTRODUCT ION  
I .  OBJ ECT IVE  AND  S I GN I F I CANCE 
The bas i c  hypothes i s  of th i s research i s  that drugs vary i n  the i r 
stabi l i ty i n  bl ood and  t i s s ues  after death and vari ous  factors can 
contr i bute to th i s vari ab i l i ty .  Th i s  p rob l em can be stud i e d  under two 
cond i ti ons : 1) i n  s i tu - when the b l ood and ti s sues  a re i n  the  body ;  o r  
2 )  � v i tro - after s pec i mens have been removed from t h e  body . I t  was  
dec i ded that the second cond i ti on wou l d be  studi ed  in  th i s resea rch ; not 
only cou l d more data about a l a rger group  of  drugs  be obta i ned , b ut  the 
pract i ca l  d i ffi cu l t i es in reta i n i ng human i ntact cadavers cou l d be  
avo i ded . Once it  was dec i ded to study � v i tro stabi l i ty of  d rug s , the 
next step wa s to des i gn p rotoco l s to study the p robl em in b l ood and  
t i s s ues . Th i s  frequently wou l d i nvo l ve the deve l opment of methods  to 
enab l e  the quanti fi cati on of the drugs  in decomposed spec i mens . D rug s  
encountered i n  foren s i c  and c l i n i ca l  tox i col ogy l aboratori es  wou l d  be  
exami ned i n i ti a l l y .  Then other drugs  wou l d be stud i ed such that  
re l at i onsh i ps between drug  stabi l i ty and funct i onal  g roups cou l d  be  
made . Chemi cal  and  mi croorgan i sm contri buti ons  to drug  instability 
wou l d  be exami ned i n  those cases  where an i n i t i a l  s creen i n g  i nd i cated 
dru g i nstabi l i ty .  
I nformat i on generated i n  th i s  research has  app l i cati ons  i n  both the 
forensic and cli n i ca l  tox i col ogy l aboratori es . I deal l y , a l l med i ca l  
exami ner a nd  coroner ca se s  shoul d be autop s i ed w i th i n  h o ur s  after death 
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and  when the s i tuat i ons  d i ctate , the re l ated tox i co l og i cal  ana lyses  
shou l d be performed as  rapi d l y  a s  poss i b l e  after rece i pt of  the s pec i ­
mens .  However , i n  the rea l  worl d ,  th i s rare ly  occurs . A more l i ke l y  
scena ri o i s  that an  autopsy i s  performed wi th i n 4 8  hours of a death a n d  
t h e  tox i co l ogi ca l ana lyses  may occur severa l  days t o  severa l weeks  o r  
even months after samp l e acqu i s i t i on .  I n  l i ght  of th i s ,  certa i n 
precaut i ons  are undertaken to ensure the i ntegr i ty of the s pec i men s .  
For examp l e ,  ti s sue  s pec i mens  a re stored i n  freezers at  -20 ° C  between 
samp l e recei pt and ana l ys i s .  For b l ood , be s i des i ts storage at  4 ° C , 
chemi ca l s  such a s  sod i um fl uori de and pota s s i um oxal ate are added to  
i nh i b i t  mi croorgan i sm growth and to p revent b l ood coagu l at i on . 
Furthermore , there a re those occa s i ona l  forens i c  cases requ i ri ng 
tox i co l og i c ana l ys i s i nvo l v i ng  bodi es  found weeks or  months after death . 
Even c l i n i ca l  samp l e s  may be sent to other l aboratori es , often t i mes  by 
ma i l  under non -refri gerated cond i t i ons . The poi nt i s  that for whatever 
reason , toxi col ogi c tests a re frequently performed some t ime after 
s pec i men acqu i s i t i on .  S i nce the resu l ts of  these tests in  foren s i c  
cases  can become i nvol ved i n  cr im i na l  o r  c i v i l l i t i gati on , i t  i s  i mpor­
tant that the resu l ts be an  accurate i nd i cati on of events at  the t i me of 
death . I n  other words , i t  i s  i mportant to know i f  changes i n  tox i cant  
concentrat i on between death  and ana l ys i s  have occurred . 
Even though a re l at i ve ly  sma l l number  of tox i cants have been 
ana lyzed for postmortem stabi l i ty ,  there i s  s uffi c i ent evi dence to s ug­
gest that  changes i n  concentrat i on can occu r over  rel ati ve ly  s hort 
peri ods of t i me .  Therefore , i t  i s  i mportant that the tox i co l og i st be  
cognizant o f  these changes . By i n i t i a l l y  studyi ng  cl asses  of compounds , 
the g reatest amount of i nformat i on  can be obta i ned i n  the s hortest 
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amount  of t ime .  Of course , there a re s tructural  d i fferences w i th i n  a 
g i ven cl a s s  of compounds and these di fferences can prov i de the b a s i s for 
further research when d i fferences i n  stab i l i ty wi th i n  a g i ven c l a s s  a re 
found . 
I I .  BACKGROUND 
Many factors can affect the postmortem b l ood and ti s sue  concentra­
ti ons  of drugs . I n  the i r boo k , Gonza l e s et a l . ( 1 )  di scus sed many of 
these factors . They i nc l uded : 1 )  the entrance of  mi croorgan i sms i nto 
the b l ood from the gastro i ntesti na l  tract ; 2) external cond i t i on s  such  
a s  temperature , h umi d i ty ,  o r  the s u rroundi ng  medi um - a i r ,  wate r , s o i l , 
etc . ; 3 )  the presence of other poi sons ; and , 4 )  cel l u l a r d i s i n teg rat i on 
l eadi ng  to the rel ease  of degradat i ve enzyme s . Pa rker et �. (2) enu­
merated other  i nfl uences on the  postmortem quanti fi cati on of drug s , i n ­
c l u d i n g  postmortem di ffu s i on o f  the drug , p resence or  absence o f  gastr i c 
contents , and postmortem body pos i t i on .  
To th i s poi nt , some work has  been done o n  the effect of these  con­
d i t i on s  on postmortem concentrati ons  of drug s  and other  toxi co l og i ca l l y  
i mportant chemi ca l s .  The fo l l owi ng  i s  a rev i ew o f  the work done t o  date 
on  b l ood and t i s s ues . 
A .  Anti convu l sant drugs and barb i tu rates . 
Attempts  to quant i fy the effects of putrefacti on on t i ssue 
concentrat ions  of barb i tu rates date back to 1942 ( 3) .  However , due to 
l i mi tat i ons  i n  methodo l ogy , the fi rst mean i ngful  quanti tati ve res u l ts 
were not produced unti l 1957 by Al geri ( 4 ) . U l trav i ol et ( UV ) 
s pectrophotometri c methods were comb i ned wi th paper chromatography to 
a na l yze a l i ver  obta i ned from a pentobarb i ta l  death . After ana l y s i s 
i mmed i ate l y  u pon autopsy , the l i ve r  was pl aced i n  a mu seum ja r w i th  a 
l oose-fi tti ng cover at 27 ° C  and parts  of the l i ve r  were removed a t  
random i nterva l s f o r  u p  t o  90 days a n d  ana l yzed f o r  pentobarb i ta l . 
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After 90 days , s l i ght  i ncreases  i n  pentoba rb i ta l  concentrat i on were 
observed . As a control a norma l l i ve r  not conta i n i ng barb i tu rates  was 
a l s o  a l l owed to decompose under the same condi t i ons ; no barb i tu rates  or 
i nterferi ng substances were produced . Al geri  s uggested that 
pentobarb i ta l  degradat i on d i d not occu r because reduc i ng  s ub stances  
produced in  an acid med i um duri ng the  putrefact i on proces s  wou l d  i nh i b i t  
" o x i dat i on "  o f  the barbi turate . The fact that an i nc rease was observed 
was attri buted to decreased prote i n  b i ndi ng , i nterference of mater i a l  
from borderi ng  zones , a n d  decreased water content wi th a s ub sequent  l o s s  
o f  we i ght o f  decompos i ng mater i a l . 
The fi nd i ng s  of Al geri  were i n  a pparent confl i ct w i th work of  
Coutsel i n i s  and  Ki ari s ( 5 )  who stud i ed the effect of putrefact i on on the 
concentrati on of pentobarb i tal  in  dog b l ood . B l ood sampl es  stored  at 
room temperatu re for two months were compared to b l ood samples refri g­
e rated at 4°C for the same l ength of t i me .  Pentobarbi tal  was quant i ­
tated u s i ng a UV spectrophotometri c method . The concentrati on  of pento­
barbital in the room temperature sampl es  decreased with increa s i ng t i me ;  
the refri gerated sampl e s  showed l i ttle change . Two expl anat i ons  were 
g i ven for the decrease  in pentobarbi tal  concentrat i on: 1) the 
" ox i dat i on"  of the barb i tu rates des p i te the p resence of the redu c i ng  
substances p roduced dur i ng  the putrefact i on p roces s ; and 2 ) the other 
factors of putrefacti on -humi d i ty ,  temperature , etc . 
Postmortem effects on sodi um secoba rb i ta l  were studi ed by 
Parker et al . i n  197 1 ( 2 ) . Group s  of rats were admi ni stered l etha l  
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doses of the drug; one g roup was ana l yzed for l i ver  secoba rb i ta l  l eve l s 
i mmedi atel y after death , thus  acti ng a s  a control . Three other g roups  
were s i mi l arl y ana l yzed at  24 , 48  and  72  hours  res pecti vel y fol l ow i n g  
death . A U V  s pectrophotometri c method ( 6 )  wa s u sed for ana l ys i s .  The 
concentrati ons of secobarb i tal  in  postmortem rat l i vers i ncreased 
greatl y duri ng the fi rst  24 hours and i ncreased to a s l i gh t l y  h i gher  
l evel  after 48  hours . A s l i g ht decrease in  secobarb i ta l  concentrat i on 
wa s observed at  72 hours  in  compari son to the 48 hou r concentrat i on . In 
a second seri es of experi ments , a g roup of rats were as phyx i a ted and 
upon death , were g i ven a dose of sodi um secobarb i ta l  v ia  a stomach tube . 
After 9 days , ana l y s i s  of the l i ver  i nd i cated s i gn i fi cant concentrat i ons  
of the drug . Th i s  i nd i cated a s i gn i fi cant  postmortem d i ffu s i on from the  
s tomach . Thi s postmortem di ffu s i on was  found to be i ndependent of  the  
pos i t i on of the  body . 
Suns h i ne and Hackett ( 7 )  u sed UV s pectrophotometri c methods to 
compa re the concentrati on of barb i tu rates i n  forma l i n-fi xed t i s sues  to 
the concentrat i on of barb i tu rates ori g i na l l y  found after autopsy . I t  
wa s concl uded that i f  " s i gn i f i cant"  amount o f  barbi tu rate were present  
in  the  ori g i nal sampl e ,  then  it  wi l l  be i denti fi ab l e in  forma l i n -f i xed 
tis sues  up  to three years after forma l i n-fi xati on . However ,  a 
quanti tati ve compa ri son between ori g i na l  and forma l i n -fi xed t i s s ues  
demonstrated ti ssue dependent d i fferences . For  examp l e ,  f ixat i on  
removed the drug  from the l i ver more qu i ckl y than from other t i s sues . 
Conversel y ,  the sp l een had a s i gn i f i cantl y h i gher b arb i tu rate 
concentrati on than the other t i s sues  after formali n -fi xati on . 
The i ntroducti on of therapeuti c drug mon i tori ng  of 
ant i ep i l ept i c  drugs wi thi n the past decade has  made the establ i s hment of 
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drug stabi l i ty an i mportant con s i derat i on i n  the c l i n i ca l  a s  wel l a s  the 
foren s i c  toxi col ogy l aboratory .  Spec i fi c poi nts of concern i nc l ude the 
storage of serum contro l s and the s h i pment of pati ent sampl es  t hrough  
t he  ma i l . Moreover ,  there i s  some controversy about t he  l ength of  t i me 
serum contro l s can be s tored wi thout a s i g n ifi cant decrea se  i n  drug  
concentrati on . van  der Kl e i j n  et �. ( 8 )  observed a 20% decrea s e  i n  
p l asma phenyto i n  concentrati ons  when stored at  4 ° C  for e i ght  weeks . 
However , Schafer ( 9 ) reported no decrease i n  the concentrat i on s  of  
phenyto i n ,  phenobarb i ta l , o r  pr imi done when stored i n  serum at 4° C for  
about 12  weeks . Al though P i ppenger et �. ( 1 0 )  found s i gnifi cant  
bacteri a l  growth in  poo l ed serum sampl es  sent by ma i l , no s i g n if i cant  
changes in  phenyto i n ,  phenobarb i ta l , pri mi done , and ethos ux imi de 
concentrat i ons  were found . W i l ensky ( 1 1 )  found no changes i n  the  
concentrat ions  of mephenyto i n ,  phenobarb i tal , pr imi done , and phenyto i n  
after 6 months  of s torage i n  g l a s s  conta i ners wi thout expos u re to l i ght  
at room temperature . Severa l expl anati ons  were offered by W i l en sky for 
these confl i ct i n g  data : ( 1 )  The presence of i nterferi ng pea ks i n  the  
gas  ch romatograph i c  methods produced duri ng the decompos i t i on p roce s s ; 
( 2 )  bacter i a l  g rowth ; ( 3 )  the pH of the serum.  Bes i des the fact that  
barb i turates are unstab l e in  base , di fferent b rea kdown products  a re 
found i f  the barb i tu rates a re stored i n  aqueous ac i d or aqueou s  b a s e . 
In summa ry ,  there appears to be confl i ct i n g  data concerning 
the stabi l i ty of anti convu l sant drugs and b arb i tu rates i n  b l ood and  i n  
ti s sues . One poss i b l e  expl anat i o n  for these confl i cts  i s  that much  of  
the data  were col l ected u s i ng  UV s pectrophotometry for quant i tat i on . 
Not on1y is thi s l es s  sen s i t i v e  than chromatograph i c  methods , i t  i s  a l s o  
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s ubj ect to more frequent i nterferences from decompos i t i on p roducts  than 
a re chromatographi c methods . 
B .  Ca rbon monox i de (CO) 
The fi rst  quanti tati ve work on postmortem effects on carbon 
monoxi de concentrati on was publ i shed in  1940 by Gettl er  and Frei muth 
( 12 ) . P rev i ou s  qua l i tati ve work by We i mann  ( 13 )  demonstrated that  i n  
two fatal i ti e s  caused by CO poi son i ng , exhumat i on s  of the bod i es  over  a 
month l ater revea l ed that CO was st i l l  found i n  l a rge amounts  i n  the  
b l ood . Gettl er  and Fre imuth  exposed human cadavers to CO in  a sea l ed 
conta i ne r .  After exami n i ng heart b l ood u s i n g  a modi fi ed Van S l yke 
procedu re ( 14 ) , they. found that CO does not reach the heart even after 
the body i s  exposed to CO for 42 hours . Thi s i mpl i es that there i s  no 
postmortem absorpti on of CO . The i r next exper iments i nvol ved the 
ana l ys i s of b l ood sampl es  wi th norma l CO content to determi ne whether 
the putrefacti on proce s s  p roduced any CO . Spec i fi cal l y , CO content of  
an  a l i quot of b l ood stand i n g  at  room temperatu re was compared to  another  
a l i quot of the  b l ood kept  in  a refri gerato r .  Even after 12  week s , n o  
s i gn i f i cant amount of CO was produced duri ng putrefacti on . Th i s study 
wa s expanded to i nc l ude abnorma l l evel s of CO . I n  e i ght of the ten 
cases reported , wi th vary i n g  degrees of t ime after exposure and  v a ry i ng  
amounts  of  CO , a l os s  i n  CO content a nd  CO capac i ty wa s  found . I n  the 
other two cases , there was no change in CO content or  CO capa c i ty .  
Domi nguez et �. ( 15 )  used dogs to study the effect of post­
mortem changes on ca rboxyhemog l ob i n  ( CO-Hb ) l evel s .  After expo s u re to 
1%  CO i n  a i r for 25 -45 seconds , the an ima l s were submerged i n  offshore 
waters at  29 . 5 ° C  i n  mari ne  p lywood conta i ners . After four days , l i ver , 
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k i dney , l ungs , heart and any sangu i neous fl u i d  present i n  the  thorac i c  
cav i ty were obta i ned . These s pec i mens  were treated i n  one of two ways : 
1 )  s pec i mens were kept frozen unt i l ana l ys i s ;  o r  2 )  s pec i mens  were 
frozen unti l at  l east  24 hours pri o r  to ana lys i s  when i t  wa s a l l owed to 
thaw at a temperature of about 2 5 ° C . Gas ch romatography wa s used  for 
ana lys i s .  When  ri g i d  p reservat ion  measures  were empl oyed , no i nc rea s e  
i n  C O  l evel s were observed ; th i s wa s true whether norma l o r  s l i g h t ly  
h i gher  than norma l CO l evel s were present . However ,  s i gn i fi cantl y 
e l evated CO l evel s were found i n  the samp l es  wh i ch thawed i n  advance of  
the ana lys i s .  Th i s  i n  v i tro formati on o f  ca rbon monox i de had a l s o  been 
reported by Sjostrand ( 16 )  who hypothes i zed that one mo l ecu l e  of  CO  i s  
re l eased when each of the porphyri n r i ngs  i n  the hemog l ob i n  mo l ecu l e  
s p l i ts .  I t  was concl uded by Domi nguez et 2l. that the amount of 
carboxyhemog l ob i n i s  not s i gn i fi cantly a l tered when 1) the s pec i mens  are 
frozen unti l exami ned and 2 )  the b l ood extracted from ti ssue  i s  q u i c k ly  
ana lyzed f or  ca rboxyhemog l ob i n .  
Ma rki ewi cz ( 17 )  a l so stressed the i mportance of the cond i t i ons  
under wh i ch the samp l e conta i n i ng carboxyhemog l ob i n  i s  stored . B l ood 
s ampl es , obta i ned 24 hours  after death and conta i n i n g vari ous  amounts  of 
carboxyhemogl obi n were a l l owed to stand at  room temperatu re for v a ry i ng 
l engths  of t ime .  A modi fi ed Wol l f  p rocedure ( 18) was u sed for quant i ta -
ti on . I ncreas i n g concentrati ons  of ca rboxyhemog l ob i n were observed from 
one to s i x  days ; after t h i s i nc rea se , decreased l evel s were observed . 
I ncreased carboxyhemog l ob i n  a l s o  appeared i n  b l ood s tored i n  a refri g­
e rato r ,  but  th i s took l onger to occur  i n  compar i son to the b l ood s amp l es  
at  room temperature . Moreover ,  coveri ng  the tube  conta i n i ng the b l ood 
with  paraffi n decreased the magn i tude of these effects . Another set  of 
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experi ments i nvol ved heat i ng the b l ood to 65° C .  An even g reater  i n­
crea se  i n  carboxyhemog l ob i n  wa s found . Stud i e s  were a l so  undertaken to 
exami ne the cond i ti ons  wh i ch wou l d  favor  hemog l ob i n  degradat i on and 
therefore , i ncrea se  CO generat i on .  Condi ti ons  condu c i ve to i ncreased 
hemog l ob i n  b reakdown i nc l uded l ow pH , hemo lys i s ,  decreased part i a l  
pres s ure o f  O2, decreased cata l ase  acti v i ty and the appearance of 
perox i des . 
Recent ly , W i nek and P rex ( 19) u sed s pectrophotometri c and  g a s  
chromatograph i c  procedures to study t he  changes  i n  CO-Hb concentrat i ons  
i n  b l ood after storage for  30 and  150 days . For the most  part , g reater 
l os se s  in  CO-Hb were observed when gas  ch romatog raphy u s i ng  thermal  
conducti v i ty detecti on was emp l oyed for ana lys i s .  The s pectrophometri c 
p rocedu re worked we l l  when the b l ood wa s fres h , but pi gments formed 
duri ng  the decompos i t i on p roces s  a l tered the carboxyhemog l ob i n  and  
deoxyhemogl obi n s pectral scans . These  i nterferences are not a prob l em 
when gas chromatography i s  u sed . The overa l l l os s  of CO-Hb mi g h t  be  due 
to : oxygen compet i n g wi th CO at the i ron heme b i nd i n g  s i te of 
hemog l obi n; ox i dat ion  of  carboxyhemog l ob i n  to methemog l ob i n  and  a 
part i a l  l os s  of CO b i nd i ng  capacity . 
I t  appears that i f  b l ood conta i n i ng CO i s  permi tted to rema i n  
a t  room temperature for l ong  peri ods of t i me , changes i n  CO-Hb  
concentrat i on a re seen . However , if  the s pec i mens  a re stored at  reduced 
temperatures , then no s i gn i fi cant changes in CO-Hb concentrati on occu r .  
Moreover there i s  n o  absorpt i on of  C O  after death . 
C .  Card i a c  gl yco s i de s  
I n  1973 , I i s a l o a n d  Nuut i l a  (20) u sed a radi o immunoas say p ro­
cedu re to anal yze serum d i gox i n l evel s p reced i ng and fol l owi ng deaths  i n  
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three fata l i t i es i nvo l v i ng an overdose of  d i gox i n .  I n  one case , a 
greater than th ree fo l d  i ncrease  was observed i n  the concentrati on  of  
d i gox i n  i n  t he  postmortem serum sampl e when compared to  a p remorten 
samp l e .  One of the other two cases a l so  showed th i s effect; however ,  i t  
was l es s  pronounced . An " accumu l ated absorpt i on "  was g i ven by the  
authors  as  the cau se  for th i s postmortem i ncreas e  in  d i goxi n 
concentrati on . No further  exp l anati on of the term " accumu l ated" 
absorpti on wa s g i ven by the authors . 
Sel e s ky et �. ( 2 1 )  studi ed fi fteen fatal i t i es i n  wh i ch there 
wa s a h i story of d i gox i n u se . I n  the on ly  case  i n  whi ch  there wa s a n  
antemortem a n d  postmortem b l ood sampl e ,  no  d i fference i n  t h e  d i g ox i n  
concentrati on between the two samp l es  was observed . Th i s  f i nd i n g  was  i n  
ag reement wi th Ho l t and  Bernstead ( 2 2 )  who stated that e l evated po st­
mortem concentrati ons  of d i goxi n probab l y  refl ected e l evated l eve l s 
before death . Both g roup s  u sed radi o i mmunoassay for di goxin ana l ys i s .  
�oreover ,  because  they observed a cons i s tently h i gher l evel  i n  heart 
b l ood than i n  b l ood from the femora l vei n ,  they recommended that b l ood 
from the femoral vei n be used  for any retrospecti ve ana lys i s .  
To reconc i l e  these d i screpanc i es , Vorpah l  and Coe ( 2 3 ) con­
ducted a thorough  study to  correlate antemortem and postmortem d i gox i n  
concentrati ons . U s i ng  samp l es  from 2 6  autops i e s , they found that  the  
average postmortem serum d i goxi n concentrat i o n s  was s i gn i fi cant l y  h i gher  
in  sampl es  obta i ned from the heart , subc l av i an ve i n ,  and  femora l  v e i n 
than the antemortem l evel s .  Rad i o i mmunoa s s ay wa s u sed for quant i tati on . 
Furthermore , a l l postmortem heart serum l evel s were g reater than  ante­
mortem heart serum l evel s when the postmortem i nterva l  exceeded one 
hou r .  Assumi ng that 2 ng/ml  is  a tox i c  serum d i gox i n  concentrat i on , 48% 
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o f  the cases wou l d  have been d i agnosed a s  v i cti ms of d i gox i n  tox i c i ty i f  
the antemortem val ue  was u sed ; thi s percentage wou l d  i ncrea se  to 89% i f  
the postmortem card i ac  s"erum va l ue wa s used . "I t  was hypothes i zed that  
after  death , the equi l i br i um of drug  between b l ood and t i s sue  changes  
such  that  the  drug  l eaves the  t i s sue  and enters  the nearby s u rround i n g  
b l ood . Analys i s  of v i treous  humor showed t hat  i n  contrast  to serum 
d i gox i n  l evel s ,  v i treous  humor d i gox i n  l evel s u s ua l l y  decreased i n  the  
postmortem peri od in  compari son to the " antemortem" peri od . However ,  
when a n  e l evated postmortem v i treous  humor d i gox i n  l evel  was found , i t  
wa s i nd i cati ve of antemortem tox i c serum l evel s .  They conc l uded that  a 
comb i nati on of femora l venous serum and v i treous  h umor a re mos t  
i nd i cati ve of antemortem d i gox i n  tox i c i ty .  
Aderj an e t  21. ( 24 )  corroborated much o f  th i s work , obta i n i ng 
b l ood samp l e s  from pati ents before death and wi th i n  thi rty mi nutes  
fol l owi ng death . At autopsy , b l ood samp l es  from the l eft ventri c l e and  
femora l ve i n  were secu red . Al l of these pat i ents di ed from cau ses  other 
than di g i ta l i s  overdose . U s i ng a s pec i a l i zed radi o immunoa s s ay 
procedure , they found that i n  none of these cases  were there s i gn i fi cant 
changes in  di g i ta l i s  concentrati on between the b l ood obta i ned pr i o r  to 
death and that obta i ned th i rty mi nutes after death . However , when these  
s pec i mens were compared to the  heart b l ood s amp l es obta i ned at  autopsy , 
s i x  of the e i ght hea rt b l ood spec i mens  were s i g n i f i cantl y higher than 
the antemortem b l ood l evel s ;  in  the other two cases , e s senti a l l y  no  
changes  were  noti ced . On the other hand , the femoral ve i n d i gox i n  
concentrat ions  were on ly  s l i ght ly  i ncreased a t  autopsy i n  compa r i son  to 
the antemortem b l ood concentrati ons . As wi th  Vorpah l  and  Coe , the 
expl anat i on  of Aderjan et 21. for thei r observati ons was that a new 
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equ i l i bri um between t he  b l ood a nd  t i s sues  wa s e stab l i shed after death . 
Among  those t i s s ue stud i ed ,  those ma i n l y  i nvo l ved i n  th i s  redi str i but i on  
were the heart and the kidneys . 
The data col l ected on card i a c  g l ycos i des  c l early i nd i cates  
that changes  in  b l ood concentrati ons  do occur  after death and that  the  
s i te of acqu i sit i on i s  very i mportant to the i nterpretati on of  resu l ts .  
The cause of these changes i nvo l ve a postmortem redi stri buti on of  
cardi ac  g lyco s i des  between the heart and nearby b l ood such that there i s  
a decreased card i a c  g lycos i de concentrati on i n  the heart and a g reate r 
concentrati on i n  the s u rroundi ng  b l ood . S i nce medi ca l  exami ners u s u a l l y  
obta i n  thei r b l ood spec i mens  from the heart, i t  wou l d be  recommended 
that in those cases  where d i g i ta l i s  tox i c i ty i s  s u spected , a b l ood 
samp l e from the femoral vei n and v i treous  humor  a l so  be obta i ned . 
D .  Coca i ne 
S i nce coca i ne has  an e ster  l i n kage and s i nce there a re var i ous  
esterases  i n  the  b l ood , i t  wou l d be rea sonab l e to expect that  the  
concentrati on of coca i ne i n  b l ood wou l d  change  i n  fresh ly  removed 
postmortem b l ood . Thi s wa s s uggested by Jat l ow and Bai l ey ( 25 ) who 
u s i ng gas ch romatography-ni trogen detecti on found that after 1 5  mi nutes  
and 30  mi nutes a t  room temperature , plasma cocaine concentrations  
decreased by  6 . 5% and 12 . 5% res pect i ve l y .  Moreover , the  rate of  l os s  of  
coca i ne wa s approx i mate ly  doub l ed at 37 ° C .  Twenty fou r hours  afte r 
b l ood storage at e i ther - 1 5 ° C  or  on so l i d  CO2 , vary i n g  decreases  i n  
b l ood coca i ne concentrati on to a max i mum o f  30% were observed . H owever , 
when the extract res i dues  were s tored i n  a des i ccator a t  - 1 5 ° C , no  
decreases were observed for  at  l ea st  7 2  hou rs . These obervati ons  we re 
made du ri ng the devel opment of a sens i ti ve ana lyti cal  method for  the  
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detect i on of coca i ne i n  p l asma . D i vori ch i k (26) reported t hat  the  rate 
of hydro lys i s  of coca i ne was s l owed if b l ood samp l es were i mmed i a te l y  
i ced u pon col l ecti on . Furthermore , by q u i ck-freez i ng the s ampl es i n  
l i qu i d  n i trogen wh i l e  shak i ng the tubes , the sampl e can b e  stored a t  
- 1 5 ° C  f o r  at l east s i x  weeks wi thout any change i n  coca i ne 
concentrati on . 
Tayl or  et �. ( 27 )  i ncubated serum conta i n i ng 14C and 3H 
l abel ed coca i ne at 3 7 ° C  and determi ned the metabo l i tes formed us i ng gas 
ch romatog raphy . After one hou r ,  20% of the coca i ne was converted to 
benzoyl ecgon i ne , ecgon i ne ,  and ecgon i ne methyl este r ;  the ecgon i ne 
methyl ester was present i n  the h i ghest concentrati on . After fou r hours 
of i ncubati on , two-th i rds of the coca i ne was hydro l yzed ; th i s  t i me , 
benzoyl ecgoni ne was the maj or  brea kdown product . 
The above fi ndi ngs were d i s puted by Stewa rt et a l . ( 28 )  who 
found no s i gn i fi cant coca i ne deg radati on when pl asma samp l es forti f i ed  
wi th l abel ed coca i ne were stored for four days at - 1 5 ° C .  They hypothe­
s i zed that the fi ndi ngs of Jatl ow and Ba i l ey cou l d be expl a i ned by the 
al ka l i ne pH ( 9 . 8 )  in wh i ch the coca i ne was extracted . The i r experi ments 
showed that cocai ne was rap i d ly  converted to benzoyl  ecgon i ne at  that  
pH . Th i n- l ayer ch romatography was emp l oyed to separate metabo l i tes . 
They determi ned that the convers i on of coca i ne to ecgon i ne methyl ester 
in  human plasma occurs enzymat i ca l l y  through the acti on of p l asma 
chol i nesterase . However , there is no detectab l e enzymati c convers i on of 
coca i ne to benzoyl ecgon i ne in human p l asma . These data wou l d i mp l y  that 
the ecgoni ne methyl ester shou l d be the only s i gn i fi cant metabo l i te 
produced from coca i ne by human p l asma . 
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The most  deta i l ed ana l ys i s  of the � vitro hydro l ysis of 
coca i ne in  b l ood was reported by Base l t ( 29 ) . U s i ng a gas  
ch romatographic method, he found that at  a coca i ne concentration of  . 1  
mg/ L  i n  refri gerated and nonfl uori dated b l ood no detectabl e amount  of  
cocaine wa s observed by  day 8 .  However, if the b l ood was refrige rated 
and fl uoridated wi th  . 5% sod i um fl uori de, 40-60% of the coca i ne  cou l d  be  
detected th ree weeks  after the addit i on of coca i ne to the b l ood . A 
simi l a r pattern wa s observed when a coca i ne concentrati on of 1 mg/ L  was  
u sed . I n  refri gerated, fl uori dated sampl es, 80% of the ori g i na l  amount  
of coca i ne wa s sti l l  present . Moreover, the hydro l ys i s of coca i ne was  
found to be temperatu re dependent ; a greater rate of d i sappearance of  
drug was observed in  fl uoridated b l ood stored at  room temperature a s  
opposed t o  fl uori dated b l ood stored i n  a refri gerator .  
Because  pl a sma chol inesterase  rema i n s  act i v e  i n  b l ood i n  
v i tro, proper s pec i men preservati on i s  req u i red to ensure sampl e 
i ntegri ty .  Freezing samp l es  at - 1 5 ° C  i mmedi ate ly  upon rece i pt h a s  been 
s hown to del ay coca i ne b rea kdown . Sod i um fl uori de, an esterase  
i nh i b i tor as  we l l a s  a mi croorgan i sm i nhib i tor, can a l so  del ay coca i ne 
brea kdown . 
E. Cyan i de 
Decreases  i n  postmortem concentrati ons  of cyan i de ( CN -) i n  
b l ood and tis sues  were first reported by Curry ( 30 )  in 1963 . In one 
fatal ity resu l ti ng  from i nha l at i on of gaseou s hydrocyan i c acid, a b l ood 
s ampl e taken at death showed a cyan i de concentrati on  of . 35 mg/ 100 ml 
wh i l e  a b l ood sampl e taken the next day at  autopsy revea l ed a cya n i de 
concentrati on of . 05 - . 1  mg/ 100 ml . A mi crodiffu s i on separa tion 
techn i que wa s coup l ed wi th a col o rimetri c procedu re for ana l ysis . There 
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h a v e  been severa l  mechan i sms proposed for th i s postmortem d i s appearance 
of cyan i de .  The mos t  obv i ou s  i s  the convers i on of cyan i de to the 
natura 1 1 y occurri ng  metabo1  i te th i ocyanate i on ( CNS -) .  Ba l l antyne et  
�. ( 3 1) added sma l l amounts of pota s s i um cyan i de to human and  rabb i t  
serum and after one hour, on ly  between 3 1  and 44% of th i s added amount  
was  detected a s  CN - . An  i ncreas e  i n  CNS- was found , but  not enough  
to compl ete ly  account  for  th i s  drop  of CN - l evel s .  However, when 
these experiments were repeated w i th who l e  b l ood a much s l ower decrease  
i n  CN - l evel s were observed . Th i s suggested that CN - had a h i gh 
affi n i ty for red b l ood ce l l s ;  th i s  wa s demonstrated by other workers 
( 32, 33, 34) . Moreover, they reported that 62 -74% of cyan i de was s t i l l  
detected i n  whol e b l ood after 24 hours, apparent ly  i n  agreement  w i th the 
observation of Barr ( 32) that cyan i de i s  70% bound to red ce l l s .  As 
wi th  serum, onl y a percentage of the cyan i de not accounted for appea red 
as th i ocyanate . Proposed mechan i sms for decreases  in cyan i de 
concentrat i on inc l uded a hydro l ys i s  reacti on  to form ammon i um formate 
( 35) and convers i on to ami noma10notri l e  ( 36, 37, 38, 39) . 
Further work by Ba l l antyne and coworkers ( 39 )  i l l u s trated the 
di fferences between removal  of b l ood i mmed i ate ly  after death and  stored 
versus removal of b l ood at vari ou s  ti mes after death. They demon strated 
that s i gn i f i cant amounts  of cyan i de were detected at three weeks  when 
the b l ood was removed at  death and stored at  10- 1 5 ° C .  When the  b l ood 
rema i ned in  the body until ana l y s i s, the amount  of cyan i de detected i n  
b l ood decreased duri ng  the fi rst wee k  after death such  that  o n l y  about  
30% of the amount of CN- present at  death  was detected a s  CN - . By 
the end of the second week, l e s s  than 3% of the CN - ori g i na l l y  present  
was detected ; by  the end of 2 1  days, CN- was bare ly  detected . They 
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comb i ned a n i trogen aerati on method for separat i on w i th 
s pectrophotometry for CN quanti tati on . They hypothes i zed that  these  
d i fferences were probabl y  due to autolys i s  and putrefacti on tak i ng p l ace  
in  the i ntact body , thus  prov i d i ng many poss i b l e  routes of  
transformati on for  cyan i de .  These  researchers s uggested that s p l een i s  
the t i s sue of choi ce for the ana l ys i s  of cyan i de when there has  been 
some t ime between death and the acqu i s i ti on of spec i mens . 
Naroyanaswan i  et� .  ( 40 )  added CN- t o  the stomach  and  
fol l owed i ts d i sappearance wi th t ime at room temperature . Quant i tat i n g  
by  a UV s pectrophotometri c procedure , they found t hat  there cou l d  be  a 
60% decrea se  i n  CN- concentrati on wi th i n  2 hours after add i ti on  to the  
s tomach . The  pH of the s tomach was 6 . 5 .  After 20 days , approx i ma te l y  
80% o f  the added CN w a s  not detected . When the pH of the s tomach  wa s 
8 . 0 , on ly  10% of CN d i sappeared after 20 days . The authors 
recommended the storage of v i s ceral  t i s sues  in a l ka l i ne med i um to 
prevent the l os s  of CN  from postmortem samp l es . 
Bes i des these observati ons  of decreased concentrat i on s  of  
cyan i de wi th t ime , i ncreases  in  cyan i de concentrati on have a l s o  been ob­
served . Bernt �� . ( 41) found that b l ood and gastri c contents  not  
conta i n i ng cyan i de y i e l ded s i gn i fi cant amounts  of cyan i de when  ana l yzed 
two to four weeks  after storage at  4 °C . However these fi ndi n g s  were not 
dupl i cated when the b l ood and gastri c contents were i ncubated for the 
s ame l ength of t ime at  37 ° C .  Gett l e r  and Ba i ne ( 42 )  u sed co l or i metry 
and found i ns i gn i fi cant postmortem producti on of cyan i de at room 
temperature . Curry et� . ( 43 )  d i d  exhaust i ve exper iments  u s i n g  v i s i b l e  
spectrophotometri c methods to c l ari fy the postmortem synthe s i s of  
cyan i de .  Among thei r res u l ts were the fol l owi ng : 1 )  cyan i de product i on 
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can  o ccur  i n  b l ood even  when no bacteri a were present i n  the b l ood ; 2 )  
s pec i mens  wh i ch were sou rces of postmortem cyan i de producti on  i nc l uded 
bra i n, l i ver, k i dney, uterus, gastri c contents, and i ntest i n a l  contents ; 
3 )  fl uori de i nh i b i ted the producti on  of cyan i de i n  b l ood ; 4) b l ood 
enzymes and Pseudomonas  pyocyaneus  were the probab l e  causes  of  cyan i de 
product i o n ; and 5) the b l ood enzymes worked better i n  the produ ct i on  of  
cyan i de at 3 7 °C  whi l e  t he  bacteri a produced more cyan i de at  4 ° C  t han  
37 ° C .  
To s umma ri ze, the maj ori ty o f  the data s uggests  that decreases  
i n  cyan i de concentrat i o n  occur  i n  postmortem b l ood and ti s sues . Some of  
the cyan i de cou l d  be converted to th i ocyanate or  l ost  as  hydrocyan i c  
ac i d ( HCN ) .  An important  fact to cons i der  i s  the pH of the spec i men ; i n  
a n  ac i di c medi um, more of the cyan i de wou l d  b e  l ost  a s  HCN . 
F .  Ethanol 
I t  i s  not s u rpri s i ng that much of the work that has  been done 
on postmortem changes in  dru g  concentrati ons  ha s been done on  ethano l . 
A rev i ew of postmortem changes i n  ethanol  concentrati on was wri tten by 
Parker ( 44) i n  1974 whi l e  Corry ( 45) devoted pa rt of her rev i ew on  
sou rces of antemortem and postmortem ethanol  to d i scuss  the postmortem 
producti on of ethanol . 
Evidence for postmortem product i o n  of ethanol  dates b a c k  to 
1935 when Nicloux (46) found that mi ce wh i ch had  no  ethanol  before death 
produced as  much a s  100 mg/ 100 g of ethanol after death . The actua l 
amount  of ethanol  produced depended on the temperature and condi t i on of 
sto rage of the bodi es . Ni c l oux ( 47 )  a l s o  pub l i shed the earl i es t  work 
done wi th human corpses ; in three cases in wh i ch there wa s no e v i dence 
to s u ggest that the peop l e invo l ved cons umed a l cohol  pri or  to death . 
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Concentrati ons  of ethano l  i n  t i s s ues  ran g i ng  from 40-132  mg/ 100 g were 
found . The method of ana lys i s  u sed by N i c l oux i nvol ved tri p l e s team 
d i sti l l ati on wi th vari ous c l ean-up  steps to remove other vo l at i l e  
materi a l s .  
After N i c l oux, severa l  other researchers have s tud i ed  th i s 
effect u s i n g  a n ima l s .  I n  1971,  Nar i kawa and Kotoku ( 48 )  u sed g a s  
chromatograph i c  methods to  obta i n  t he  fol l ow i n g  resu l ts :  1 )  a max i mum 
of 100 mg/ 100 ml ethano l  wa s produced i n  the i ntraperi toneal  fl u i d  of 
mi ce i ncubated at  30° C  i n  a i r for 4-5 days ; 2 )  g reater postmortem 
ethanol  concentrati ons  were found when g l u cose  was i nj ected i nto  mi ce 
before death ; 3 )  u s i n g  rabb i t  corpses, they found that after 7 days at  
1 5 ° C, ethanol  concentrati ons  were h i gher  in  pl eural  fl u i d  and  card i a c  
b l ood than i n  femora l ve i n  b l ood and v i treous  humo r .  Davi s et� . ( 49 )  
determi ned that even under steri l e  cond i t i ons, ethanol  wa s detected i n  
b ra i n, l i ve r ,  and l ung  of mi ce after 5 days . However, n o  ethano l  was  
found when germ-free mi ce were u sed, imp l y i n g  that postmortem ethano l  
producti on wa s due  to mi croorgan i sms . I ri be et a l . ( 50 )  confi rmed the  
work of these  two groups  and found that rats  b urned to death  showed l es s  
ethanol  producti on than d i d  control rats . 
Redetzki et�. (51) used enzymatic methods of analys i s  to de­
monstrate that sma l l er amounts  of ethanol  were produced postmortem i n  
h uman s  i n  the extremi t i e s  than i n  the deeper s i tes . Th i s  was veri fi ed 
by Wol thers ( 52 )  who sa i d  that sma l l er amounts  of newl y produced ethano l  
in  the peri phery were probab l y  re l ated to the amount  of a va i l a b l e  oxygen 
and to s l ower cool i n g  of t i s s ues  i n  the extremi t i es . P l euckhahn  ( 5 3 )  
gave a range o f  ethanol  concentrat i ons  i n  h uman heart b l ood from e i ght  
putrefi ed bod i es of 33- 127 mg/ 100 ml ; i n  h a l f of these  cases,  it  was  
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known that the i ndiv i dual  d i d not cons ume ethanol  before death . 
Moreover , the concentrati ons  of ethanol  in femora l b l ood wa s l ower than  
in b l ood from a deep  t i s s ue, the heart . Gonza l es  et� .  ( 1) ob served an  
i ncreased ratio of l i ver  ethanol  concentrat i on to b ra i n  ethanol  
concentration in  putrefi ed bod i e s  that were s u bmerged a s  opposed to 
bodi es  putrefying in a i r .  Gormsen ( 54) reported that in an  autopsy of  a 
person not consumi ng  ethano l  prior to death , a b l ood concentration of 20 
mg/ 100 ml and gastri c concentration of 230 mg/ 100 g were found 20 hours  
after death . Var i ous  fungi  and yeast  were observed to be present a l s o . 
I n  a subsequent paper ( 55) , Gormsen stated that un l e s s  a l cohol  i s  found 
in  urine as  wel l a s  in b l ood and t i s sues, any a l cohol  concentration 
detected i s  mean i ng l e s s  i n  determining whethe r  a l cohol  was present pr i or  
to death . O ' Tool e et� . ( 56 )  ascertained that under steri l e  
condit i ons , human body tis sues  rema i ned free of bacteri a and fun g i  for 
at  l east  twenty hours after death . Moreove r, they s uggested that  
postmortem ethanol  producti on  is caused by peri mortem i nfect i on s  or  
other  contami nati ons  rather than  mi croorganisms exi s t i n g  i n  the body 
before death . 
C l ark and Jones  ( 57) stud i ed postmortem ethanol  p roduction i n  
2 6  h uman cadavers which were refri gerated with i n  4 hours after death . 
In no  b l ood wa s an ethanol  concentrati on g reater than 100 mg/ l  found at  
autopsy (3-27 hours after refri gerati on) ; this  wa s true whethe r  the 
b l ood gave a pos i t i ve or  negati ve b l ood c u l ture . 
Bes i des  the work done on i ntact a n i ma l  and human bod i es, many 
researchers have stud i ed postmortem product i on of ethanol  in iso l ated 
t i s s ues . Fre imuth et� . ( 58) a l l owed isol ated human b l ood, b rain, and  
l i ver  not previou s l y  contain i ng ethano l  to s i t  at 20 -26 ° C  for th i rteen 
20 
days . The l owest  amount  of ethano l  wa s produced i n  the b l ood ; the  
greatest amount of ethanol  was produced in  the b ra i n .  Moreover, 
refri gerated samp l es  produced l es s  ethano l . Th i s l atter fi nd i n g  was  
confi rmed by  Gonza l es  et� .  ( 1 ) . More of  these types o f  data have  been  
s ub sequent ly  reported ( 59-62) . 
P 1 ueckhahn and Ba l l a rd ( 63) attempted to i so l ate s ome of  the 
mi croorgan i sms wh i ch were i nvol ved in  the postmortem producti on  of 
ethano l . Among  those organ i sms wh i ch were ab l e to ferment  g l ucose  and 
other reduci ng  substances were I. col i ,  Streptococcu s feca1 i s, P roteu s  
�., a nd  Candi da� . However, on ly  aerob i c organi sms were i so l ated i n  
th i s  study .  B l ackmore ( 64) i so l ated those organ i sms that produced 
ethanol  from the bodi es  of crew members from a crashed a i rp l ane . 
Moreover after i so l ati on, these organ i sms were added to med i a  conta i n i ng 
carbohydrates and ami no  ac i d s  to determi ne  the ab i l i ty of each o rgan i sm 
to produce ethanol . 
B l ood, u n l i ke other t i s s ues, can have chemi cal s added to i t  to 
del ay or  prevent postmortem changes . Several stud i e s  have been u nder­
taken to study the ab i l i ty of vari ous  chemi ca l s  to prevent changes i n  
a l cohol  concentrat i on . I n  1965, Gl enden i ng and  Waugh ( 65) used  sod i um 
fl uori de and potas s i um oxal ate as preservati ves and found no  s i gn i f i cant  
pos tmortem producti on  of a l cohol  i n  three month s . Tes t  tubes  sea l ed  
with  b l ack-rubber stoppers were u sed to store the b l ood . B radford ( 66 ) , 
u s i n g  sodi um n i trate and mercu ri c ch l ori de as a preservati ve, found  no 
change i n  a l cohol  concentrati on  over s i x  mon th s . However, i f  sod i um 
fl uori de wa s u sed i nstead of mercu ri c ch l ori de, both i ncreases  and  
decrea ses  in  b l ood a l cohol  concentrati on  we re observed . P 1 euckhah n  (53) 
stated that i n  bl ood s amp l es  obta i ned from an autopsy, no l es s  than  5 mg 
2 1  
of  sodi um fl uori de per mi l l il i ter  o f  b l ood s hou l d  b e  added for proper  
preservation . Fu rthermore , samp l e s  mu s t  be  stored be l ow 6 ° C  i f  the  
ana l ysis is not done within twenty-fou r hours  fol l ow i n g  col l ect i on . 
Ru s se l  ( 67 ) observed decrea ses  i n  b l ood a l cohol  concentrati on with . 7 5% 
w/V potas s i um oxal ate , both i n  the presence and absence of . 25% w/V  
s odium fl uori 'de . B l ood samp l es  were s tored at 4-6 ° C  for u p  to five  
weeks . However ,  t he  sampl es  n ot  containing fl uoride showed greater 
decreases  in a l cohol  concentrat i on . Hayden et� . ( 68 )  found upon  
reana l ys i s of 200  b l ood samp l es  stored at  4°C  for 30 to 50 days , no  
s i gnificant changes in  b l ood a l cohol  concentrat i on  occu rred . F l u o ride 
and oxal ate were u sed as the preservative . Some sampl es  a n a lyzed after 
refrigerated s torage for one yea r showed no  significant changes in 
a l cohol  concentration . 
Brown et a l . ( 6 9 )  studied the stabil i ty of ethanol  i n  s tored 
b l ood u s i ng three parameters -temperature , fl uor i de concentrat i on , and 
t i me .  They interpreted the i r observed l os se s  of ethanol  in terms of 
th ree mechanisms : 1 )  temperatu re-dependent ox i dati on  of ethano l  to 
aceta l dehyde ; 2) mi croorganism destruct i on  of  ethanol in the absence  of 
fl uoride , and which cou l d be prevented with . 5% w/V s od i um fl uo ride ; and  
3 )  di ffusi on from polypropylene cups used for storage of b l ood i n Great 
B rita i n .  
Postmortem diffu sion o f  a l coho l from tis sues  t o  surrounding 
b l ood ha s been studied by several researchers . I n  1949 ,  Bowden and 
McCa l l um ( 70) reported diffu sion from the s tomach to heart b l ood , but 
there were some probl ems wi th the i r data . I n  1956 , Gifford and Turkel  
( 7 1 ) introduced 86 proof wh i s key into the stomach of cadavers  between 1 
and 55 hours fol l owi ng  death . The bodies were then autop s i ed between 1 0  
22 
and  24 hours . l ater .  A b l ood sampl e was taken from the femora l ve i n  and  
from vari ous parts of the heart before and  after the i ntroduct i on  of  a l ­
cohol . S i gn i f i cant  d i ffus i on of a l coho l  from the stomach  to the  heart 
wa s observed ; no change i n  a l cohol  concentrati on  was observed i n  the  
femoral  vei n .  I n  a subsequent study ( 7 2) ,  b l ood s ampl es  were obta i ned 
from the femoral vei n and from the heart in  75  autops i es .  Of the  5 1  
cases  wh i ch s howed the presence o f  a l cohol  i n  the b l ood, 3 5  o f  these had  
card i ac  bl ood wi th  a h i gher  a l cohol  content than femoral b l ood, pre­
sumab ly  due to postmortem d i ffu s i on of a l coho l  from the stomach . From 
the i r fi ndi ngs , they suggested that i n  postmortem cases , b l ood from the 
femora l vei n s hou l d be  u sed to obta i n  a b l ood a l cohol  concentrat i on  at  
the t ime of death . P l uekhahn  ( 53 ) d i d s i mi l a r experi ments wi th  over  200 
cadavers and col l ected b l ood from va ri ous  s i tes  throughout the  body . 
Postmortem d i ffu s i on of a l cohol  was found to occur from the stomach  i nto  
the peri ca rd i a l  fl u i d  and the pl eura l  fl u i d  wi th i n  several  hours  after 
death . However ,  a l cohol  concentrati ons  i n  b l ood from the i ntact 
chambers of the heart rema i ned the same for up  to 48 hours fol l ow i n g  
death . 
I n  concl u s i on , there i s  a l a rge amount of data i l l u s trat i n g 
the postmortem production of ethanol  by a w i de range of mi croorgan i sms 
i n  b l ood and in t i s s ues . Th i s  mi croorgan i sm acti v i ty can be  i nh i b i ted 
by the add i t i on o f  one of several chemi cals to the  b l ood . When  a nalysis 
of b l ood for ethanol  was performed i n  the absence of these  chemi cals, i t  
i s  important  to cons i der  ethanol  concentrati ons  i n  ur i ne, v i treou s  
h umor, or  t i s sues  to  ensure proper i nterpretati on of the  b l ood ethanol  
concentrati on . 
G .  Methaqua l one 
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Kaefers te i n  ( 7 3 )  stud i ed the effects of putrefact i on on  t i s s ue 
concentrations  of methaqual one u s i ng gas  chromatography , Methaq u a l one  
concentrations decreased by 28%  in  b l ood , kidney , and b ra i n  after 26  
months  of l aboratory s torage fol l owi ng removal  from a fresh  cadaver .  
Refri gerated storage of the ti s s ues  retarded these changes . A b ra i n  
homogenate stored a t  30 ° C  for 9 weeks  showed n o  change i n  dru g  
concentration . 
H .  Methyl pheni date 
� v i tro hydro l ys i s  of methyl pheni date to a-phenyl -a-p i peri ­
d i ne  acet i c aci d i n  u rine wa s stud i ed by Schubert ( 7 4 ) . U s i ng  th i n  
l ayer and gas chromatog raphy h e  found that when the u ri ne was stored  at  
2 1 ° C , on ly  3 2%  of t he  methy l pheni date added to t he  ur i ne rema i ned i ntact 
wh i l e  74% of the methyl pheni date was unchanged when the ur i ne wa s stored 
at 4 ° C . 
24 
I .  Narcoti cs 
I t  had been known for a l on g  t ime that � v i tro deacety l a t i o n  
of hero i n t o  monoacety l mbrph i ne occu rs very rap i d l y  i n  b l ood ( 75 -7 7 ) .  
Na kamura et� .  ( 7 8 )  studi ed � v i tro hydro l ys i s  of hero i n  i n  h uman 
b l ood to determi ne the rate of degradat i on and producti on of h uman 
metabo l i tes . Fresh  b l ood and serum obta i ned from a norma l ma l e  subj ect, 
and postmortem, hepari n i zed whol e b l ood were u sed i n  the experi ments . 
To these phosphate b uffered ( pH 7 . 4 )  l i qu i ds were added known amounts  of 
hero i n  hydroch l ori de and i ncubated at  37 . 5 ° C .  At vari ous  t i me 
i nterva l s, a l i quots of the serum or  b l ood were removed and ana l yzed for 
hero i n  and i ts metabo l i tes  by gas  chromatography . Hydro l y s i s of  h ero i n  
occurred twi ce a s  fast i n  who l e  b l ood than i n  serum ; the ha l f- l i fe i n  
who l e b l ood was 9 mi nutes whi l e  i t  was 22 mi nutes i n  serum . Moreover , 
i n  serum, no cl eavage of 6 -monoacetyl morph i ne was observed wh i l e  i n  
whol e b l ood , the hydro l ys i s  conti nued , res u l t i n g  i n  the format i on of  
morph i ne .  Nonethe l e s s, i n  both serum and who l e  b l ood, the concentrati on  
of 6 -monoacety l mo rph i ne was rel at i vel y l a rge, suggesti n g  that postmortem 
b l ood sampl es  shou l d  be  exami ned for monoacety l mo rph i ne i n  hero i n  
overdoses . 
Ga rrett and GU rkan ( 7 9 )  u sed dog p l asma to o bta i n  further i n ­
format i on on the  hydro l ys i s of hero i n .  I n  the absence o f  a pre serva ­
t i ve, t he  apparent ha l f- l i fe of hero i n  wa s 8 mi nutes . T he  add i ti on of  
10 mg of sodi um fl uori de i ncreased the h a l f- l i fe to 40 mi n utes ; 
tetraethyl pyrophosphate a l so  i ncreased the ha l f- l i fe of heroi n .  When 
hero i n  was added to p l a sma kept at  room temperatu re for twenty -four 
hou rs, no  s i gn i f icant  l os s  of hero i n was observed thus  i nd icat i n g  that 
the enzyme system i nvol ved i s  rapi d l y  i nact i vated at  room temperature . 
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Garrett and GUrkan confi rmed the fi nding s  of  Na kamura et� . i n  that  the 
maj o r  product observed in the p l a sma was 6 -monoacety l morph i ne .  
The enzyme system respon s i b l e for the hydro l ys i s  of h ero i n was  
e l uc i dated by  Smith and Co l e ( 80) . I t  had  been prev i ou s l y  determi ned 
( 76,77) that chol i nesterase  probab l y  wa s not i nvo l ved in  the degradat i on  
of heroi n .  They concl uded that  an  aryl e sterase, one  of a group  of  
esterases which hydro l yze phenol i c  e sters on l y ,  was respons i b l e  for the 
hydro l ys i s of hero i n in  human p l a sma . Furthermore, s i nce on ly  30-35% of  
hero i n hydro l ys i s  occu rred in  the p l a sma , there were esterases  present  
on the outer  s urface of the red  b l ood cel l s  to account  for  the remain i ng 
a b i l ity to hydro l yze hero i n .  
Frans i o l i et a l . ( 8 1 ) studied the detectabil i ty o f  methadone 
and propoxyphene in  frozen and forma l i n -fi xed tis sues  at vari ou s i nter­
va l s fol l ow i n g  autopsy . Using EMIT  R and gas  ch romatography for quant i -
tati on , they examined b ra i n, k i dney, l i ver, l ung, and spl een . I n  
genera l , decreases  in drug concentration over a two year span were 
observed i n  a l l t i s s ues . However in those  t i s sues  i n  wh i ch drug was  
ori g i na l l y  found, it  wa s stil l detected after th i s t ime peri od . Since 
th i s  study was retrospect i ve in natu re, the ori g i na l  t i s s ue 
c o n c e n t ra t i o n s  were n o t  obta i ned . 
Bednarczyk  et� . (82 ) noted a g reater than 2 . 5  fo l d  i nc rea se  
in  the  b l ood concentration of propoxyphene and a fou r fo l d  increase  i n  
norpropoxyphene when comparing premortem b l ood concentrat i on s  and  post -
mortem b l ood concentrat i ons . Even though the pat i ent  wa s on a resp i ra -
tor for over two days after i ngestl on before death occurred , the a u thors 
ru l ed out  the pos sibi l i ty of conti nued drug absorpt i on  fol l owing ho s pi­
ta l ization . I n s tead , they s uggested that duri ng  the "induced s tate of 
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s i mu l ated l i fe " ; organ necros i s  caused the re l ease  of drug ori g i na l l y  
bound to ti ssues . Furthermore, empha s i s  wa s pl aced on the tox i co l og i c 
i nterpretati on of postmortem sampl es  when the v i ct i m  wa s on a res p i rator  
for a l ong  peri od of t i me .  
J .  Pancuron i um 
W i ngard et� . ( 83) stud i ed the effect of s torage on  a s erum 
so l uti on  of .5  mg/ l  pancu ron i um .  Emp l oy i n g  a fl uorometri c procedu re, an  
i n i t i a l ana lys i s  of the  serum so l u t i o n  was made . Sampl es  from th i s so­
l ut i on were removed, frozen, and ana l yzed at  vari ous  t ime i nterva l s fol ­
l owi ng  freez i n g .  They observed that fl uores cence read i ngs were s i gn i fi ­
cantl y l ower wi th i n  a twenty-fou r hour  peri od . The authors d i d  not  know 
whether thi s change i n  fl uorescence was due to drug instab i l i ty or to 
some other facto r .  Pok l i s  and  Me l anson  ( 84 )  stud i ed the effects of 
storage on pancuron i um concentrati ons  in  postmortem b l ood, serum, and 
uri ne . Sampl es  were stored in  a refri gerator and al i quots we re removed 
and ana l yzed over a 10 day peri o d .  Wh i l e  u ri ne s howed s l i ght  decrease  
over  a week peri od, a sharp decrease  i n  t he  serum concentrati on  of 
pancuroni um was observed . Decrease in  the postmortem b l ood con­
centrati on of pancuron i um was dramati c, but  i ncon s i stent . The fact that  
decreases  were observed in  serum and b l ood, but  not ur i ne, s uggested to  
the authors that i rrevers i b l e b i nd i n g  of the drug  to b l ood components  
had occu rred . Nonethe l es s, they concl uded that u se  of the blood for 
i denti fi cati on of the drug i s  u seful . They recommended the  analy s i s of 
pancuron i um be  done a s  q u i c k ly  a s  pos s i b l e upon recei pt of  the s pec i men . 
K .  Pestl c i des 
Kyofuj i ( 85 )  examl ned the postmortem stabi l i ty of vari ous  
groups  of pesti c i des i n  many b i o l og i ca l  fl u i ds and t i s sues . B a s i ca l l y, 
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he  tound that organ i c  phosphate pest i c i des such  as  parath i on, d i a z i non  
and ma l athi on, showed rap i d decreases  i n  t l s s ue concentrati on  to the  
po i nt where on ly  7 - 16% of the org i na l  concentrati on rema i ned after 7 
days . Moreover, endri n and ruberon  concentrati ons  decreased by bo-70% 
over a week peri od . Converse l y, other o rgan i c ch l orl ne pesti c i des, s uch  
a s  hexachl orocyc l ohexane and pentach l oropheno l , were more s tab l e over  
the same l ength of t ime .  Tsunenari et� . ( 86 )  s tudi ed the postmortem 
stabi l i ty of paraquat  i n  rat t i s s ues . He found a decrease wi th i n  
paraquat concentrati on i n  the stomach and cecum wh i l e  a pos tmortem r i se  
i n  paraquat concentrati on  was  observed i n  the l i ve r .  I n  a l l o f  the  
above experiments, the t i ssues  rema i ned in  the cadaver unti l a n a lys i s .  
The authors hypothes i zed that decreases  i n  paraquat concentrati on  i n  the 
G I  tract were due to i ts chemi ca l degradati on  by bacteri a produced or 
acti vated duri ng  the  putrefacti on process . Al ternati vely, pos tmortem 
d i ffus i on  from the stomach  to the l i ver  through the portal ve i n  cou l d  
expl a i n  both the decreases  observed i n  the s tomach and i ncrea ses  
observed i n  the  l i ve r .  I ncreases  i n  l i ver paraquat concentrat i on  cou l d 
a l s o  be due to rel ease  of chemi ca l  from t i s sue  b i nd i n g  s i tes . 
L .  Phencycl i d i ne ( PCP ) 
C l ardy and Rag l e  ( 87 ) exami ned the stabi l i ty of PCP  stored i n  
b l ood conta i n i ng sodi um fl uori de a s  a preservati ve and pota s s i um oxa l ate 
as an anti coagu l ant . After an  i n i ti a l  quant i tat i on by gas 
chromatography-ma s s  spectrometry, the b l oods were s tored for a t i me i n  
the refri gerator and then a t  room temperature . No changes  i n  PCP  
concentrat i on s  were found i n  the b l ood samp l es  after 18 months .  
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M. Theophyl l i ne 
Jonkman et a l . ( 88 )  stud ied  the stabi l i ty of theophy l l i ne  i n  
serum, p l asma, and sa l i va for 1 week a t  6° C and 25 °C  and for 6 months  a t  
-20 ° C .  I n  a l l cases, they found l es s  than 7%  decrease  i n  theophyl l i ne 
concentrati on i n  these fl u i ds .  Thei r a s say i nc l uded extract i on of b l ood 
and  ana l ys i s  by l i q u i d chromatography . From these resu l ts, they con­
cl uded that storage or  trans portat ion  of theophy l l i ne conta i n i n g  s amp l es  
for  a few days cannot s i gn i f i cant ly  a l ter the  reported val ue . 
N .  Tri cyc l l c  anti depres sants 
Bandt ( 89 )  presented a paper concern l ng the rel i ab i l i ty of  
postmortem serum tri cyc l i c  anti depressant  concentrati ons  at  vari o u s  
t i mes  after death . Antemortem concentrati ons  were compared to  
postmortem concentrati ons  u s i ng a gas  chromatog raphy-e l ectron l mpact 
ma s s  spectrometry method for ana l ys i s  ( 90 ) . Of the n i ne cases  
d i s c u s sed , ei ght were found to have h i gh l y  s i gn i fi cant i ncreases  in  the 
serum drug concentrati on a s  the postmortem i nterva l  i ncreased . There 
wa s some evi dence to suggest  that th i s  same effect occu rred i n  v i treou s 
humo r , but the rate of change of concentrati on of tri cycl i c  
anti depressant wa s more g radual . As a mechan i sm for these changes , the 
author proposed that fol l owing death, the decrea s i ng pH of the body 
changed the equi l i br i um between bound and free drug i n  t i s sues  s u c h  that  
l es s  drug  was  bound to t i ssues . Thi s free  drug worked i ts way i nto  the 
extracel l u l a r fl u i d  by pas s i ve di ffu s i on .  I t  wa s concl uded that  when 
determi n i ng  the re l at i onsh i p  between tri cyc l i c  ant i depres sants  and 
death , it was necessary to obta i n  a b l ood sampl e a s  c l ose  to death as 
pos s i b l e ;  when th i s i s  not feas i b l e ,  factors such  a s  h i story ,  l i ver  
concentrat i ons , gastri c concentrat i ons , and the rati o of parent drug to 
i ts acti ve metabol i te in the l i ver  mus t  a l s o  be con s i dered . 
O .  Summa ry 
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The above d i scu s s i on i l l u strates that a l though a rel at i v e ly  
sma l I number of drug s  h a ve  been ana l yzed for  stabi l i ty i n  b l ood and  i n  
t i s sues , there i s  s uffi c i ent evi dence to suggest  that changes i n  drug  
concentrati on a s  a funct1 0n of t ime do occu r .  I t  1 S  bel i eved tha t  th i s  
research wi l l  i nc rease  or  i mprove the current knowl edge on the s ubj ect 
in  severa l  ways . F i rstl y , th i s  research wi l l  es tab l i s h protoco l s where 
these questi ons  can be exami ned in  a n  o rga n i zed manner .  Moreover , drugs  
wi l l  be exami ned wh i ch have not been stud i ed prev i ou s l y ,  such  a s  
benzod i azepi nes a n d  l i doca i n e .  Furthermore , i t  wi l l  exami ne  
barb i tu rates , a group of drug s  in  wh i ch there i s  a conf l i ct  in  the 
prev i ou s l y  reported data . One of the s trengths  of the work p ropo sed  i s  
that the drug ana lyses  a re performed u s i ng  ch romatograph i c  methods ; one 
prob l em wi th much of the prev i o u s ly  pub l 1 shed  data i s  that the d i t t e rent  
ana l yses  u sed spectrophotometr1 c procedures for quanti tati on ; these  




1 .  MATERIALS 
A .  Standards 
1 .  Benzod i azep i nes . D i a zepam , nordi azepam , fl u razepam , 
N - 1 -desal kyl fl u razepam , ch l o rd i azepoxi de , norch l ord i zepox i de ,  n i trazepam 
and demoxepam were donated by Hoffman-LaRoche C o . , Nutl ey ,  N .  J .  
Standa rds wi th the equ i va l ent of 10 mg/ l  of free base  i n  methano l  were 
prepared . D i azepam was u sed a s  the i nterna l  s tandard except when 
d i azepam wa s stud i ed  i n  wh i ch case fl u razepam wa s used a s  the i nterna l  
standard . 
2 .  Oxybarb i tu rates . Free a c i ds or sodi um s a l t s  of the  
fo l l owi ng  barb i tu rates were obta i ned from the  Med i cal  Co l l ege of  
V i rg i n i a  Hosp i tal s Tox i co l ogy Laboratory :  amobarb i ta l , butabarb i ta l , 
pentoba rb i tal , phenoba rb i ta l , secobarb i ta l . Methano l i c  standards of 
concentrati on 200 mg/ l were p repared . Amobarb i ta l  was used a s  the 
i nternal standard f o r  butabarbi tal ; butabarb i tal was  used a s  the 
i nterna l  standard for the other oxyba rb i turates . 
3 .  Th i opental . F i ve g rams of sodi um th i o penta l wa s 
d i s so l ved i n  HC l  and extracted wi th  methy l ene c h l or i de . The methy l ene 
ch l ori de l ayer was separated and evaporated to dryne s s . The pur i ty ot  
the s o l i d  wa s determi ned by  d i s s o l v i ng a known amount of so l i d  i n  a 
known vo l ume of . 5N NaOH and then , obta i n i ng a UV scan . The a b sorbance 
at  300 nm and the Ai�m ( 930 ) were used  to ca l cu l ate the puri ty .  A 200 
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mg/ l methano l i c s tandard wa s then prepared . The i nterna l  standard was  1 
mg/ml pheno l phtha l e i n l n  methano l . 
4 . L i doca i ne ( US P- N F )  and mep i v i ca i ne ( USP -NF ) . 200 mg/ l  
aqueou s sol uti ons . 
5 .  No rtryptyl i ne ( USP-NF ) .  200 mg/ l aqueous  s o l u t i on  of  
the free base . 
6 .  Proca i nami de t Squ i bb i nj ector v i a l ) .  93 mg/ l  
methano l i c  so l ut i on o t  the free base . 
I .  D i sopyrami de ( G . D .  Searl e and Company ) . 200 mg/ l 
aqueou s so l ut i on of the free base . 
B .  Reagents . 
1 .  Buffers 
a .  Borate so l ut i on ( pH 9 . 2 ) . 14 9 sodi um b orate  
( F i sher  5-249 ) i n  200  ml d i st i l l ed wate r .  
b .  Phosphate buffer ( pH 1 1 ) .  1 . 0M sod i um phosphate 
monoba s i c ( pH 4 . 3 )  added to 1 . 0M sodi um phosphate  tri bas i c  to b r i n g  the  
f i na l  pH to 1 1 .  
c .  Phosphate buffer ( pH 5 . 5 ) . Equa l  amounts  o f  . 5M 
KH2 P04 and . 5M Na2HP04 ( 17 . 0 9 of KH2P04 di l uted to 250 ml wi t h  
d i s t i l l ed water a nd  17 . 7  9 of  Na2HP04 d i l uted to 2 50  ml d i s t i l l ed 
wate r ) . The sol ut i ons  a re mi xed to br i ng  the f i na l  pH to 0 . 5 .  
2 .  So l vents 
a .  Methyl ene ch l or i de , to l uene , h exane , i soamy l  
a l cohol , methanol  ( F i s her  HPLC  or  pesti c i de grade ) .  
b .  Extract i on so l vents : I .  to l uene : hexane : 
i soamyl  a l cohol ( 78 : 20 : 2 ) . I I .  methyl ene ch l ori de . 
3 .  Other reagents 
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a.  Sod i um fl uori de ( Na F ) : ( Ba ke r )  potas s i um oxa l ate 
( K2C204 ) :  ( Ma l l i n k rodt ) . Each tube conta i n i ng F
-/ C204
= had  10  mg N a F  
a n d  3 . 75 mg K2C204 p e r  m l  b l ood . 
b .  HC 1 : ( He i co ) ; NaOH : ( Ba ker )  
c .  TMPAH . . 1M tri methy l phenyl ammon i um hydrox i de i n  
methano l . ( Ea stman Koda k  Co . ) .  For methyl at i on of barb i tu rates  1 part 
TMPAH : 2 parts  methanol  wa s used  
C .  Spec imens  
B l ood was obta i ned from cadavers  autop s i ed at  the  Offi ce  
of the Ch i ef Med i ca l  Exami ner ' s offi ce for the Commonweal th of V i rg i n i a .  
I t  was stored i n  a freezer at -20 ° C  unt i l u sed . Before addi t i o n  of  
drugs , t he  b l ood wa s ana l yzed to ensure t h at  no i nterferences wi th  t he  
added drugs occurred . 
Serum was obta i ned from the Med i ca l  Col l ege of V i rg i n i a  
Hosp i tal  Toxi col ogy l a bo ratory .  The serum from pat i ents rece i v i ng the  
d r u g s  of i nterest wa s c o l l ec ted , comb i ned , a n d  s to red a t  - 2 0 ° C  u n t i l 
u sed . 
T i s sues  were obta i ned from autop s i ed cases  from the  
Offi ce of the Ch i ef Med i ca l  Exami ner ' s for the Commonwea l th  of V i rgi n i a .  
Drug i denti ty was confi rmed by GC/MS . Between rece i pt and ana l ys i s ,  the 
ti s sues  were stored in waxed cardboard conta i ners  a t  -20 ° C .  
I i .  EXPERIMENTAL PROCtUURE 
A .  B l ood 
An a l i quot  of a methano l i c  s tandard of the drug to be 
ana l yzed wa s added to a g l a s s  conta i ner and evaporated to dryne s s  at 
6 5 v c .  I he res i due was recon st i tuted w i th b l ood obta l ned from cadavers 
wi th i n  48 hours atter death and st i rred magneti cal l y  for 1 - 1 . 5  hours . 
After an i n i t i a l quant i tatl on the b l ood was then d i v i ded i nto 2 
portl ons : one port i on wa s stored i n  a corked Erl enmeyer f l a s k  at  room 
temperatu re and the other was stored i n  a corked Erl enmeyer fl a s k  a t  
4V C .  A t  vari ous  t imes , a l l quots o f  t h e  b l ood were quanti tated for  t h e  
" s p i ked" drug . 
B .  Serum 
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When  approx imate l y  30 -40 ml of s erum conta i n i ng the drug  to  
be  ana lyzed was  poo l ed ,  an i n i t i a l  drug  quanti tati on was performed . I he 
serum was di v i ded i nto 2 porti ons : one was stored i n  a capped test  tube 
at  4°C and the other wa s stored in  a capped tube at  25 ° C .  Al i quots  were 
removed peri od i ca l l y  and quanti tated . 
c .  T i s sues 
The ti s sues  were cut i nto sma l l p i eces and d i v i ded up i nto 
10 9 porti ons . One port i on wa s ana l yzed i n i ti a l l y  and the other 
port i ons  were d i v i ded i nto two g roups . Two port i ons  were s to red i n  
separate capped g l a s s  tubes a t  room temperatu re wh i l e  the other  porti ons  
were s tored in  separate , capped  g l a s s  test tubes in  the  refri gerato r .  
A t  1 month t ime i nterva l s ,  a 1 pa rt t i s s u e  t o  2 pa rt water homogenate 
was prepared u s i ng a port i on stored at  each temperatu re . Al i quots  of 
these homogenates were then anal yzed . 
D .  B l ood for spec i a l ch l ord i azepox i de/demoxepam study 
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B l ood wa s obta i ned from cadavers wi th i n  24 hours  afte r 
death and frozen at -20 ° C  unt i l needed . The pH of the b l ood was  
adj u sted by the addi t i on of g l ac i a l  aceti c ac i d o r  concentrated ammo n i um 
hydroxi de . Aqueous  phosphate buffer ( O . lM )  was adj u s ted to the s ame pH 
wi th  4N NaOH . An a l i quot  of a methanol i c  s tandard of ch l ordi azepox i de 
or  demoxepam was added to a g l a s s  conta i ner  and evapo rated to d rynes s  at  
65 v C .  The  res i due  was recons t i tuted wi th  e i ther b l ood o r  buffe r .  After 
a n  i n i ti a l quant i tat i on , the b l ood and buffer were each d i v i ded u p  i nto 
4 pa rts : 1) 2 5 v C  wi thout fl uori de/oxa l ate ; 2 )  4°C wi thout 
fl uori de/oxa l ate ; 3 )  25°C  wi th fl uori de/oxa l ate ; 4 )  4UC  wi th 
fl uori de/oxa l ate . At vari ous  i nterva l s ,  a l i quots from each part was 
ana lyzed . 
E .  Methodo l ogi es  
The methodol ogy emp l oyed for the quant i tati on of 
benzod i azepi nes  came d i rect ly  from the paper by Peat and Kopj a k  ( 19 ) . 
Moreover ,  the ana l ys i s  of d i sopyrami de , nortryptyl i ne ,  and l i doca i ne i s  
based  on th i s  procedu re , wi th a change i n  i nterna l standard bei n g  the  
on ly  d i fference . I he gas  chromatograph i c  procedure for  oxybarb i tu rates  
wa s presented by B l anke  and Saady ( 92 ) ;  the l i qu i d  chromatograph i c  
procedure for oxybarb i turates and th i opental  u se s  the same extract i on  
condi t i ons . Proca i nami de 1 S  quanti tated u s i ng the method of Rocco , et  
a l . ( 93 ) . 
I I I .  I NSTRUMENTATI ON 
The spec i fi c  i nstrument condi ti ons  for each drug a na lys i s  a re 
g i ven i n  Tabl e 1 .  
A .  Gas ch romatographs ( GC) 
HP5880 wi th n i trogen : phosphorus  detector .  A 2 m x 2 mm 
1 . 0 .  g l a s s  col umn packed wi th 3% OV R 10 1  on 80/ 100 Supel coport was 
used . The carri er  gas  was he l i um at a fl ow rate of 30 mL/mi n .  The 
i nj ect ion  port temperature 225 ° C  and the detector temperature was 300° C .  
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Hewl ett- Packard 5730 wi th 63N i  e l ectron captu re detector ;  1 . 3  
m x 2 mm 1 . 0 .  g l a s s  col umn packed wi th 3% OV-17  R o r  3% OV-7 R on 80/ 100 
Ga s Ch rom Q was u sed . The carri er  gas  wa s methane : argon ( 10 : 90 )  a t  a 
f l ow rate 30 ml /mi n .  The oven temperatu re was 250° C .  and the detector 
temperatu re was 300 ° C .  
B .  Gas  Chromatograph/Mass  Spectrometer 
( GC/MS ) Hewl ett-Packard 5985A ; A 1m x 2 mm 1 . 0 .  g l a s s  
co l umn packed wi th 3 %  OV-IU1  o n  80/ 100 Supel coport wa s used . The  
carrl er  gas was  hel i um at a fl ow rate of 33 ml /mi n .  The i n i ti a l  oven  
tempe ra t u re wa s ��O ° C . w i th a 10 ° C .  pe r mi nute r i se to 280 ° C . 
C .  L iqu i d ch romatograph 
( LC )  Hewl ett- Packard 1080 and an  Al tex Model 332 Grad i ent 
l i q u i d chromatograph attached to a G i l son Ho l ochrome var i ab l e wave l ength 
detector and a HP  3390A i ntegrator were u sed for l i q u i d chromatograph i c  
procedu res . 
Drug 
D i azepam 
F l u raze�am 
Chl ordi a zepox i de 
Demoxepam 
N i trazepam 






Metho- I n s trument 
dol ogy 
GC HP5730 
Co l umn 
3%  OV R 7 on 
80/ 100 Ga sChromQ 
LC  Al tex Mode l Al tex U l trasphere 
332 ODS 5 )J ; 4 . 6  nun I D  
Temp . 
P rogram 
250 ° C  
i sotherma l 
amb i ent  
temperatu re 
Mob i l e  
Phase  
10%  methane  
in  a rgon 
70% methanol  
30% water 
Wave l e ngth 
of  Detec­
t i on ( nm) 
240 
Norch l ord i azepox i de x 25  cm f l ow 1 ml /mn 
Nord i aze�am 
Oxybarb i turates 92 LC HPI080 C hromanet i cs amb i ent 65% methanol  
10 )J ; 4 . 6  mm IDX  temperatu re 35% water 220 
2 5  cm f l ow 1 ml /mn 
GC HP5880 3% OV R 101  on  140 ° C  for 1 mi n 
80/ 100 Su pe l co- t 15 ° C/mi n+220 ° C  he l i um 
�ort t20 ° C/mi n+280 ° C  
Th i openta l 92 LC Al tex Mode l A l tex ODS amb i ent 60% methanol  
332  10)J ; 4 . 6  nun I Dx temperature 40% water 290 
25 cm fl ow 2 ml /mi n 
L i doca i ne 3% OV R 101  on 195 ° C  for 1 mi n 
Nortryptyl i ne 9 1  G C  HP5880 80/ 100 Su pe 1 co- t 1 5 ° C/mi n+220°C  he l i um 
�ort t20 ° C/mi n+280 ° C  
Proca i nami de 93 LC Al tex Model  Al tex ODS 40% methanol  
332 10 )J ; 4 . 6  mm I Dx amb i ent 59% water 278 
25  cm temperatu re . 4% tr i ethyl ami ne  
pH a dj u s tment  to 
4 . 8  wi th acet i c  a c i d 
D i  sopy rami de 91  GC HP5880 3% OV R 101  on 220° C  for 1 mi n 
80/ 100 Su pe l co- 20° C/mi n+280°C 
port v.> 0'1 
I V .  EXTRACTION  
I 
A .  B l ood o r  serum 
bl ood or s erum 
i ntern a l  s tandard so l u t i on 
buffer 
extract i on  s o l vent  
I I 
aquf.!ou s l �yer 
t d l sCard ) 
i nj ect i on  of 
4 �l i nto  GC 
( for di azepam 
�g'" ' :':::::'t; ." t. 
and fl u razepam)  
drynes s a t  40° C  
- reconst i tut i on 
- i nj ecti on  
T h e  s pec i f i c s  for each drug extract i on a re g i ven in  Tab l e  2 .  
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TABL E 2 .  Spec i f i c  Extract i on Condi t i ons  
Drug  I n terna l  Buffe r  Extract i on  Recon st i tut i on 
Standard Sol vent Chemi ca l  
D i a zepam 1 1 1g borate I 
fl u razepam 
Fl u razepam l \1g borate 
f l u razepam 
Chl ordi azepo x i de 
Norch l ord i azepox i de 5 )Jg borate methanol  
Nord i a zepam d i azepam 
N i trazepam 5 )Jg borate methano l  
nord i azepam 
Oxyb a rb i turates 20 )Jg phosphate I I  . 033M 
(GC ) butaba rb i ta l  (pH 5 . 5 )  H1PAH 
Oxyb a rb i turates 20 )Jg phosphate I I  methanol  
(L C )  b arb i ta l  (pH 5. 5 )  
Th i openta l 200 )Jg phosphate I I  methanol  
pheno l phtha l e i n  (pH 5. 5 )  
L i doca i ne 10 )Jg borate methanol  
mep i v i ca i ne 
Di sopyrami de 10 \1g phos phate methanol  
mep i v i ca i ne (pH 1 1 )  
Nortryptyl i ne 10 )Jg phosphate methanol  
l i doca i ne (Ph 1 1 )  
Proca i nami de 10 )Jg phosphate I I  methanol  
N - prop i ony l  (pH 1 1 )  
proca i nami de 
Reconst i tut i on  
Vol ume (ml } 
0 . 3  
0 . 3  
0 . 1  
0 . 3  
0 . 3  
0 . 1  
0 . 1  
0 . 1 
0 . 3  
Vol ume ()Jl )  













B .  T i s sues  - benzod i azepi nes  
aqueou s 
( d i scard ) 
aqueou s 
aqueou s 
( d i scard ) 
2 . 0  ml homogenate 
2 ml borate b uffer 
200 �l of  1 0  mg/ l n i trazepam ( i ntern a l  s tandard ) 
2 ml extracti on  s o l vent 
vortex 5 sec 
rotate 1 5 -20  mi n 
centri fuge 2000 rpm 1 0  mi n 
orgarri c 
add 3 ml IN  HCl 
rota te 15 -20 mi n 
centri fuge 2000 rpm 5 mi n 
orga n i c  
( d i scard ) 
add 1 ml 12N NaOH 
add 1 ml extract i o n  s o l vent 
rotate 15-20 mi n 
centri fuge 2000 rpm for mi n 
organi c 
. I 
i nJ ect 4 �l i nto the GLC- ECD 
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The only dev i ati on from thi s procedu re wa s for ti s s u e s  
conta i n i ng fl urazepam . where the i n i t i a l  extracti on wa s wi t h  2 ml 
n-hexane ( See Di scuss i on ) . Quanti tat i o n  wa s based on the area rati o o r  
hei gh t  rati o of ana lyte peak t o  i nterna l  s tandard peak i n  compa ri son to  
rati o s  from forti fi ed ti s sue  standards . 
C .  T i s sues  - oxybarbi tura te s  
2 . 0  m1 h omogenate 
200 \.11 of 200 mg/ 1 butabarb i ta 1  ( i nternal standard ) 
2 m1 phosphate buffer - pH 5 . 5  
1 5  m1 tol uene : hexane : i soamyl a l cohol (78 : 20 : 2 )  
Rotate mechan i ca l l y  for 1 0  mi n 
centri fuge 
t 
aqueou s l ayer ( d i s c ard )  . 
1
1 orgam c ayer 
40 
3 m1 of s a tu rated borate buffe r (pH 9 . 5 )  
aqueou s l ayer 
1 ml I N  HC l  
rotate mecha n i ca l ly for 1 0  mi n 
centri fuge 
organi c l ayer ( d i s ca rd )  
10  m l  methy l ene c h l or i de 
rotate mechan i ca l l y  for 10 mi n 
centri fuge 
aqueou s l aye r ( d i scard )  o rgan i c l ayer 
evapo rated t o  drynes s  a t  40°C  
recon sti tute res i du e  wi th 100 II I  
of  . 033M TMPAH i n  methanol 
i nj ecti on of 1 III i nto gas 
ch romatograph 
D .  T i s s ues  - th i openta l 
1 . 0  ml t i s s u e  homogenate 
300 �l  1 mg/ml pheno l phtha l e i n  ( i nterna l  s tanda rd )  
1 ml phosphate buffer 
10 ml CH2C 1 2 
mechan i cal  rotat i on  and  
centri fugat ion  
aqueou s ( di scard )  o rgan i c  
4 1  
3 ml . 1M NaOH  ( d ro pw i s e ) 
mechan ica l  rotat i o n  and 
centr i fu ga t i o n  
aqueous o rg an i c  ( d i s c a rd ) 
1 ml IN HC l  
10 ml CH2C 1 2 
mecha n i ca l  rotati on 
and centri fugat ion  
aqueous  ( di scard )  organ i c 
evaporat i o n  to dryness  
recon st i tuti on  wi th 300 �l methano l  
i nj ecti on  of  2 0  �l  i nto  L C  
E .  T i s sues  - l i doca i ne 
2 . 0  ml t i s s u e  h omogenate ( 1  part t i s su e : 2 parts \'/ater )  
200  mg/ l mep i v i ca i ne ( i n te rn a l  s tanda rd )  
2 m l  borate s o l ut i on  
5 ml extracti o n  s o l vent 
mecha n i ca l  rotat i on  for 1 0  mi n and  centri fugation  
aqueous  l ayer 
( d i scard )  
o gan i c  l ayer  
-addi t i on  of  3 ml I N  HCl  
-mecha n i ca l  rotat i o n  for 1 0  mi n 
and  centri fugat i on 
aqueou s  l ayer  or�a n i c  l ayer 
{di scard )  
-add i t i on of  1 m l  4 N  NaOH 
and 2 ml extract i on  s o l vent 
-mechan i ca l  rotat i o n  for 
10 mi n .  and centri fugat i on  
aqueo u s  
l ayer  
( d i scard ) 
organ i c  
l ayer  
-evaporat i o n  to dryn e s s at  40°C 
- recons t i tu t i on  of res i du e  w i t h  
1 0 0  ]..11 methanol 
i nj ecti on  of  1 ]..1 1 i nto g a s  chromatogra p h  
42. 
V .  RECOVERY STUDY FOR BARB ITURATE LC METHOD 
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Two groups of  b l ood s tandards  were prepa red ; one  
group had  50 �l of the i nterna l  s tandard added  to it  whi l e  the other  
group  had no i nterna l  standard . Buffer and 5 ml of methyl ene c h l or i de 
were added to both groups of  b l ood s tandards . After mechan i ca l l y  
rotati ng  for � mi nutes , the methyl ene ch l ori de from the g roup  conta i n i ng 
the i nterna l standard was fi l tered i nto con i cal  centri fuge tube s . I n  
the g roup wi thout the i nterna l  s tandard , 2 . 5  m l  of the methyl ene 
ch l ori de was fi l tered i nto con i cal  centri fuge tubes . Then , 25 � I  o f  the 
i nterna l  standard so l ut i on was added to these tubes . Both g roups  were 
evaporated to dryness  and reconst i tuted w i th 200 �l of mob i l e  phas e .  20  
� I  wa s i nj ected . The  percent recovery was ca l cu l ated by d i v i d i n g  the 
a rea  rat i o  ( barb i tu rate to i nterna l  standard ) of the sampl es  to wh i ch 
the i nternal standard wa s added before extracti on by the a rea  rati o o t  
t he  s ampl es to  whi ch t he  i nterna l  s tandard wa s  added after the 
extracti on and mu l ti p lY l ng  by 100 . 
V I .  FRACT I ON COLL ECT I ON 
Fracti ons  col l ected l for  benzod i azepi nes ) from the l i q u i d 
ch romatograph i c  col umn were made bas i c  wi th borate buffer and  extracted 
wi th  the extracti on so l vent . I he o rgan i c  extracts were then s u bj ected 
to the fol l owi ng : 1 )  i nj ecti on of an a l i quot of the extract i n to the 
GLC - ECD , and 2 )  evaporat i on of the extracti on  so l vent fo l l owed by 
recon sti tuti on wi th methanol  and i nj ect i o n  i nto the GC/MS . 
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V I i .  STAT I ST I CAL MAN I PULAT IONS 
L i near regre s s i ons  for b l ood , serum , and buffer data were 
performed and 95% confi dence i nterva l s  for the s l ope ( 95% C l ) were 
obta i ned 1 94 ) . See Append i x  1 for greater deta i l .  T i s s ue  data was 
comp i l ed as  fol l ows : For each  t i s s ue , the i n i t i a l quant i tati on was  
a s s i gned a val ue of 100% . Succe s s i ve quant i tati ons  were made and  the  
" percent (% )  of or i g i na l present"  wa s ca l cu l ated . Data  from each drug  
i n  each t i s s ue were then  comp i l ed and an average " %  of ori g i na l  present"  
was obta i ned for each  t i me peri od . 
I .  BENZODIAZEP I NES 
A. B l ood 
RESULTS 
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1 .  D i azepam and nord i azepam . The resu l ts from the 
storage of b l ood conta i n i ng d i azepam at  2 5 ° C  and  4°C are shown i n  F i g u re 
1 .  I t  i ndi cates that d i azepam i s  very stab l e  i n  b l ood when stored a t  
room temperature or  at  refri gerated temperature o v e r  a 9 0  day peri od , 
s i nce no stati st i ca l l y s i gn i f i cant  changes  i n  the s l ope were o b served 
under e i ther condi t i on . Moreover , even after � month s , no changes  i n  
concentrati on at  e i ther temperature were detected . However , confl l ct i n g  
data were produced when s i mi l a r experi ments  were performed wi th  
nordi azepam. An  i n i ti a l study demonstrated a decrease  in  nordi a zepam 
concentrati ons at  2 5 u C  and no s i gn i f i cant change at  4°C ( Tab l e  3 ) . The 
data obtai ned at 2 5 ° C  were rearranged by p l ott i ng  the natural  l ogar i thm 
of concentrat ion  vers u s  t i me and then performi ng  the  l i near  reg re ss i on . 
S i nce the h i gher corre l ati on coeffi c i ent wa s obta i ned  when I n ( ND ) was 
pl otted vs . t ime a s  opposed to a p l ot of ( ND ) vs . t i me ,  the 
decompos i t i on of nordi azepam fol l owed pseudo fi rst  order k i neti c s . 
However , when thes e  experi ments  were repeated , no s i gn l t i cant  changes  
were observed i n  e i ther b l ood or  buffer over a 2 month peri od t l a b l e 4 ) . 
To date , no expl anat i on has  been found to expl a i n  these  confl i ct i ng 
data . 
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TABLE  3 
Storage of b l ood conta i n i ng nord i azepam I 
T IME  ( days ) 2 5 ° C  4 ° C  
( NO )  I n ( NO )  NO  I n ( NO )  
0 3 . 4  1 . 22 3 . 4 1 . 22 
3 2 . 0  . 69 2 . 8  1 . 03 
5 2 . 5  . 92 3 . 1  1 . 13 
1 2  1 . 6  . 47 2 . 5  . 92 
19 0 . 8  - . 22 2 . 5  . 92 
33 
49 0 . 5  - . 69 
7 5  0 . 4  - . 92 2 . 6  . 96 
S l ope - . 03 2  - . 027  - . 0068 - . 0023  
Intercept 2 . 3  . 84 2 . 9  1 . 06 
Corr . Coef . - . 8 1  - . 92 - . 5 1 . - . 50 
95% C I  for S l ope ( - . 020 . 006 ) 
( NO )  = nordi azepam concentrati on ( mg/ l ) 
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TABLE  4 
Storage of B l ood Conta i n i ng Nordi azepam- I I  
T IME ( days ) Concentrat i on  ( mg/ l ) 
2 5 ° C  4 ° C  
0 5 . 1  5 . 1  
3 4 . 3  5 . 0 
7 5 . 1  4 . 3  
10 5 . 0  4 . 8  
14 4 . 9  4 . 6  
28 4 . 4  4 . 4  
42 4 . 7  4 . 7  
49 4 . 4  4 . 5  
63  4 . 9  4 . 7  
S l ope - . 0037  - . 0038 
Intercept 4 . 8  4 . 8  
95% C I  ( - . 025 , . 0 1 7 ) ( - . 022 , 0 1 4 )  
f o r  S l ope 
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2 .  F l u razepam and des a l kyl fl u razepam .  F i gures  2 and 3 
i l l u s trate the storage effects of fl u razepam and N - l -desa l kyl f l u razepam 
at  4 ° C  and 25 ° C .  No s i �n i f i cant changes  in  the concentrati on of e i ther  
parent drug  or  metabo l i te were found . 
3 .  Ch l ordi azepoxi de ( COP )  and  norch l ordi azepox i de ( NCO P ) . 
The decay curves for these compounds  i n  b l ood are g i ven i n  F i g u re s  4 and  
5 .  I t  i s  c l ear from the g raph that when both the parent drug and  
metabo l i te are stored at room temperature , thei r presence i s  not 
detected wi th i n 18 days after thei r addi ti on to the b l ood . 
To obta i n  further  i nformat i on on the degradati on  of  
c h l ordi azepox i de ( COP ) and norch l ord i azepox i de ( NCOP ) exper i ments  were 
undertaken to i denti fy and pos s i b l y  quanti tate the b rea kdown p roducts  
from these  drugs . By ana l yz i ng  d i fferent L C  fract i ons  a s  d i s c u s s ed  i n  
the  Experi mental sect i on ( p .  4 3) ,  two b reakdown products were 
tentati vely i denti f i ed by retenti on t i mes  or  GC/MS-demoxepam ( O EM )  and  
nord i azepam ( NO ) . The structures of these a s  wel l a s  the other benzo­
d i azepi nes exami ned are g i ven in  Tab l e 5 .  Oemoxepam was i denti f i ed  by 
GC and LC retenti on t ime ;  no ma s s  s pectrum wa s obta i ned . Therma l 
i nstab i l i ty of demoxepam prevented i t  from e l ut i ng i ntact from the  GC 
col umn to the ma s s  spectrometer .  
LC  retenti on t imes  and by  GC/MS . 
N o rd i azepam wa s i de n t i f i ed by GC a n d  
B l ood s tandards  of these  dru g s  were 
prepared and when pos s i b l e ,  these compounds were a l so  quant i tated when 
presen t .  Representati ve data  from these exper iments  a re g i ven  i n  
F i g u res  6 and 7 .  S i nce demoxepam appeared earl i er ( 2  days ) than  
nord i azepam ( 4  days ) ,  it  was evi dent that demoxepam was the fi rst  
breakdown product . 
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F I GURE S .  Storage of norch l ordi azepox i de i n  b l ood at 25°C and 4°C . 
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TAB LE 5 .  Structure s  of Benzod i azep ; ne s  
R ,  = CH 3 - Di azepam 




;®:: ' CH 
Cl C=N / Z 
@ �
o 
Rz = N H C H 3 - Chl ord iazepoxid e  




CI C = N /  @JF 
R3= C H z C H 2 N (CzH5k F l u razepam 
= H - N - I - desa l ky l  Fl ura zepom 
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F I GU RE 6 .  Demoxepam concentrati ons i n  norchl ordi azepoxide bl ood 
sol uti ons stored at 2SoC .  
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F IGURE 7 . Nord i azepam concentrat i on s  i n  norchl ord i azepoxide 
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I t  was dec i ded to s tudy the mec han i sm of  ch l o rd i azepox i de 
b rea kdown l n  greater deta i l .  Specl fi ca l l y ,  i t  wa s a s sumed that  a t  l ea s t  
2 d i fferent processes  c a n  be occurri ng  i n  t h e  b l ood : 1 )  chemi ca l 
degradat ion  of ch l ord i azepox i de i n  a pH-dependent aqueous med i um  a nd  2 )  
mi croorgan i sm i nduced degradati on . To s tudy these effects , a s er l e s  of  
tubes  were set u p  a s  outl l ned in  the experi menta l sect i on ( Spec i a l  
c h l ordi azepoxi de study ) . Presumab ly , the presence o f  fl uori de , a 
mi croorgan i sm i nh i b i to r ,  wou l d prevent any changes  i nduced by 
mi croorgan i sms and aqueous  butter cou l d  be u sed as an i ndl cator of  
changes  occurri n g  i n  any aqueous  med i um .  Three pH ' s  were stud i ed :  5 ,  
6 . 5 ,  and 8 and each exper iment was carri ed on over a 3-4 week peri od . 
The data from these  experi ments  a re g i ven i n  Tab l es  6 - 1 1 .  
Qua l i tati ve l y ,  when ch l ord i azepox i de was stored i n  b l ood a t  room 
temperature at pH 8 and pH 6 . 5  i n  the absence of F -/ C204 , none of the 
COP  added (5 mg/ l ) was detected after 15 days . Approx imate l y  2 5 -40% of 
thi s wa s converted to NO through the i ntermed i ate OEM . Th i s wa s 
i l l u s trated by the fact that the concentrat i on of OEM , not o ri g i na l l y  
present , i ncreased t o  a max i mum o f  1 . 6  mg/ l by day 6 and then decreased  
to <0 . 1  mg/ l by  day 15 . Th i s wou l d  suggest  that v i rtua l l y  a l l of the 
C D P  that wa s conve rted t o  DEM wa s t h e n  conve rted to NO . N o t  a l l o f  DEM 
was converted to NO because a sma l l ,  but  detectab l e amount of the 
2 -ami no-5-ch l orobenzophenone ( see D i s c u s s i on )  wa s observed . No attempt 
was made to quanti tate the benzophenone because  no pure standard wa s 
ava i l ab l e .  Tentat i v e  i denti f i cati on of the benzophenone wa s made based  
on  the  LC  and  GC-ECD retenti on t i mes  i n  compari son  to a q ua l i tat i ve  
benzophenone standard . I he p resence of F-/ C204 i n  b l ood  at  pH ' s  8 and  
6 . 5 s i gn i f i cantl y changed  the observati ons . Approx i mate l y  80 -90% of the  
TABLE  6 
Spec i a l  CDP  B l ood/ Buffer Study : pH 8 ,  no F/ C204 
25 ° C 4°C 
BLOOD BUFFER  BLOOD BUFFER 
T IME ( days ) ( CDP ) I n ( CD P )  ( CD P )  I n ( CD P )  ( CD P )  I n ( CD P )  ( CD P )  I n ( CDP ) 
0 5 . 7  1 .  74  5 . 0  1 . 6 1  5 . 7  1 . 74 5 . 0  1 . 6 1 
2 5 . 4  1 . 69 4 . 8  1 . 57 5 . 1  1 . 63  4 . 9  1 . 59 
4 4 . 9  1 . 59  4 . 2  1 . 44 4 . 9  1 . 5 9 5 . 1  1 . 63 
8 2 . 4  . 88 4 . 0  1 . 39 5 . 3  1 . 67  4 . 2  1 . 44 
10  0 . 9  - . 1 1  4 . 1  1 . 4 1  4 . 8  1 . 57 4 . 5  1 . 50 
14  0 . 2  - 1 . 6 1 2 . 7  . 99 4 . 9  1 . 59 4 . 4  1 . 48 
16  N . D .  2 . 8  1 . 03 4 . 9  1 . 59 
18 N . D .  2 . 4 . 88 4 . 6  1 . 53 4 . 5  1 . 50 
22  N . D .  2 . 3  . 83 4 . 4  1 . 48 3 . 8  1 . 34 
25 N . D .  2 . 0  . 69 4 . 6  1 . 53 4 . 0 1 . 39 
S l ope - . 44 - . 27 - . 1 3 - . 039 - . 036 - . 0072  - . 043 - . 0096 
I ntercept 5 . 7  2 . 1 1  4 . 9  1 . 64 5 . 4  1 . 68 5 . 0  1 . 6 1 
Corr . Coef . - . 97 - . 93  - . 97 - . 98 - . 82 - . 82 - . 86 - . 86 
95% CI for S l ope ( - . 057 , - . 0 15 ) ( - . 065 , - . 02 1 ) 
( CDP ) = CDP concentrati on ( mg/ l ) 
N . D .  = none detected 
U1 co 
TABLE  7 
Spec i a l  COP B l ood/Buffer Study : pH 8 ,  F/C204 











S l ope 
I ntercept 
Corr . Coef . 
95% C 1  for S l ope 
BLOOD 
( CO P )  I n ( CD P )  
5 . 7  1 . 74 
5 . 0 1 . 6 1  
5 . 0  1 . 61  
4 . 9  1 . 59 
5 . 0 1 . 6 1  
4 . 6  1 . 53 
4 . 6  1 . 53 
- . 033 - . 0066 
5 . 3  1 . 68 
- . 84 - . 84 
( COP ) = COP concentrat ion  
25°C 
BUFFER BLOOD 
( CO P )  I n ( CD P )  ( CO P )  I n ( CD P )  
5 . 0  1 . 6 1  5 . 7  1 . 74 
4 . 5  1 . 50 5 . 1  1 . 63 
4 . 6  1 . 53 5 . 3  1 . 67 
4 . 0  1 . 39 5 . 3  1 . 67 
3 . 2  1 . 16 4 . 9  1 . 59 
2 . 8 1 . 03 4 . 9  1 . 59 
2 . 6  . 96 4 . 6  1 . 53 
2 . 8 1 . 03 
2 . 3  . 8 3  4 . 4  1 . 48 
2 . 2  . 7 9  4 . 6  1 . 53 
- . 1 2 - . 036 - . 042 - . 0084 
4 . 8  1 . 60 5 . 5  1 . 70 
- . 96 - . 98 - . 89 - . 90 
( - . 058 , - . 026 ) 
4°C 
BUFFER 
( CO P )  I n ( CD P )  
5 . 0  1 . 6 1 
4 . 8 1 . 57 
5 . 3  1 . 67 
4 . 3  1 . 46 
4 . 3  1 . 46 
4 . 2  1 . 44 
4 . 2  1 . 44 
4 . 6  1 . 53 
4 . 1  1 . 4 1  
- . 036 - . 0077  
5 . 0  1 . 60 
- . 76 - . 7 7  
( - . 062 , - . 0 10 )  
<II <0 
TABLE  8 
Spec i a l COP B l ood/ Buffer study :  pH 6 . 5 ,  no F /C204 
25°C 4°C 
BLOOD BUFFER BLOOD BUFFER 
T IME ( days )  ( CO P )  I n ( CD P )  ( COP ) I n ( CD P )  ( CO P )  I n ( CD P )  ( COP ) I n ( CDP ) 
0 4 . 9  1 .  59 5 . 0  1 . 6 1  4 . 9  1 . 59  5 . 0  1 . 61 
2 4 . 7  1 . 55 4 . 4  1 . 48 4 . 8  1 . 57 4 . 6  1 . 53  
4 4 . 2  1 . 44 3 . 8  1 . 34 4 . 6  1 . 53 4 . 2  1 . 44 
8 1 . 8 . 59 3 . 1  1 . 1 3 4 . 1  1 . 4 1  4 . 3  1 . 46 
10 1 . 6 . 47 2 . 8  1 . 03  4 . 4  1 . 48 3 . 8  1 . 34 
1 4  1 . 4  . 34 2 . 3  . 83 3 . 5  1 . 25 
18 N . D .  2 . 3  . 83 3 . 9  1 . 36 3 . 5  1 . 2 5  
22 N . D .  2 . 2  . 79 4 . 1  1 . 4 1  
2 4  N . D .  2 . 0  . 6 9  4 . 0  1 . 39 4 . 0  1 . 39 
28 N . D .  1 . 9  . 64 4 . 2  1 . 44 3 . 9  1 . 36 
Sl ope - . 028 - . 13 - . 10 - . 036 - . 028 - . 63x10-
4 
- . 034 - . 0 1 1  
I ntercept 4 . 9  1 . 67 4 . 3  1 . 49 4 . 7  1 . 55 4 . 5  1 . 52 
Corr .  Coef . - . 97 - . 96 - . 92 - . 96 - . 80 - . 78 - . 67 - . 7 3 
95% C I  for S l ope ( - . 047 , - . 009 ) ( - . 062 , - . 006 ) 
( COP ) = COP concentrati on ( mg/ l ) 
N . D .  = None detected 
Ol 0 
TABLE 9 
Spec i a l  COP B l ood/Buffer Study : pH 6 . 5 ,  F/ C204 
25°C 4°C 
BLOOD BUFFER BLOOD BUFFER 
T IME ( days ) ( CO P )  I n ( CD P )  ( CO P )  I n ( CDP ) ( CO P )  I n ( CD P )  ( CO P )  I n ( CD P )  
0 6 . 0  1 . 7 9 5 . 0  1 . 6 1  6 . 0  1 . 7 9  5 . 0  1 . 6 1 
2 5 . 3  1 . 67 4 . 3  1 . 46 5 . 5  1 . 70 4 . 7  1 . 55 
4 5 . 2  1 . 65 3 . 6  1 . 28 5 . 0  1 . 6 1 4 . 0  1 . 39 
8 5 . 4  1 . 69 3 . 2  1 . 16 5 . 4  1 . 69 4 . 2  1 . 44 
10 5 . 3  1 . 67 3 . 1  1 . 1 3 5 . 3  1 . 67 3 . 9  1 . 36 
1 4  5 . 5  1 . 70 2 . 4 . 88 5 . 0  1 . 6 1  3 . 7  1 . 3 1  
1 8  5 . 4  1 . 6 9  2 . 3  . 8 3  5 . 5  1 . 70 4 . 3  1 . 46 
22  5 . 0  1 . 6 1  2 . 2  . 79 5 . 1  1 . 63 4 . 0  1 . 39 
24 5 . 2  1 . 6 5  1 . 8  . 59 5 . 4  1 . 69 3 . 7  1 .  3 1  
28 1 . 6  . 47 3 . 8  1 . 34 
Sl ope - . 0 18  - . 0047 - . 1 1 - . 038 - . 0 14  - . 0023 - . 03 1  -8 . 2xlO -4 
I ntercept 5 . 6  1 . 7 1  4 . 4  1 . 50 5 . 5  1 . 70 4 . 5  1 . 52  
Carr . Coef . - . 56 - . 68 - . 95 - . 97 - . 38 - . 36 - . 70 - . 70 
95% C I  for S l ope ( - . 026 , - . 002 ) ( - . 057 , - . 005 ) 
( CO P )  = COP concentrati on ( mg/ l ) 
'" 
TABLE 10  
Spec i a l  COP B l ood/Buffer Study : pH 5 ,  no F /C204 
25°C 4°c 
BLOOD BUFFER BLOOD BUFFER 
T IME ( days ) ( CO P )  I n ( CD P )  ( COP ) I n ( CDP ) ( CO P )  I n ( CD P )  ( CO P )  I n ( CD P )  
0 5 . 2  1 . 65 5 . 4  1 . 69  5 . 2  1 . 65 5 . 4  1 . 69 
1 4 . 7  1 . 55 4 . 9  1 . 59 5 . 1  1 . 63 5 . 3  1 . 67 
2 4 . 8  1 . 57 4 . 8  1 . 57 5 . 1  1 . 63 5 . 2  1 . 65 
5 3 . 8  1 . 34 4 . 0  1 . 39 4 . 9  1 . 59 4 . 7  1 . 55 
7 3 . 3  1 . 19 3 . 6  1 . 28 4 . 1  1 . 4 1  4 . 4  1 . 48 
9 2 . 4  . 88 2 . 6  . 96 3 . 7  1 . 3 1  4 . 2  1 . 44 
12  2 . 4  . 88 2 . 5  . 92 3 . 7  1 . 3 1  4 . 5  1 . 50 
14 1 . 8 . 59 1 . 9  . 64 
16  1 . 6  . 47 1 . 8  . 59 4 . 4  1 . 48 
1 9  2 . 1  . 74 4 . 0  1 . 39 4 . 5  1 . 50 
2 1  1 . 2  . 18 1 . 5  . 4 1  4 . 7  1 . 5 5 
23 1 . 4  . 34 4 . 8  1 . 57 
S l ope - . 18 - . 064 - . 18 - . 062 - . 083 - . 033 - . 028 - . 0053 
I ntercept 4 . 8  1 . 62 4 . 9  1 . 65  5 . 0  1 . 67 5 . 0  1 . 6 1  
Corr . Coef . - . 95 - . 96 - . 96 - . 99 - . 8 1  - . 95 - . 56 - . 53 
95% C I  for Sl ope ( - . 1 1 , - . 054  ) ( - . 055 , - . 00 1 ) 
( COP ) = COP concentrat i on ( mg/ l ) Q) N 
TABL E 1 1  
Spec i a l  COP B l ood/Buffe r  Study : p H  5 ,  F/ C204 
25°C 4°C 
BLOOD BUFFER BLOOD BUFFER 
T IME  ( days ) ( CO P )  I n ( CDP ) ( CO P )  I n ( CD P )  ( CO P )  I n ( CDP ) ( CO P )  I n ( CD P )  
0 5 . 2  1 . 65 5 . 4  1 . 69  5 . 2  1 . 65  5 . 4  1 . 69 
1 4 . 9  1 . 59 5 . 0  1 . 6 1  5 . 1  1 . 63 4 . 8  1 . 57 
2 4 . 7  1 . 55 4 . 9  1 . 59 5 . 1  1 . 63  5 . 0  1 . 6 1  
5 4 . 6  1 . 53 3 . 9  1 . 36 5 . 1  1 . 63 5 . 2  1 . 65 
7 3 . 3  1 . 1 9 3 . 1  1 . 1 3 4 . 5  1 . 50 
9 2 . 9  1 . 06 3 . 0 1 . 10 4 . 6  1 . 53 4 . 9  1 . 59  
12  2 . 6  . 96 4 . 1  1 . 4 1  4 . 5  1 . 50 
14  2 . 5  . 92 2 . 9  1 . 06 4 . 6  1 . 53 4 . 8  1 . 57 
16 4 . 6  1 . 53 
19  2 . 3  . 83 4 . 2  1 . 44 4 . 5  1 . 50 
2 1  1 . 8  . 59 1 . 6 . 47 4 . 6  1 . 53 
2 3  1 . 5  . 4 1 1 . 2  . 18 4 . 0  1 . 39 
S l ope - . 16 - . 053 - . 16 - . 056 - . 053 - . 0 1 1  - . 03 1  - . 0064 
I ntercept 4 . 9  1 . 6 5 5 . 0  1 . 67  5 . 1  1 . 64 5 . 1  1 . 64 
Corr . Coef . - . 96 - . 99 - . 96 - . 97 - . 90 - . 89 - . 79 - . 78 
95% C I  for S l ope ( - . 094 , - . 0 10 ) ( - . 056 , - . 006 ) 
( COP)  = COP concentrat i on (mg/ l ) '" w 
COP added was detected at the end of the 3 wee k  peri od . Sma l l amounts  
of OEM  and no NO were detected . 
The s to rage of COP  i n  buffer at  pH 8 and 6 . 5  at  2 5 ° C  
d i ffered from e i ther condi ti on observed i n  b l ood at  correspondi n g  pHs . 
COP  b ro ke down to OEM at both pHs and the tota l COP and OEM , on the  
average , was about 90%  of the tota l COP added  to the buffe r .  F -/ C204 
had  no effect on COP stabi l i ty i n  bufter at e i ther pH . 
The res u l ts from s torl ng  the b l ood and buffer at  pH 5 a t  
2 � v C  contrasted t o  thei r counterpa rts at  t h e  other pHs . For  exampl e no 
NO  wa s detected in  e i ther of the b l ood samp l es .  L arger concentrat l ons  
of OEM were observed i n  b l ood samp l es wi th and wi thout F-I C20; 
( approx i mately 3 mg/ I J . Moreover , the tota l ot COP and OEM 
concentrati ons , on the average , approx i mated tlU -90% of the COP  
or i g i na l l y  added to the b l ood . � u rthermore , the presence of F -/ C204 had  
l i tt l e  or  no effect on the b reakdown of COP . 
Tab l e s  6 - 1 1  a l s o g i ve data on the effects of these  
storage condi ti ons  on COP stabi l l ty in  b l ood at  4° C .  I t  i s  c l ea r  that 
under a l  I condi t i ons , COP i s  more stabl e at  4°C  than at  2� v C .  However ,  
i n  a l l cases , there were stati st i ca l l y  s i gn i f i cant decreases  l n  COP  
concentra ti on over  the 3 -4 wee k  peri od , s i nce 0 d i d  not fa l l  w i t h i n  t h e  
95% confi dence i nterva l  for the s l opes . 
The data i n  Tab l es  6 - 1 1  at  2 5 ° C were rearranged by 
p l otti ng  l n  ( COP concentrati on )  versus  t i me and  obta i n i ng the s l opes , 
i ntercepts and corre l at i on coeffi c i ents ot these l i ne s  by perform i n g  
l i near  regres s i ons . I n  most  cases  I n ( CO P )  v s . t p l ots gave equa l  or  
s l i ght ly  better corre l at i ons  than  ( CO P )  v s . t p l ots . The  s l opes a re 
comp i l ed i n  Tab l e  1 2 . F rom thi s tab l e ,  many po i nts  are evi dent : 1 )  i n  
64 
B l ood 
B l ood+F-/ C204 
Buffer 
TABLE  1 2  
S l opes of I n ( CD P )  v s  t i n  B l ood 
* 
and Buffer at  D i fferent  pHs  a t  2 5 ° C  
pH 8 pH 6 . 5  
- . 27 - . 1 3 
- . 0066  - . 0047 
- . 039 - . 036  
Buffer+F-/ C204 - . 036 - . 038 
* - un i ts  are i n  ( - 1  days ) 
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pH  5 
- . 064 
- . 05 3  
- . 062  
- . 056  
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b l ood  w i thout F-/ C204 , COP i s  mos t  stab l e a t  pH 5 and  l ea s t  s ta b l e a t  pH 
8;  2 ) in  b l ood wi th  F-/ C204 , COP i s  mos t  stab l e a t  pH 6 . 5  and 
pH 8;  3) the presence of F-/ C204 ha s  no effect on the stab i l i ty 
of COP i n  buffer ;  4 )  i n  buffer , COP i s  most  stab l e at pH 6 . 5  and  pH 8 ;  
5 )  the presence of F-/ C20� i n  b l ood h a s  i ts greate s t  stabi l i z i ng 
effect at  pH 6 . 5  and pH 8 ,  ma k i ng  i t  more s tabl e than i n  the 
correspond i ng  buffer so l ut i ons ; 6)  the presence of F-/ C20� i n  
b l ood a t  pH 5 has  n o  effect and  moreover ,  the stab i l i ty o f  COP i n  b l ood 
approx i mates the stab i l i ty of COP in  buffer at  pH 5 .  
To l ea rn more about nord i azepam format i on , i t  was  dec i ded 
to perform s i mi l a r types experi ments a s  above except that demoxepam was  
u sed a s  the start i ng  materi a l . Speci fi c a l l y ,  it  was hoped that  the  pH 
dependence of OEM stab i l i ty and  NO format i on cou l d be  a scerta i ned  i n  
g reater deta i l . The fol l owi ng i s  a s umma ry o f  the re su l ts obta i ned : 1 )  
few changes « 10% ) were found i n  a l l condi t i ons  a t  4° C ;  2 ) 20-30% 
decrease in demoxepam in buffer was seen at  a l l pH ' s  a t  25 ° C  but none of 
the OEM was converted to nord i azepam ; the b l oOd data at  25 ° C  a re 
s umma ri zed i n  Tab l e 13 . 
S i nce the data s uggest  that  the convers i on of demoxepam 
to nordi azepam occu rred by mi crobi a l  acti on , i t  became nece s s a ry to 
determi ne the type of mi croorgan i sms be i ng produced . To accompl i sh 
th i s ,  b l ood stored at 2 5 ° C  and 4 °C  i n  the ab sence and  presence  of F/ C204 
were ana l yzed for anaerob i c  bacteri a ,  aerob i c  bacteri a ,  and  yea s t . 
B l ood at pH ' s  5 and 6 . 5  were ana l yzed because  the nordi azepam format i on 
wa s seen at  pH 6 . 5  and  not at  pH 5 .  The res u l ts  a re g i ven i n  Tab l e 14 . 
At both pH ' s ,  there appears to be l i tt l e q u a l i tat i ve  d i fference  i n  the 
types  of organ i sms present under each  condi t i on . However , s i nce  n o  
TABLE  1 3 . Summary of Res u l t s  From Spec i a l  
Oemoxepam Study - B l ood a t  2 5 ° C  
p H  F -/ C20� PRESENT or  ABSENT RESULTS 
5 absent - 20% decrease  in  OEM concentrat i on 
- No NO format i on 
5 present  - 20%  decreas e  in  OEM  concentrat i on 
- No  NO  format i on 
6 . 5  absent  - 50% decrea s e  in  OEM concentra t i o n  
- Aabout 5 0 %  o f  ori g i na l  OEM 
converted to NO 
6 . 5  present  10-15%  decrease  in  OEM concentrat i on  
- No NO  formed 
AThe  sens i t i v i ty of the ana l yti ca l  p rocedu re for OEM was 10% and there­
fore , not sen s i t i ve enough to s tate that a l l OEM that d i sappeared was  
converted to NO . 
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pH 
6 . 5  
6 . 5  
6 . 5  
6 . 5  
5 . 0  
5 . 0  
5 . 0  
5 . 0  
TABL E  14 . Res u l ts  of Mi c roorgan i sm Study 
Storage Con-
d i t i on of B l ood 
2 5 ° C  - F/C204 
4 ° C  - F/C204 
2 5 ° C  + F/C204 
4° C  + F/ C204 
2 5 ° C  - F/ C204 
4° C  - F/C204 
2 5 ° C  + F/C204 
4° C  + F/ C204 
Bacter i a Detected 









Aerob i  c 
enteri c Streptococci 
Pseudomonas  aerugi nosa  
l.  col  i 
enteri c Streptococci  
Pseudomona s 
E .  col  i 
- --
aerugi nosa  
enteri c Streptococci 
Pseudomonas  
E .  col i 
- --
enteri c Streptococci 
Pseudomonas  
enteri c Streptococci 
enteri c Streptococci  
Pseudomonas  ma l toph i l i a 
none 
enteri c Streptococci 
68 
Yea s t  Detected 
none 
none 
Sacchanomtce s  







quant i tati ve determi nati ons  were made , i t  i s  pos s 1 b l e that an  i nc reased  
number  of mi croorgan i sms can account  for  nordi azepam format i on i n  one  of  
the s ampl es  and not in  the others . 
4 .  N i trazepam . Tab l e  1 5  i l l u s trates the stabi l i ty of  n i tra­
zepam in  b l ood and buffer ( pH 7 . 5 ) . I t  i s  ev i dence that n i trazepam i s  
unstab l e  i n  b l ood , d ro pp i n g  from a n  i n i ti a l concentrati on of 5 mg/ l a t  
day 0 to none detected b y  day 24 .  L i near regres s i ons o f  ( N I T )  v s . t and  
I n ( N I T )  vs . t s uggest  a pseudo-fi rst  order decay proces s ,  but  the  
d i fference in  r va l ues  i s  qu i te sma l l .  N i trazepam appears  to b e  q u i te  
stab l e when  stored a t  4 ° C  in  b l ood and butter  over  a 2 month  peri od  a s  
i nd i cated by t h e  9 5 %  C I  f o r  t h e  s l opes . About  30% of n i trazepam 
d i sappears in buffer at  2 5 ° C . and  l i near  regre s s i ons  of t N I T )  v s . t and 
I n ( N I T )  v s . t do not i nd i cate whether th i s proce s s  i s  O-order or 
p seudo-fi rst orde r .  
B .  Ti s s ues  
I he t i s s ue  data  for  benzod i azep i nes  a re g i ven i n  F i g u re s  
8 - 1U . Several po i nts  a re suggested from t h e s e  data : 1 )  There wa s no  
s i gn i f i cant  change  in  the concentrat i on of d i azepam in  both l i ve r  and  
bra i n for  3 months  fol l owi ng i ts storage at  e i ther  room temperatu re or  
a t  refri gerated temperatu re ( F i g .  8 ) . 2 )  When l i vers conta i n i ng 
nordi azepam a re stored at  25 ° C , there i s  approxi mate l y  a 50% decrease  i n  
nordi azepam concentrat i on by day 25 ( F i g ure 9 ) . At l ea s t  80% of' 
fl u razepam ori g i na l l y  present  i s  detectab l e  when the l i vers were s tored 
at  2 5 ° C  o r  4° C ( F i g ure 10 ) . 
N - 1 -desa l kyl fl u razepam was not quant i tated a l ong  w i th  
f l u razepam because  a change 1n  the extract i on procedu re wa s nece s s a ry .  
TABL E  1 5  
Stabi l i ty o f  N i t ra zepam i n  B l ood a n d  Buffer 
25°C 4°C 
BLOOD BUFFER BLOOD BUFFER 
T IME ( days ) ( CD P )  I n ( CD P )  ( CD P )  I n ( CD P )  ( CD P )  I n ( CD P )  ( CD P )  I n ( CDP ) 
0 4 . 5  1 . 50 4 . 1  1 . 4 1  4 . 5  1 . 50 4 . 1  1 . 41 
4 4 . 0 1 . 39 4 . 4  1 . 48 4 . 6  1 . 53 4 . 5  1 . 50 
8 2 . 0  . 69 4 . 3  1 . 46 4 . 4  1 . 48 4 . 3  1 . 46 
1 1  1 . 4 . 34 3 . 9  1 . 36 5 . 0  1 . 6 1 4 . 1  1 . 4 1  
1 5  1 . 0 0 4 . 0  1 . 39 4 . 4  1 . 48 4 . 1  1 . 4 1  
1 8  0 . 5  - . 69 3 . 0  1 . 10 4 . 0 1 . 39 4 . 1  1 . 4 1  
22  0 . 7  - . 36 3 . 1  1 . 1 3 4 . 0  1 . 39 
24 N . D .  2 . 8  1 . 03 4 . 6  1 . 53  3 . 7  1 . 3 1  
3 1  N . D .  3 . 2  1 . 16 4 . 5  1 . 50 
36 N . D .  3 . 2  1 . 16 4 . 6  1 . 53  4 . 3  1 . 46 
43 N . D .  2 . 9  1 . 06 4 . 6  1 . 5 3  4 . 3  1 . 46 
S l ope - . 18 - . 10 - . 036 - . 010  7 . 1 x 10-
4 
3 . 0x10  -
4 
7 . 2x10  -
4 
1 . 8x10  -4 
I ntercept 4 . 1  1 . 56 4 . 2  1 . 45 4 . 5  1 . 50 4 . 1  1 . 43  
Corr . Coef . - . 94 - . 96 - . 81  - . 81  
for  S l ope ( - . 023  , . 02 1  ) ( - . 0082 , . 0096 ) 
'-J 
0 
F I GURE 8 .  Effect of temperature on the storage of ti ssues  contai n i n g  
d i azepam . 
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Th i s  was due to a peak  i nterfe rri ng  w i th the  f l u razepam pea k .  Gas  
ch romatograph i c  retenti on t i me s  suggested that th i s pea k was  
hydroxyethyl fl u razepam , a metabo l i te of  fl u razepam . I n  o rder to remove  
th i s  i nterference , a l es s-po l a r  s o l vent , hexane , wa s  empl oyed i n  the  
i n i t i a l extracti on step . However , t h i s change  caused  the more po l a r  
metabo l i tes  o f  fl u razepam such  a s  N - 1 -desa l kyl f l u razepam 'to rema i n  
l arge l y  i n  the aqueous  l ayer ,  thus p reventi n g  thei r quanti tati on . 
Moreover ,  due to the sma l I quant i t i e s  of fl u razepam detected i n  the  
b ra i n  « 0 . 1  mg/ l ) ,  no  attempts were made  to s ubmi t them to these  
experi ments . 
7 5  
I I .  BARB ITURATES 
A.  Oxybarb i tu rates  
1 .  LC Method Deve l o pment  
a .  L i neari ty and sen s i t i v i ty 
The l i neari ty of p l ots  of peak  a rea rat i o s  of  
the  barb i tu rate peak to the i nterna l  s tandard peaks  was estab l i shed  by 
add i ng known amounts  of the barbi tu rate to b l ood not  conta i n i ng 
barb i tu rate and then s u bmi tti ng  the b l ood so l ut i ons  to the extracti on  
procedure . T he  standard c urves  obta i ned a re i l l u strated i n  F i g u re s  1 1  
a nd  12 . T he  curves were determi ned to be  l i near  ( corr > . 99 )  f or  
amobarb i tal , butabarb i ta l , pentobarb i ta l , a nd  secobarb i ta l from 0 . 2 mg/ l 
to 60 mg/ l . S i nce the  concentrat i ons  of phenobarb i ta l  encounte red i n  
c l i n i ca l  and foren s i c l ab s  a re s omewhat  h i gher  than those  of the  other  
barb i tu rates , h i gher  concentrat i ons  of  phenobarb i ta l  were tested . 
L l neari ty ( corr > . 99 )  wa s e s tab l i shed from O . �  mg/ l to 120 mg/ l  for  
phenobarb i tal . S i nce the l owes t  therapeut i c concentrat i on of 
pentoba rb i tal  and secobarb i ta l  i s  . 5  mg/ I ,  th i s  method has s uffi c i ent  
sen s l t i v i ty for  the detecti on of  therapeut i c concentrati ons  of the  
barb i tu rates . 
F I GURE  1 1  
The ordi nate p l ots  the a rea  rat i o o f  barb i tu rate t o  barb i ta l , the  
i nterna l  s tandard . L i near  reg re s s i on of each l i ne y i e l ded the 
fo l l ow i ng :  
butabarb i ta l  : s l ope = . 029 ;  i ntercept = . 0063 ; r> . 99 
pentobarb i ta l  : s l ope = . 03 1 ; i ntercept = - . 048 ; r> . 99 
amobarb i ta l  : s l ope = . 037 ; i ntercept = - . 02 ; r> . 99 
secobarb i ta l  : s l ope = . 038 ; i ntercept = . 00 5 ; r> . 99 
F IGURE 1 1 . Standard curve for b l ood barb i turate s . 
o � a:: 
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F I GURE  1 2  
T he  ord i nate p l ots  the a rea rati o of  phenoba rb i ta l  to barb i ta l , 
the i nternal  s tandard . L i near regre s s i on of the l i ne y i e l ded the  
fol l ow i ng :  
s l ope . 043 ; i ntercept . 20 ;  r> . 99 
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b .  Prec i s i on 
The reproduc i b i l i ty of the method wa s 
determi ned by prepari ng 1 b l ood s amp l e ,  conta i n i ng 2U mg/ l  of the  
barb i tu rates and d i v i di ng  i nto 5 porti ons . I he se  port i ons  were 
extracted and chromatographed . The coeffl c 1 ent  of vari at i o n  for tne  
a rea  rati o of barbi tu rates to i nternal  standard 1 S  g i ven in  Tab l e  16 . 
c .  Speci t l c i ty 
7 8  
From t he  pH ot t he  extract i on , i t  wou l d  be  
expected that wea k  ac i d and neutra'l drugs wou l d  enter  the organ i c l ayer . 
Therefore a seri es  ot these compounds were i nj ected to determi ne  the i r 
retent i on t i mes . These retenti on t i mes  a re g i ven i n  Tabl e 1 7 . Several  
po i nts  become evi dent from the tabl e .  For examp l e ,  pentobarb i ta l  
co-ch romatog raphs  wi th amobarb i ta l . Th i s mean s  that e i ther o n e  of  these  
drugs  can  be quanti tated a s  l ong a s  the other  i s  not present . Moreover ,  
a n  a l ternate method wou l d  b e  req u i red for qua l i tati ve i denti fi cat i on . 
Fortunate ly , these drug s  a re rare ly  co-admi n i stered . A more severe 
l i mi tati on i s  that pri mi done and phenobarb i ta l  are poorl y reso l ved . 
Phenobarb i ta l  i s  a metabo l i te of pri mi done and both compounds wou l d  
appea r i n  a sampl e from a pati ent rece i v i ng pri mi done . Butal b i ta l  and  
butabarb i ta l , two drug s  wh i ch a re d i ffi c u l t to separate u s i ng gas  
c h romatog raphy , d i ffer in  thei r retenti on t i me s  by about  0 . 2  mi nutes . 
Th i s  wou l d  not on ly  a l l ow quanti tati on , b ut  a l so  can permi t q u a l i tati ve 
i denti fi cati on . 
TABL E  16  
Coeffi c i ent  of V ari a t i o n  for the Barb i tu rate 
Determi nati on  at  20 mg/ l in B l ood 
Barb i tu rate 
amobarb i ta l  
butabarb i ta l  
pentobarb i ta l  
phenobarb i ta l  
secobarb i ta l  
Coeffi c i ent  of Var i at i on ( % )  
8 . 1  
5 . 0  
7 . 3  
2 . 4  
7 . 9  
7 9  
TABL E  1 7  
Retent i on T ime s  of s ome Co-extracted Drug s  
u s i ng  HPLC  barb i tu rate procedu re 
Drug  
amobarb i ta l  
aprobarb i ta l  
b arb i ta l  
butabarb i ta l  
buta l b i ta l  
ca rbamazep i ne  
cyc l obarb i ta l  
g l uteth i mi de 
hexoba rb i ta l  
meprobamate 
mesanto i n  
methaqua l one 
pentoba rb i ta l  
phenobarb i ta 1 
phenyto i n  
pri mi done 
secobarb i ta l  
th i opental  
Retent i on T i me 
( ± . 05 mi n . ) 
4 . 8  
3 . 1  
2 . 2  
3 . 6  
3 . 8  
6 . 0  
3 . 7  
4 . 5  
4 . 3  
not observed 
3 . 8  
8 . 0  
4 . 8  
2 . 8  
3 . 9  
2 . 9  
5 . 4  
5 . 8 
80 
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d .  Recovery 
Recovery stud i e s  for barb i tu rates were 
performed as outl i ned  i n  the Exper imental  Sect i on ( p .  43 ) .  I he average  
of  these res u l ts for each  i s  g i ven i n  Tab l e 18 . 
e .  Pati ent  Sampl e s  
T o  determi ne further t h e  va l i d i ty of t h i s 
method , serum samp l e s  conta i n i ng phenobarb i tal  were obtai ned from the  
Med i ca l  Col l ege of V i rg i n i a  Hosp i tal s Tox i co l ogy Laboratory .  These  
s ampl es  a re a s s ayed for phenobarb i ta l  u s i ng the gas  c hromatograph i c 
method of B l anke and Saady ( 92 ) .  These  spec i mens  were a l s o  run t hrough  
th i s LC method and p l ots  of t he  concentrat i ons  u s i ng  t he  2 method s are  
g i ven i n  r i gure 1 3 . Before t he se  s ampl es  we re a s s ayed by the l i q u i d  
ch romatograph l c  method , a s tandard curve  for serum phenobarb i ta l  l eve l s 
was generated . Good agreement between the two methods wa s found  ( r= . 99 )  
for phenobarb i ta l s amp l es .  
2 .  �tabi l i ty i n  b l ood and t i s s ues  
uata  of concentrati on  vers u s  t i me for  the  
barb i tu rates i n  b l ood and serum are g i ven i n  Tab l es 19 -24 . Two sets  of  
data were  obtai ned , one set for " therapeut i c "  concentrat i on s  and  one  set  
t o r  " tox i c "  concentrat 1 0ns . S i nce 0 i s  wi th i n  the 95% confi dence 
i nterval  ( C I ) for the s l ope ,  1t  can be  s tated that there 1 S  no  
stat i st i ca l l y  s i gn i fi cant change in  the barb i tu rate concentrat i ons  over  
the 2-3  month peri od  at  2�vc  and 4 ° C .  ( See Append i x  tor  further 
di scus s i on )  
TABLE  18  
Extracti on Effi c i ency of B arb i tu rates 
by Methyl ene C h l o ri de 
Average 
Barb i turate % Recovery 
amobarb i ta l  7 2  ± 1 
butabarb i ta l  8 1  ± 1 1  
pentoba rb i ta 1 7 3  ± 1 2  
phenobarb i ta l  8 2  ± 1 4  
secobarb i ta l  7 9  ± 12  
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F I GURE 1 3  
The x-ax i s g i ves t h e  concentrat i on of serum s ampl es  conta i n i ng 
phenobarb i ta l  a s  obta i ned by the GC method of B l anke  and Saady (92 ) . 
The y-axi s g i ves the concentrat i ons  of the same spec i mens  a s  obta i ned 
by th i s  LC method . L i near  regre s s i on y i e l ded the fol l owi ng : 
s l ope = 1 . 00 ;  i ntercept = . 069 ; r = . 99 ;  n = 18 
F I GURE 13 . Scatter p l ot for serum p henobarb i ta l  concentrati ons  u s i n g  
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S l ope 
I ntercept 
95% C I  
f o r  s l ope 
TABL E  19 
Storage of  B l ood Conta i n i ng Amobarb i ta l  
at  2 5 ° C  and  4 ° C  
"Therapeut i c "  " Tox i c "  
84  
Concentrat i on ( mg/ l ) Concentrati on ( mg/ l ) 
2 5 ° C  4 ° C  2 5 ° C  4 ° C  
2 . 2  2 . 2  2 1 . 8  2 1 . 8  
2 . 6  2 . 3  2 1 . 7  2 3 . 4  
2 . 4  2 . 7  19 . 4  2 3 . 3  
2 . 0  1 . 8 1 7 . 2  1 9 . 1  
2 . 2  2 . 0  18 . 2  2 2 . 8  
2 . 4  2 . 0  1 7 . 0  1 9 . 4  
2 . 5  2 . 1  20 . 3  20 . 1  
1 . 6x 10  -4 - . 0052  - . 0036 - . 039  
2 . 3  2 . 3  20 . 7  2 2 . 8  
( - . 007 , . OO? ) ( - . 0 1 , . 00 1 ) ( - . 086 , . 078 ) ( - .  1 1  , • 028 ) 









S l ope 
I ntercept 
95% C I  
for S l ope 
TABLE  20 
Storage of  B l ood Conta i n i ng Butabarb i ta l  
at  2 5 ° C  a n d  4 ° C  
" Therapeut i c "  " Tox i c "  
Concentrat i on ( mg/ l ) Concentrat i on ( mg/ l ) 
25 ° C  
6 . 2  
4 . 5  
5 . 3  
5 . 0  
4 . 7  
5 . 1  
4 . 8  
- . 0084 
5 . 2  
4 ° C  
6 . 2  
4 . 5  
4 . 5  
4 . 7  
5 . 5  
4 . 8  
5 . 8  
. 00 10  
5 . 1  
2 5 ° C  
20 . 6  
16 . 8  
19 . 6  
18 . 3  
17 . 3  
18 . 6  
18 . 6  
- . 0077 
18 . 8  
4 ° C  
20 . 6  
18 . 1 
1 8 . 7  
18 . 9  
1 9 . 4  
18 . 6  
18 . 8  
18 . 4  
- . 0 l 3  
1 9 . 5  
85  
( - . 020 , . 004 ) ( - . 029 , . 03 1 ) ( - . 056 , . 03 1 ) ( - . 043 , 0 1 7 ) 









S l ope 
I ntercept 
95% C I  
for S l ope 
TABLE  2 1  
Storage of B l ood Conta i n i ng Pentoba rb i ta l  
at  2 5 ° C  a n d  4° C 
" Therapeu t i c "  " Tox i c "  
Concentrat i o n ( mg/ l ) Concentrat i o n ( mg/ l ) 
2 5 ° C  
1 . 7  
1 . 4  
1 . 1  
2 . 3  
1 . 8 
1 . 9  
. 0042 
1 . 5  
4 ° C  
1 . 7  
1 . 7  
1 . 2  
1 . 2  
2 . 1  
1 . 5  
1 . 8 
. 0023  
1 . 6  
2 5 ° C  
19 . 3  
1 9 . 2  
19 . 7  
1 9 . 7  
20 . 8  
20 . 5  
19 . 7  
. 0091  
1 9 . 5  
4 ° C  
1 9 . 3  
2 1 . 4  
20 . 4  
20 . 3  
20 . 3  
18 . 8  
1 9 . 9  
19 . 4  
- . 0048 
1 9 . 7  
86 
( - . 0 1 3 , . 02 1 )  ( - . 0 18 , . 0 14 ) ( - . 0 16 , . 034 ) ( - . 0 1 1 , . 00 1 2 )  






3 5  
42 
81 
S l ope 
I n tercept 
95% C I  
for S l ope 
TABLE  2 2  
Storage of  B l ood Conta i n i ng Phenoba rb i ta l  
a t  2 5 ° C  and  4 ° C  
" Therapeut i c "  " Tox i c "  
Concentrat i on ( mg/ l ) Concentrat i on ( mg/ l ) 
2 5 ° C  4 ° C  2 5 ° C  4 ° C  
20 . 7  20 . 7  60 . 5 60 . 5  
20 . 6  2 1 . 0  57 . 3  
1 9 . 4  2 1 . 0  56 . 6  58 . 6  
18 . 5  2 1 . 3  53 . 0  56 . 2  
18 . 0  
2 1 . 7 2 1 . 2  6 1 . 7  58 . 0  
2 2 . 7  22 . 4  5 9 . 4  5 2 . 2  
20 . 5  20 . 8  55 . 8  6 1 . 3  
. 0 13 . 0035  - . 020 . 008 
20 . 2  2 1 . 1  58 . 4  5 7 . 5  
87 
( - . 62 , . 66 ) ( - . 17 , . 18 )  ( - . 17 , . 2 1 )  ( - . 1 3 , . 1 5 ) 






3 5  
4 2  
7 2  
S l ope 
I ntercept 
TABL E  23 
Storage of  B l ood Conta i n i ng Secoba rb i ta l  
at  2 5 ° C  and  4 ° C  
" Therapeut i c "  " Tox i c "  
Concentrat i o n ( mg/ l )  Concentrat i o n ( mg/ l ) 
2 5 ° C  
2 . 3  
1 . 9  
2 . 1  
2 . 9  
2 . 6  
2 . 1  
3 . 0  
0 . 15 
2 . 1  
4 ° C  
2 . 3  
2:7 
2 . 5  
2 . 9  
2 . 8 
2 . 4  
2 . 9  
2 . 3  
. 008 
2 . 4  
2 5 ° C  
18 . 1  
22 . 5  
18 . 2  
19 . 6  
18 . 3  
22 . 0  
19 . 5  
. 026 
1 9 . 3  
4 ° C  
18 . 1  
2 2 . 2  
2 2 . 3  
1 7 . 8  
1 9 . 4  
20 . 8  
1 9 . 3  
. 00 1 6  
20 . 1  
88 
95% CI ( - . 002 , . 03 2 ) ( - . 004 , . 020 ) ( - . 029 , . 08 1 ) ( - . 0 56 , . 060 ) 
for S l ope 










S l ope 
I ntercept 
95% C I  
for s l ope 
TABLE  24 
Storage  of Serum Conta i n i ng 
Phenobarb i ta l  at 2 5 ° C  and  4 ° C  
Phenoba r b  i ta 1 
Concentrat i o n ( mg/ l ) 










- . 018  
20 












( - . 026 , . 0 1 4 )  
8 9  
The f i rst  2 data po i nts  for each b arb i tu rate we re 
obta i ned u s i ng the l i q u i d  ch romatograph i c  method d i s cu s sed a bove . 
However , due to the presence of i nterference s u b stance s , a g a s  
chromatograph i c  method ( 92 )  had  to be u sed  to f i n i s h  t h e  experi ments . 
Th i s i s  d i scus sed i n  g reater deta i l i n  the  D i scu s s i on ( p .  1 20 ) .  
90 
Data from l i vers  conta i n i n g  barb i turates a re g i ven 
in  Tab l e  25 . The fi g ures  were obta i ned by comb i n i ng data from 
i nd i v i dua l  l i vers as outl i ned i n  the Exper imental  Secti on . For a l l of  
the barb i tu rates stud i ed , g reater t han  75%  of t he  barb i turates 
or i g i na l l y  present were detected at  the end of the 2 month peri od  a t  4 ° C  
a n d  2 5 ° C .  
B .  Th i opental  
1 .  LC  method devel opment 
a .  Samp l e Chromatog rams , l i neari ty ,  and  
sen s i t i v i ty 
F i g u re 14 i l l u s trates samp l e ch romatog rams 
of a b l ood extract conta i n i n g th i opental  and i nternal  standard . A 
s tandard curve p l ott i ng area rat i o  of t h i opental  to pheno l phtha l e i n  
versus  th i openta l concentrat i on was prepared b y  extract i ng  b l ood  afte r 
the  add i ti on of known amounts  of th i opental  ( F i gu re 1 5 ) .  The p l o t  was  
l i near  from 1 mg/ l to 60 mg/ l  th i opental  ( corr > . 99 ) . S i nce pl a sma 
concentrat i ons  g reater than 7 mg/ l  a re a s s oc i ated wi th anesthe s i a  ( 94 ) , 
th i s p rocedu re can be  u sed to quant i tate th i opental  therapeuti ca l l y  a s  
wel l a s  i n  overdose s i tuat i ons . 
T i me 
( month s )  
Amoba  rb i ta 1 
2 5 ° C  4 °C  
0 100 100 
9 l±8 9l±8 
2 77±5  76±9 
TABLE  25 . B a rb i tu rafe Ti ssue  Study 
% o F O R I G I N A L  P R E  S E N  T 
Pentobarb i ta l  Phenobarb i ta l  
2 5 ° C  4 ° C  2 5 ° C  4 ° C  
100 1 00 100 100 
100 100 88±5 83±5 
100 1 00 90±6 86±10 
(x  ± s )  
Secobarb i ta l  
25 °C  4 ° C 
100 100 
9l±23  78± 1 3  
97±16  9l±12  
<.0 ..... 
F I GURE  14  
The  verti cal  ax i s i s  t i me ( mi n )  and  the  hor i zontal  ax i s i s  
detector res pon se . 
14 a )  l i q u i d chromatogram of a b l ood extract conta i n i ng 
th i opental  and i nterna l  standa rd . 
14 b )  l i q u i d chromatogram obta i ned after extract i n g  a b l a n k  b l ood 
samp l e .  
F I GURE 14 . Samp l e  chromatogram for t h i opental . 
0 )  STA R1






F I GURE  1 5  
T he  ord i nate p l ots  a rea  rat i o of  th i openta l to i nterna l  standard . 
L i near  regres s i on y i e l ded the  fol l ow i n g : 
s l ope = - . 062 ; i ntercept = - . 09 ;  r> . 99 
FI GURE 1 5 .  Standard cu rve for b l ood th i openta l . 
3. 0 0  
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b .  Precl s i on 
W i th i n day preC1 S l on was  determi ned by 
prepa ri ng 6 sampl es , each conta i n i ng 30 mg/ l th l opental . These  s amp l es 
were then extracted and  chromatographed . The mean and  stardard 
dev i at i on of the b a rea rat i o s  were used to ca l cu l ate the coeffl c l ent  of 
v ari at i on ( 3 . 9% ) . 
Day to day preci s i on was ca l cu l ated by 
prepa ri ng a 30 mg/ l standard whenever th i openta l s amp l es  were ana l yzed 
( approx i mate ly  once a week over a 2 months  peri od ) . Day to day 
p reci s i on was tl . 2% .  
c .  Speci t l c l ty 
Weak l y  ac i d i c  and neutra l drugs wou l d  
co-extract wi th th i opental  and i nterna l  standa rd . Therefore , methano l i c 
standards  of these drugs  were i nj ected i nto the l i qu i d  chromatograph  to 
determi ne  whether they i nterfere wi th  th i s  a s s ay .  Tab l e 26 l i st s  the 
drugs exami ned and found not to i nterfere . Moreover ,  on ly  carbamazep i ne  
gave  a peak when present  ln  therapeuti c concentrati ons  in  the b l ood . 
� .  I h i opental  stab i l i ty i n  b l ood and aqueou s bufter  
T abl e 27 i l l u s trates t h e  s t a b i l i ty of th i opental  i n  
b l ood and i n  phos phate b uffer a t  p H  7 . 0 .  S i nce 0 i s  wi th i n the 95%  
confi dence i nterva l for  the s l opes  of  these  curves , no  s i gn i f i cant 
changes  in  t h i opental  concentrat i on  occurred under any of the cond i t i ons  
tested . Pentobarb i ta l ,  a metabol i te of th i openta l and  the equ i va l ent  
oxybarb i tu rate to th i openta l , was quanti tated at  the  beg i nn i ng  and  end 
of the 2 month peri od ; none was detected in  any of  the  sampl es . 
TABL E 26  
Co-extracted D ru g s  Found  not  to I nterfere 
wi th  Th i openta l As say 
amoba  rb i ta 1 
butabarb i ta l  
buta l b i ta l  
ca rbamazep i ne 
g l utet h i mi de 
meprobamate 
mesanto i n 
methaqua l one 
methypry l on 
pentobarb i ta 1 
phenobarb i ta l  
phenyto i n  
pr im i done 
secobarb i ta l  
95  







S l ope 
I n tercept 
TABL E  27  
Storage  of  Th i openta l i n  B l ood and Buffer 
at  2 5 ° C  and 4 ° C  
C O N  C E N T R A T  I O N  ( mg/ l ) 
2 5 ° C  
2 5  
2 2  
2 5  
2 2  





4 ° C  
2 5  
2 5  
2 7  
2 5  




2 5 ° C  
1 6  
1 5  
1 3  
1 4  
1 7  
1 3  
- . 0 18 
1 5  
BUFFER  
4 ° C  
1 6  
1 4  
1 3  
1 8  
1 7  
14  
- . 007  
15  
95%  C I  ( - . 07 6 , . 12 )  ( - . 0 15 , . 1 2 )  ( - . 090 , . 054 ) ( - . 096 , . 082 ) 
fo r S l o pe 
96 
97 
I I  1 .  L I DOCA I N E  
A .  GC method devel opment  
1 .  Samp l e chromatograms , l i neari ty and  sen s i ti v i ty 
Samp l e ch romatograms for the  l i doca i ne a s s ay a re 
g i ven i n  F i gure 16 . The l i neari ty of l i doca i ne concentrati on  v s  peak  
a rea rati o of l i doca i ne to i nternal  s tandard was  estab l i s hed by  add i ng 
known amounts of l i doca i ne to serum , b l ood , o r  t i s sue  homogenate , not  
conta i n i n g l i doca i ne and  then  extracti n g  after addi t i o n  of  i ntern a l  
standard . I he curves were observed to be  l i near  ( r  > . 99 )  from 0 . 1  mg/ l 
to 1� mg/ l  l i doca i ne .  An examp l e  i s  i l l u strated i n  F i gure 17 . S i nce  
the therapeuti c concentrat i on  of l i do ca i ne i n  s erum i s  1 -5 mg/ l , t h i s 
p rocedure provi des a l l near  curve  i nto the  tox i c range of l i doca i n e . 
2 .  P rec i s i on 
The "wi th i n day" preci s i on of the  method was 
determi ned by extracti n g  10 samp l es , each  conta i n i ng 4 . 6  mg/ I l i do ca i ne .  
The coeffi c i ent of var i at i on was 2 . 9% .  Moreover ,  rep l i cate i nj ect i o n s  
of t h e  same sampl e o v e r  a two hour  peri od s howed l es s  t h a n  a Z� c h a n g e  
i n  a rea rati o o f  l i doca i ne t o  i nterna l standard , i nd i cati n g  stab i l i ty of  
the reconsti tuted res i due . 
The " day to day " prec i s i on of the method  wa s 
ca l cu l ated from 4 . 6  mg/ l  serum l i doca l ne qua l i ty control  s amp l e  fre s h l y  
prepared a n d  run wi th  each batCh o f  l i doca i ne over  a 3 months  per i od . 
The coeffi c i ent  of var i ati on was � . 8% . Dur i n g  th i s  peri od l i do ca i ne 
ana l yses were performed by 8 techn i c i an s . 
F I GURE  16  
The verti ca l ax i s i s  t i me ( mi n )  and the hor i zonta l ax i s i s  
detector response . 
1 6  A ) : gas chromatogram obta i ned after extracti ng  a b l a n k  serum 
s amp l e 
16 B ) : gas  ch romatogram obta i ned after extracti ng a serum samp l e 
conta i n i ng l i doca i ne and i nterna l standard 
16  C ) : gas chromatogram obta i ned after extracti ng  an a l i qu ot  of 
a l i near  homogenate sp i ked wi th l i doca i ne and  i nterna l  standard 
FlGURE *6 .  S amp l e  chromatogram for 1 i doca  i n e .  
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F I GURE 17  
The ord i nate p l ots a rea  rat i o of l i doca i ne to mepi v i ca i ne , the  
i nterna l  standard . L i near regres s i on y i e l ded the fol l ow i n g : 
s l ope = . 14 ;  i ntercept = . 007 ; r> . 99 
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3 .  Spec i fi c i ty 
A l i s t of  b as i c  and  neutra l drugs wh i ch were 
extracted and found not to i nterfere wi th  the quant i f i cat i on of 
l i doca i ne i s  g i ven i n  Tab l e 28 . I n  other  words , base l i ne separa t i on  
between e ach  of t he se  drugs , l i doca i ne , and  i nterna l standard , was  
obta i ned . 
1 00 
Monoethyl g lycyl xy l i d i de ( MEGX J , an i nact i ve  
metabol i te of l i doca i ne ,  was a l s o  s u bj ected to t he  extra ct i on  procedu re . 
I ts retenti on t i me was 1 . 3  mi nutes . I n  a l l pati ent samp l e s  q uant i tated 
for l i doca i ne , no i nterferences by MEGX  were observed . 
B . L i doca i ne s tab i l i ty i n  b l ood , serum and l i ver  
The  d ata  obta i ned from t he  poo l ed  serum and poo l ed  b l ood  
study a re g i ven in  Tab l e s  29-30 . After 70  days , approx i mate l y  80% of  
the l i doca i ne i n i ti a l l y  present wa s s ti l l  detected i n  serum ; there 
appeared to be l i tt l e temperature effec t ;  stat i st i ca l  eva l uat i on 
i nd i cated that these were i ns i gn i fi cant  changes . No s i gn i f i ca n t  l os s  i n  
l i doca i ne wa s seen i n  b l ood at  e i ther temperatu re a s  i nd i cated by the  
95% confi dence i nterva l for the s l ope of  the  concentrati on vers u s  t i me 
p l ots . 
The res u l ts from the 4 l i vers  stud i ed a re g i ven  i n  Tab l e 
3 1 . After tne two month  peri od , approxi mate l y  70% of l i do ca l ne 
o ri g i na l l y  present was st i l l  detected when the  l i vers  were s tored a t  
room tempe rature . L i vers kept l n  t h e  refri gerator reta l ned 87%  o f  the  
l i do ca i ne ori g l na l l y  present  over  the s ame l ength  of t i me .  
l V . NORTRYPTY L I NE , D I SUPYRAM I DE , AND PROCAI NAM l D E  
TABLE  28 
D ru g s  Found Not  to I n terfere wi th  the 
L i doca i ne Assay when Present i n  
Therapeut i c Concentrat i on 
Ami tryptyl  i ne  
Ch l o rd i axepox i de 
Code i ne 
Des i prami ne  
D i azepam 
D i sopyrami de 
Doxep i n  
F l u razepam 
Imi p rami ne 
Meprobamate 
Methadone 
Methaqua l one  
Nord i  azepam 
Nortrypty l  i ne 
Procai  nami de/ NAPA 
Propoxyphene 
Proprano l o l  
Qu i n i d i ne  
1 01 
TABL E  29  
Stab i l i ty of L i doca i ne in  Poo l ed Serum 









S l ope 
I n tercept 
95% C1  
for S l ope 
Concentrat i on ( mg/ l )  
2 5 ° C  
6 . 3  
5 . 8  
5 . 6  
5 . 5  
5 . 2  
5 . 3  
5 . 4 
5 . 3  
- . 0 1 1  
5 . 9  
( - . 06 ,  . 04 )  
4 ° C  
6 . 3  
6 . 0  
6 . 2  
5 . 9  
5 . 2  
5 . 3  
5 . 2  
5 . 6  
- . 0 1 3  
6 . 1  
( - . 084 , . 058 ) 
1 02 
TABL E 30 
Stabi l i ty of  L i doca i ne in  Poo l ed  B l ood 









S l ope 
I n tercept 
95% C I  
for S l ope 
Concentrat i on ( mg/ l )  
2 5 ° C  4 ° C  
2 . 3  2 . 3  
2 . 6  2 . 3  
2 . 2  2 . 2  
2 . 2  2 . 4 
2 . 0  2 . 2  
2 . 5 2 . 0  
2 . 0  2 . 2  
2 . 3  2 . 2  
- . 00 19  - . 0023  
2 . 3  2 . 3  
( - . 0 10 , . 0063 ) ( - . 0063 , . 0020 ) 
1 03 
TABL E  3 1  
L i doca i ne L i ve r  Study 




% Or i g i n a l  Present ( x±s ) 
2 5 ° C  4 ° C  
100 100 
75±4 90±12  
7 0±35 87±16 
1 04 
1 05 
The concentrat i on versus  t i me data at  2 5 ° C  and  4 ° C  for these  
dru g s  are g l ven i n  Tab l e s  32-34 . The data  suggests  that  no  s i g n i fi cant  
changes  i n  drug  concentrat i on were t ound  a t  e i ther  temperature under  
these  storage condi t i ons . I h i s  i s  ev i dent from the tact  that  0 i s  
conta i ned wi th i n  the 95%  confi dence i nterva l for the s l ope fo r a 1  I 3 
dru g s  at 2 5 ° C  and 4 ° C .  
A po i nt b rought  u p  dur i ng  th i s research  was  the ettect that  � 
v i tro ethano l format i on mi ght  have  on drug quant i tati ons . Therefore , i t  
was  deci ded to a na l yze  b l ood  spec i mens  a t  2 5 ° C  and  at  4 ° C  a t  the  
beg i nn i ng and end of the  experi ment  tor  ethanol . A gas  ch romatograph i c  
method wa s u sed for ethanol  quant i tat i on ( 96 ) . N o  ethano l was found i n  
any o f  the spec i mens  over the 2 month  peri od . 
TABL E  32  
Storage of Nortryptyl i ne in  B l ood 
T ime ( days ) 
0 






S l ope 
I ntercept 
95% C I  
for S l ope 
Concentrat i on (mg/ l ) 
25 ° C 
5 . 1  
5 . 2  
4 . 4  
4 . 5  
3 . 8  
3 . 8  
- . 022 
5 . 1  
( - . 14 , . 10 ) 
4 ° C 
5 . 1  
4 . 3  
4 . 4  
5 . 3  
3 . 8  
4 . 6  
- . O lD 
4 . 9  
( - . 024 , 004 ) 
1 06 
TABLE  3 3  
Storage of D i sopyrami de i n  B l ood 
T i me ( days ) 
0 
1 5  




S l ope 
I ntercept 
95% C I  
for S l ope 
Concentrat i on ( mg/ 1 ) 
2 5 ° C  4 ° C  
5 . 6  5 . 6  
5 . 2  5 . 2  
5 . 4  
6 . 0  4 . 9  
6 . 0  5 . 1  
5 . 1  6 . 0  
- . 00 1 2  . 0045 
5 . 2  5 . 2  
( - . 030 , . 028 ) ( - . 03 1 , . 02 1 )  
1 07 
TABL E  34 
Storage of P roca i nami de in  B l ood 







S l ope 
I n tercept 
95% C I  
fo r S l ope 
Concentrati on ( mg/ l ) 
2 5 ° C  4 ° C  
5 . 8  5 . 8 
5 . 1  5 . 5  
4 . 9  5 . 3  
5 . 0  5 . 4  
5 . 3  5 . 1  
4 . 6  4 . 7  
- . 00 1 5  - . 0018  
5 . 4  5 . 7  
( - . 023 , . 0 19 ) ( - . 0033 , . 0003 ) 
108 
D I SCUSS ION  
I .  BENZOD IAZEP I NES 
The methods used  i n  the performance of the exper iments  
i nvo l v i n g  benzod i azepi nes  were  based  on the paper by Peat and Kopj a k  
1 09 
( 9 1 ) wh i ch empl oyed a comb i nat i on of e l ectron capture gas  ch romatography 
( GC-ECD ) and l i qu i d  ch romatography ( LC ) to ana lyze for benzodi azep i nes . 
Thes e  methods afforded several  advantages i nc l ud i ng  rap i d ana ly s i s  t i me ,  
sens i ti v i ty and good recovery ( >85% ) . F urthermore , because  of the 
s pec i fi c i ty of the e l ectron captu re detector ,  i nterferences by putre­
fact i ve-base  producti on were not a s i gn i fi cant prob l em in the a n a ly se s  
i n  wh i ch gas  chromatography wa s  u sed . Unfortunate l y , ch l ord i azepox i de 
and  norch l ord i azepox i de cou l d not be quant i tated by GC-�CD becau s e  of 
thei r therma l i nstab i l i ty at  the h i gh oven temperatu re . Moreover , the  
po l a ri ty of nordi azepam caused s uch  poor pea k  effi c i ency that repro­
duc i b i l i ty became a s i gn i f i cant  prob l em .  These prob l ems were a l l ev i ated  
by u s i ng l i qu i d  chromatog raphy . However , the product i on of an  
endogenou s  i nterference p roduct unre l ated to the drug made the 
quant i tati on of demoxepam d i ffi cu l t and  frequent ly  i mpo s s i b l e .  
The quanti tati on of benzod i a zep i nes  i n  t i s sues  i nvo l ved a b a c k  
extractl on  i nto ac i d fol l owed by  extract i o n  from t he  a q ueou s  l ayer  after 
a l ka l i n i zatl on . These c l ean-up  steps were nece s s i tated by the presence 
ot neutra l  s ub stances , especi a l l y  l i p i ds ,  in  b ra l n  and  l i ve r .  
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The method of  t i s s ue  storage deserves some d i s cu s s i on .  
Spec i fi ca l l y . i t  was deci ded t o  cut  the t i s s u e  i nto sma l l p i eces  a nd  
p l ace wei ghed port i ons  i� s toppered g l a s s  te s t  tubes . There were 
several  reasons  for s to rage in th i s  manner  a s  opposed to keep i n g  the  
t i s sue  i ntact or  a s  an aqueous  homogenate . C hanges  i n  drug  
concentrat i on s  of t i s sue  homogenates may not  accu rate ly  represent  
changes  i n  i ntact t i s s ue .  For  examp l e v i scos i ty o r  i on i c s trength  may 
i nf l uence a drug ' s  stab i l i ty .  Conversel y .  keep i n g  the t i s s u e  ent i re l y  
i ntact may present probl ems for i nterpreta t i o n  i f  there was a l ac k  of  
homogenei ty wi th i n the  t i s sue . S torage i n  the form of sma l l p i eces  was  
fe l t  to be  the  best  compromi s e . Al s o  by  wei g h i ng  the port i on s  i n i t i a l l y  
effects  o f  dehydrati on were neg l i g i b l e .  
The res u l ts i nd i cate that d i azepam s tored i n  b l ood for  u p  t o  5 
months  wa s stabl e .  even at  room temperature . F l u razepam and i ts 
N - l -desal ky l metabo l i te a l s o  s howed s i mi l a r stab i l i ty .  On the other  
hand . ch l ord i azepox i de i s  u n s tab l e espec i a l l y  a t  room tempe rature . I n  a 
s o l ut i on ori g i na l l y  at  5 mg/ l ch l ordi azepox i de .  the drug was not  
detectab l e wi th i n  1 - 2  weeks . Even at refri gerated temperatu res . a 
decrease was observed i n i t i a l l y  before a l eve l i ng off occurred . The  
d a t a  wi th no rch l o rd i azepo x i de were qual i ta t i v e l y s i mi l a r .  a l though t h e  
t i me unt i l comp l ete d i sappearance of the compound was s l i gh t l y  l onge r .  
Thi s i n stabi l i ty o f  ch l ord i azepox i de observed  i n  b l ood h a s  
prev i ou s l y  been reported i n  aqueous  so l ut i o n s . The mechan i sm o f  COP  
b rea kdown i n  water  i s  g i ven  i n  F i g u re 1 8  ( 97 ) . I n  these  experi ments , 
the format i on of demoxepam was observed . However ,  one compound  produced 
du ri ng the ag i ng  proces s  from ch l ordi azepox i de and  norch l ord 7azepox 7 de 
F I G U RE ;1 8 .  Chemi ca l  degradat i on of  ch l ord i azepoxi d e  i n  wate r . ( 95 )  
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wh i ch was not reported to be  formed i n  wate r .  i s  nord i azepam . wn l ch 
i nvo l ves  the  l os s  ot tne n i t rone  oxygen . 
The experi ments  i n  wh i ch CUP was added to b l ood and aqueous  
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buffer  a t  d i fferent pHs  i n  tne presence and absence  ot  r / C204 revea l e d  a 
l arge amount of i nformat i on  about the mechan i sm of COP  brea kdown a t  room 
temperature . I n  order to make more quant i tat i ve compar i sons  between 
b l ood  and buffer at  the vari ou s pHs . s ome s i mp l e pharmaco k i neti c 
ca l cu l at i ons  were made . Spec i fi ca l l y . i t  h a s  been reported that  COP  
decomposes  i n  aqueou s s o l ut i ons  by  a fi rst  order  p roces s  ( 98 ) . That  
means  that the rate  of COP  b reakdown i s  d i rect ly  proport i ona l  to  the  COP  
concentrati on ( 96 ) . Mathemat i ca l l y .  
-dC = kC  Cit 
where C = COP concentrat i on 
-dC 
<It rate of COP  b rea kdown 
k proporti ona l i ty constant 
Rearran g i n g  the above equati on . 
dC 
r - kdt 
I n tegrat i ng  the l eft s i de of the equat i on from the i n i ti a l  COP  concen­
trati on Co to s ome COP concentrat i on C and i ntegrati n g  the ri g ht  s i de 
from t=O to t=t . one obta i n s  
l n  C - l n  Co = -kt  
Aga i n  rearrang i ng .  
l n  C = -kt  + l n  Co  
Th i s  i s  a n  equati on  of  a l i ne  i n  the form y=mx+b ; where 
b = i ntercept 
m = s l ope 
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These mathemat i ca l  man i pu l at i ons  i mp l y  that a p l ot  of  l n  C v s  
t y i e l ds a stra i ght  l i ne wi th s l ope  - k  a n d  i ntercept l n  Co . Therefo re , 
sampl es  wi th the s ame rate of decompo s i ti on s hou l d have the s ame s l ope . 
I n  th i s way , quant i tat i ve  compari sons  between the  d i fferent  b l ood  and  
aqueous  s pec i mens  can be  made . Data from Tab l es 6 - 1 1  at  25 °C  were 
comp i l ed i n  s uch  a way . The data suggest  that b rea kdown of  COP i s  
affected by pH and  mi croorgan i sm ( F i g u re 19 ) .  
To summar i ze , i t  appears that  a t  pH 8 and  pH 6 . 5 , b l ood  i s  not  
s i mp l y  an aqueous  so l ut i on . I n  one cond i t i on ( b l ood  wi thout F/ C204 ) ,  a 
compound ( NO ) , i s  formed wh i ch does not appear i n  aqueous  buffe r ;  i n  the  
other cond i t i on ( b l ood wi th  F/ C204 ) , COP  appears  to be  more stab l e than  
i n  aqueous  buffe r ( F i g .  19a ) . However , a t  pH 5 ,  b l ood does a ct  l i ke a 
s i mp l e aqueous so l ut i on i n  that  the rate of decompos i t i on i s  
a pprox imate ly  the s ame i n  b l ood and buffe r ,  both i n  the presence  and  
absence of  F/ C204 ( F i g .  19b ) . Th i s  wou l d suggest  that at  pH 6 . 5  a nd  
8 . 0 ,  there i s  s ome component of the b l ood , wh i ch ,  when n ot  s u bj ect  to  
mi c roorgan i sm attac k , can protect COP  b rea kdown i n  b l ood . Th i s 
component mi ght  then be destroyed at  pH 5 wh i ch then causes  the  b l ood  to  
behave a s  an aqueou s  s o l ut i on . 
These types  of cal cu l at i ons  w i th COP b reakdown have  p rev i o u s l y  
been performed i n  va r i o u s  aqueou s med i a  b y  Mau l d i ng �� . ( 99 ) . 
Spec i fi ca l l y ,  they made Arrhenu i s  p l ots  for the convers i on of  C O P  to O EM 
i n  pH 7 phosphate buffer w i th  i on i c  strengh  0 . 5M .  By extrapo l a t i n g  
the i r p l ot  of  l og k v s . = 1 / T  to 2 9 8  K ,  a k va l u e  of  . 00 72  ( days ) - 1  wa s 
obta i ned . I n  the exper iments  performed i n  th i s  research , a k va l ue  for 
I n ( CD P )  v s . t p l ot  of phosphate buffer pH 6 . 5  and  i on i c  s trength 0 . 6M 
wa s . 036  ( day ) - l ( Tab l e 1 2 ) .  Convert i n g  the data to l og k ,  a k v a l u e  of  
F I GURE 1 9 .  Proposed mechan i sm for c h l o rd i azepox i de breakdown . 
o .  b l o o d , p H  6 . 5 , 8  
2 5 - 40 %  
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. 0 1 5  ( day ) - l obta i ned . Therefore there i s  approx i ma te l y  a 2 -fo l d  
d i fference between the  2 sets  of  data . Cons i de r i n g  the d i fferences  i n  
start i n g  concentrati on  ( � 90 mg/ml v s . 5 mg/ l ) and  methodol ogy 
( th i n - l ayer chromatography v s . l i qu i d  chromatography ) ,  the data reported 
here i s  i n  good agreement wi th  the prev i ou s l y  pub l i shed  data . 
The decay pattern observed wi th  c h l o rd i azepox i de and  
norch l ord i azepoxi de  a t  room and  refri gerated temperatures has  been 
prev i o u s l y  observed wi th  c l onazepam , another benzod i azepi ne . Kno p  et  
�. ( 100 ) reported that  a p l a sma c l onazepam concentrat i on of 25  �g/ l  
d i s appeared wi th i n  6 days  when stored a t  20 ° C .  Approx i ma te l y  85% o f  
c l onazepam o ri gi na l l y  present  rema i ned after 2 0  days o f  s torage  a t  1 ° C ; 
about  95% rema i ned after the s ame l ength of t i me when s tored at  -20 ° C .  
Becau se  o f  th i s  reported decrease  i n  c l onazepam concentrat i on  
at  2 5 ° C , i t  wa s  deci ded to exami ne  another benzod i azepl ne  conta i n i ng a 
n i tro group , n i trazepam . L i ke c l onazepam , n i trazepam was found  to  
d i sappear  at  room temperature , from 5 mg/ l i n i t i a l l y ,  to none detected 
by day 25 . 
The data from the t i s sues  corroborates many of the res u l ts  
from the  b l ood data . D i azepam , for examp l e ,  was  found to be  stab l e i n  
t i s s ues  a s  wel l a s  i n  b l ood . F l u razepam a l so a ppeared to be moderate l y  
stab l e .  One prob l em that arose dur i ng the  research was the  acqu i s i t i on 
of  t i s s ue s  conta i n l n g ch l ordi azepox i de .  I hroughout  a 2 year peri od , 2 
l i ve rs conta i n i ng COP  were obta i ned and  prepared a s  out l i ned  i n  the  
txper imental  Sect i on t p .3 3 ) .  However , the i n i t i a l  a na l ys i s  s h owed no  
COP  p resent  in  the l i ve r  even though  COP' wa s detected in  b l ood  in  both 
cases . Moreover nordi azepam wa s detected both l i ve rs . Th i s was  dete r­
mi ned  by LC  and GC retent i on t i mes . tven though nordi azepam i s  a 
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metabo l i te of COP , i t  i s  u n l i ke l y  that i t  wou l d  b e  detected i n  the  l i ve r  
wi thout  the detect i on  o f  other metabo l i tes , norch l ord i azepox i de and  
demoxepam . S i nce nord i azepam i s  a b rea kdown product of COP , i t  wou l d  
appear  that COP had  b roken down before the  commencement  of  the  experi ­
men t .  The l i vers were s to red i n  a freeze r  a t  - 20 ° C  pr i o r  to the  
exper iment , but l t  cou l d not b e  determl ned how l ong  the l i vers  were  a t  
body temperature , room temperatu re o r  4° C before p l acement  i n  t h e  
freezer .  i n  genera l  f o r  med i ca l  exami ner  c a s e s  i n  V i rgi n i a ,  autop s i e s  
a re performed wi th i n  4 8  hours  after death a n d  t i s sue  s pec i mens  a re 
p l aced  i n  the freezer wi th i n hours  after  autopsy . Neverthel e s s , i t  c a n  
be  s a i d  wi th rel at i ve certa i nty t h at  COP  i· s very unstab l e i n  l i ve r ,  e ven  
t h o u g h  no quant i tati ve data were obta i ned . 
Several exp l anat i on s  can be  offered for the re l at i v e l y  l a rge  
coeffi c i ent of vari at i on  wi th i n  a homogenate : 1 )  l ac k  of homogene i ty o f  
t h e  h omogenate ; 2 )  contami nat i on of t h e  t i s s u e  wi th  s u rround i n g  b l ood ; 
o r , 3 )  di fference i n  drug d i str i but i on wi th i n  a t i s sue . I ntrat i s s u e  
d i fferences i n  drug d i str i but i on a re known f o r  certa i n  chemi ca l s .  
S i mi l a r d i stri but i on  stud i es  have  been done w i th  benzod i azep i nes . 
P l ac i d i � !l. ( 10 1 )  found severa l fo l d d i fferences  i n  the concentrat i on  
of di azepam and i ts three maj o r  metabo l i te s  i n  the  d i fferent  l obe s  o f  
t h e  b ra i n  a n d  i n  t h e  wh i te a n d  g ray matter wi th i n .  S i mi l ar f i nd i n g s  
wi th c h l o rd i azepox i de a n d  d i azepam were a l s o  observed b y  van  der  Kl e i g n  
( 102 ) i n  mi ce . Moreover ,  t h e  mi ce l i vers  a l s o  demonstrated a n  u ne qu a l  
pattern of  d i str i b ut i on after i ntravenou s admi n i s trat i on ot  d l a zepam and  
c h l o rd i azepox i d e .  T h i s pattern of unequ a l  d i str i b u t i on  h a s  been  
observed wi th i mi p rami ne ( 103 ) and  barb i tu rates  ( 104 ) .  I he se  a n i ma l  
s tu d i e s  i nd i cate the i mportance of  u s i n g  a l a rge  mas s  o f  t i s s u e  when  
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obtai n i ng an " average"  drug concentrat i on  i n  a t i s s ue . Beca u s e  ot  the  
re l at i vel y sma l l amount  ot tl s s u e  ava i l ab l e for the studi es  reported 
here ( about 100-I�O g ) , and because of  the mu l t i p l e data po i nts  
req u i red , on l y  10 g port i ons  cou l d  be  u sed  for each  quanti tatl on . 
Many i mp l i cat i ons  ar i s e  from these  data both for c l i n i ca l  a nd  
forens i c  l aboratori es . Acqu i s i ti on and  ana lys i s of s pec i mens  s h ou l d  
a l ways b e  done promptl y .  However ,  i n  the case  o f  c h l ordi azepox i de 
greater care i s  requ i red than wi th  other drug-conta i n i ng s pec i men s . 
Ch l o rd i azepoxi de p l a sma o r  who l e  b l ood contro l s  s h ou l d  be s to red  i n  the  
freezer unti l they a re requ i red . C h l o rd i azepox i de standards  s h ou l d  be  
prepared in  a l cohol , stored in  amber  bottl es  and peri odi ca l l y  mon i tored 
for the presence of  demoxepam . For examp l e ,  i n  th i s l aboratory ,  i t  wa s 
found that approx ima te l y  5% of a methano l i c  standard of c h l o rd i azepox i de 
wa s converted to demoxepam over a 6 month  peri od when stored i n  amber  
bott l e s  i n  t he  freeze r .  U nder  refri gerated cond i ti ons  i n  reg u l a r  
bottl es , decompo s i ti on wa s more exten s i ve .  N orch l ord i azepox i de was 
found to be  even more unstab l e .  Quant i tat i on o f  ch l ordi azepox i de and  
i ts metabo l i tes  s h ou l d  be  performed a s  rap i d l y  a s  pos s i b l e .  When  
s amp l es  a re sent to other l aboratori e s , i t  i s  p referab l e that  they be  
s h i pped frozen o r  in  refri gerated conta i ners . I n  foren s i c cases , when  
ana l yses  a re not performed a s  q u i c k l y  a s  in  c l i n i ca l  s i tuat l o n s , i t  i s  
recommended that the sampl e s  conta i n  a chemi ca l  preservati ve  and  be  
stored in  the freezer unt i l the t i me of ana l y s i s .  Moreover ,  the  l nter­
pretat l on of  ch l ord i azepox i de and  metabo l i te concentrat i on s  i n  post­
mortem cases  becomes much  more d i ff i cu l t  when  there i s  a t ime l ag of 
greater than ' several  days between death and  s pec i men  acqu i s i t i on .  The  
data  show that  an i n l ti a l c h l ord i azepox i de concentrati on of 5 mg/ I , a 
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concentrati on con s i dered tox i c ,  can rap i d l y decrea se  wi th i n days t o  a 
concentrat i on  wh i ch cou l d  be con s i dered therapeutl c i f  the body rema i n s 
at  room temperature . Furthermore , i f  the body rema i n s  a t  room tempera ­
tu re for too l ong , then nord i azepam wou l d be  detected . S pec i f i c c are 
mu st  a l s o  be exh i b i ted i n  i nterpret i ng  concentrat i ons  of demoxepam a nd  
nord i azepam; n ot  o n ly  a re they metabo l i tes  of  ch l o rd i azepox i de ( F i g u re 
20 ) ,  they a re a l s o  brea kdown products of c h l o rd i azepoxi de i n  b l ood . 
I I .  BARB ITURATES 
A. Oxybarbi tu rates . There a re several  advantages to the  L C  
method deve l oped f o r  barb i tu rate quant i tati on . I ts sens i t i v i ty a l l ow s  
t h e  detecti on of s ub-therapeut i c  concentrat i ons  of  t h e  mos t  frequen t l y  
pre s c ri bed barbi tu rates . No deri vati zati on to obta i n good peak  
eff i c i ency was req u i red . Further�o re , an i socrat i c mob i l e  phase  u s i n g 
methanol  and an unbuffered aqueous  so l ut i on wa s empl oyed . Th i s  mob i l e  
phase  i ncreases  the l i fet ime of the ana lyt i ca l  co l umn , requ i re s  a l ower  
pump  pres sure and avo i ds the i ntens i ve c l ean - up  du r i n g  the s h ut-down 
procedure . A bri ef fl u s h i ng of the co l umn wi th methanol  at  the  end of 
the day i s  suffi c i en t .  The turn - around t i me for th i s procedu re i s  l es s  
than  one hou r ;  therefore , i t  i s  q u i te u seful  i n  emergency tox i co l ogy 
s i tuati ons . 
Bes i des the many advantages to th i s  method , there a re a l s o  
s ome l i mi tat i ons  t o  i t .  T h e  wave l ength of  detect i on i s  2 1 0  nm , t h u s  
requ i ri n g  a vari ab l e  wave l ength detector .  Amobarb i ta l a n d  pentoba rb i ta l  
a re n o t  separab l e u s i n g  th i s method . Theretore , an  a l ternate method  to 
determi ne the i denti ty of the barb i turate i s  requ i red . The b i ggest  
s hortcomi ng  of th i s method i s  the poor  reso l ut i on  between pri mi done  and  





CI � C = N/ ® 'o  





I 'CH / 2 CI � C = N  ® 
N O R D I AZEPAM 
� 




a � C = N/ 
® 





CIO�:� :;C ® �  







CI � C = N /  ® 'o  
DEMOX E PAM 
conjugation as glucuronIde 
ond excretion 
1 1 9 
1 20 
phenobarbi tal . Becau s e  of th i s ,  th i s system cannot be u sed for samp l e s  
from pati ents rece i v i ng pr imi done . Al s o , t h e  ab i l i ty t o  co l l ect  
fract i ons  comi ng  off  the detector a l  l ows  s i mp l e r  confi rmat i on  by mas s  
s pectrometry . Confi rmat i on  1 S  nece s s ary i n  forens i c  cases  i n  wh i ch 
these  drugs  may be a factor i n  the  cause  ot death . 
The ana lys i s of barb i tu rates i n  decomposed b l ood and t i s s u e s  
i s  somewhat more d i ff i c u l t  t h a n  t he  ana lys i s  of  more rout i ne  tox i co l o g i c 
spec i mens . I n  th i s  resea rch , a l i qu i d  chromatograph i c method was  
spec i fi ca l l y  deve l oped to quanti tate b arb i tu rates wi th the hope  that  the  
advantages of  l i q u i d  c hromatography i n  barb i tu rate ana lys i s  cou l d be  
ut i l i zed . For exampl e ,  no deri vat i zati on i s  req u i red and more  po l a r  
metabol i tes , i f  p roduced , cou l d be  more eas i l y  quant i tated u s i ng l i q U 1 d  
ch romatography . However , a s  the research  deve l oped , l i q u i d 
chromatography became u n s u i tab l e  for quant i tati on  because  of the  
p re sence of i nterferi n g  s ub stances  produced duri n g  the decompos i t i on 
proces s .  When th i s  probl em fi rst  deve l oped , i t  cou l d  be so l ved by 
adj u st i ng  the pH of the water i n  the mob i l e  pha s e , but  eventua l l y ,  the  
i n terference pea ks  became s o  l a rge that even  th i s d i d not work . A 
c l ean - up  step where the i n i ti a l organ i c extract  was back  extracted i nto  
b a se  and  then  back  extracted after a c i d i fi cat i on  a l s o  permi tted 
quant i tati on , but th i s p roved to be  q u i te t i me comsumi ng . F i n a l l y ,  i t  
became nece s s ary to return to g a s  c h romatography wi th n i trogen 
phosphoru s  detecti on for quanti tat i on .  Even t h i s d i d not  s o l ve  a l l of  
the prob l ems wi th quanti tati on of  barb i turates in  l i ve r .  I n i t i a l l y  a 
three step extract i o n  u s i n g  methyl ene c h l or i de a s  the extract i on  s o l vent 
was u sed . However , in  decomposed t i s s u e , th i s  caused  the co-extra c t i o n  
of i nterference products whi ch  rendered quant i tati on i mpos s i b l e .  Th i s  
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p rob l em was a l ev i ated for the most  part by u s i n g  a s l i g ht ly  more po l a r  
so l vent , tol uene : hexane : i s oamy l  a l cohol  ( 78 : 20 : 2 )  t o r  the i n i t i a l 
extracti on . 
I t  a ppears that amobarb i ta l , butabarbi ta l , pentobarb i ta l , 
phenobarb i ta l , and  secobarb i ta l  a re qu i te stab l e when stored i n  b l ood  
both  at  room temperatu re and at  4 uc  over  a 2 to 3 month peri od . S i nce  
barb i tu rate i n stabi l i ty in  aqueous  a l ka l i ne med i um i s  we l l known ( 104 ) , 
i t  was i mportant that the pH of the b l ood be mon i tored throughout  the  
tl me course of th i s exper iment . I t  was found  that the pH of the  b l ood 
at  the beg i nn i ng of  the experi ment was 6 . 4 and  rema i ned under 7 . 0 
throughout . Th l S wou l d  expl a i n  the observed chemi ca l  stabi l i ty of the  
barb l turates in  the b l ood . To l nc rease  the uti l i ty of these  data , a 
seri e s  of b l ood samp l e s  obta i ned from the Offi ce of the Ch i ef Medi ca l  
Exami ner of V i rg i n i a  wa s exami ned for  pH . T he  pH va l ues  ranged from 5 . 0  
to 7 . 0 ,  wi th the maj ori ty ot the s pec i mens  hav i ng  a pH of 6 . 0  t o  6 . 5 .  
Th i s  s uggests  that the maj ori ty of b l ood samp l e s  are s l i g ht ly  a c i d i c  o r  
neutral , wh i ch means  t h a t  t h e  b l ood pH favors chemi ca l stab i l i ty of  
barb i  turates . 
Some work h a s  be.en done on i dent i fyi  n g  the breakdown products  
of barbi turates in  aqueous  so l ut i ons . Goyan et �. ( 106 ) fi r st  p roposed  
mechan i sms for the hydro l ys i s  of barbi turate s ; these  mechan i sms depended 
on  whether the barbi tu rates were in  i on i zed or  u n i oni zed forms . 
U n i on i zed barbi turates were hydrol yzed at  the  1 , 2 -pos i ti on s  wh i l e  
i on i zed barbi turates were hydro l yzed at  the 1 , 6 - pos i t i on .  Depend i n g  on  
the s i te of a ttack ,  d i fferent b reakdown p roducts cou l d  be  formed . These  
schemes are  demonstrated in  F i g u re 2 1 . 
FI GURE . � 1 . Degradat i on pathways for barbi tu rate s  00 '6) . 
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Th i s  mechan i sm wa s veri f i ed by Ti s h l e r  et �. ( 107 ) who we re 
ab l e to fol l ow spectrophotometri ca l l y  the degradat i on of phenoba rb i ta l  
a n d  the formati on of phenyl -ethy l acetyl u rea , the u re i de formed from the  
b reakdown of phenoba rb i ta l . Us i ng the absorbance at  245 nm and 260  nm 
and s ome a l gebra i c  man i pu l at i ons , they were ab l e to quanti tate the  
u re i de in  the presence of  phenobarb i ta l  and the d i ami de . W h i l e  study i ng 
the k i neti cs of hydro l ys i s  of barb i tu ri c  a c i d  deri vati ves , Ga rrett et  
a l .  ( 105 ) di scovered tha t  in  a l ka l i ne s o l ut i on , convers i on of b arb i ta l  
to d i ethy lma l onuri c ac i d i s  revers i b l e ;  that 1 S ,  once the 
di ethyl ma l onuri c ac i d i s  formed , e i ther deca rboxy l at i on to the 
acetyl u rea deri vati ve o r  recycl i zati on to barb i ta l  can occu r .  
I h i n - l ayer chromatography wa s u s e d  t o  sepa rate a n d  i dent i fy s ome of  t h e  
deg radati on products . I he revers i b i l i ty of barb i ta l  degradat i on  was  
confi rmed u s i ng mas s  s pectrometry by Ga rdner  and Goyan ( 108 ) . Howev e r , 
there was no ev i dence to s uggest  the revers i b i l i ty of th i s react i on  w i th  
other  barbi tu rates . r o r  examp l e ,  Fretwu rst t 109 ) reported a 50%  
recovery of degraded barb i ta l  a s  d i ethy l ma l onur i c ac id  but  no 
phenyl ethy l ma l onuri c ac i d was found in  tne degradati on of phenOba rb i ta l . 
I t  wou l d  appear that the decarboxy l at i on of phenyl ethyl mal onur i c a c i d i s  
muc h  fa ster than the deca rboxyl at i on of d i ethy l ma l onuri c ac i d ,  render i n g  
t h e  i n i ti a l breakdown step of phenobarb i ta l  e s senti a l l y  i rreve rs i b l e  by 
equ i l i bri um forces . 
Bes i des chemi ca l  stab i l i ty ,  a factor i n  b l ood wh i ch  i s  a 
g reater prob l em than i n  water i s  the presence of mi croorgan i sms . S i nce  
no chemi ca l  preservati ves  were added to the b l ood , mi c roorga n i sm g rowth 
cou l d  conti nue  rel a t i v e ly  umi mpeded at  room temperatu re and th i s  wa s 
veri fi ed by some of the phys i ca l  characteri st i c s  of the b l ood . The  data  
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s uggest  t�at mi croorgan i sm enzymes d i d  not a l ter the s tructu re of the  
barb i tu rate ri ng . These data  a re in  agreement  wi th s ome of  the  data  on  
b a rb i tu rate stab i l i ty in  b l ood and are in  confl i ct wi th others . F or  
examp l e ,  Coutsel i n i s  and Kear i s ( 5 )  found decreases  i n  pentobarb i ta l  
concentrat i on  i n  dog b l ood when s tored a t  room temperatu re over  a two 
month peri od . However , one potent i a l  probl em w i th  these data i s  that  
quant i tat i on of pentoba rb i ta l  wa s by  a UV  s pectrophotometri c method , 
wh i ch wou l d be more s u s cepti b l e to i nterferences from decompos i t i on 
products than wou l d  the gas  ch romatograph i c  method u sed i n  the l atter 
pa rt of these experi ments . Schafer ( 9 )  reported no change in  s erum 
phenobarb i ta l  concentrat i on when stored at  4°C for about 1 2  wee k s . 
W i l ensky ( 1 1 )  found  no changes  i n  serum phenob a rb i ta l  concentrat i on s  
after 6 months  of storage i n  g l a s s  conta i ners  w i thout expo s u re to l i gh t  
a t  room temperature . 
The l i ve r  data corroborated the f i n d i n g s  i n  b l ood , that  i s ,  no  
s i g n i fi cant changes  were observed over a two month peri od . Th i s con­
fl i cts wi th prev i ou s l y  reported data  wh i ch reports both  i ncrea se s  a nd  
decrea ses  i n  barb i turate concentrat i on ( 2 , 6 ,  7 ) . As wi th  the  confl i ct s  
observed i n  b l ood a n d  d i scus sed i n  t h e  preced i ng paragraph , i t  i s  
be l i eved that d i ffe rences  i n  storage cond i t i ons  and i n  methodo l ogy can  
account  for  these  d i fference s .  
B .  T h i openta l . Among  the advantages that l i q u i d 
chromatography ha s  over ga s  chromatog raphy i s  i ts a b i l i ty to hand l e 
therma l l y  u n stab l e compounds , i e . , compounds wh i ch decompose  at  the h i gh 
temperatures of the ga s  chromatog raph i c  i nj ect i on  port , oven and  
detecto r .  Th i openta l  i s  one such  compound . A UV scan of th i openta l 
suggested that a detecti on  wave l ength of �90 nm wou l d  prov i de the 
greatest  sen s i ti v i ty for quant i tati n g  th i opental . 
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The b i ggest  p rob l em i n  the deve l opment  of th i s a s s ay wa s 
the searc h  for an i nterna l standard . Spec i fi ca l l y , a weak l y  a c i d i c  
compound wi th s uffi c i ent U V  ab sorbance a t  290 n m  was needed . T h i s  
l atter req u i rement excl uded mos t  of  the common barb i turates . I de a l l y , 
an i nterna l s tandard shou l d  be s tructu ra l l y  s i mi l a r to the ana l yte . 
Th i amyl a l , th i oamobarb i ta l  was  tested , b ut  i ns uffi c i ent  reso l ut i o n  from 
t h i opental  was obta i ned . The o n ly  chemi ca l that cou l d be found wh i ch 
met a l l of the cri teri a was phenol phtha l e i n ;  i ts pheno l i c  groups  enab l ed  
i ts extracti on at  pH 5 . 5 .  Moreover , i t  had  s uffi c i ent  UV  a b sorbance  at  
290 nm . 
Pentobarb i ta l , a metabo l i te of th i opental  mi ght  a l s o  
req u i re quanti tati on  when th i openta l i s  present . S i nce pentobarb i ta l i s  
a b rea kdown product of  th i openta l when ana l yz i ng  by g a s  chromatography , 
the s i mu l taneou s quanti tat i on of th i opental  and  pentobarb i ta l  by GC  i s  
v i rtua l l y  i mpos s i b l e .  Unfortunate l y ,  pentoba rb i ta l  ha s  l i ttl e UV  
absorbance at  290 nm and thus , cannot be  quanti tated wi th th i openta l at  
that wave l ength . However , s i nce  pentobarb i ta l  and  th i opental a re 
cl earl y  separated , i t  1 S  pos s i bl e to q u a n t i tate pentob a rb i tal at 210 nm .  
Pheno l phtha l e i n  a l s o  h a s  a UV  ab sorbance at  2 1 0  n m  and can b e  u sed  a s  a n  
1 ntern a l  standard f o r  pentobarb i ta l  quant i tati on  a s  we l l . T h e  fact tha t  
a l l 3 compounds  have s uffi c i ent  ab sorbance at  2 1 0  n m  wou l d  s uggest  the 
use of  th i s  wave l ength tor  s i mu l taneou s quant i tat i on of t h i opental  and 
pentobarb i ta l . The prob l em wi th th i s i s  the  decrea sed  UV  a b s orbance  ot  
th i o�ental  at  2 10  nm  1 n  compa ri son  to 290  nm . Moreover ,  detect i on a t  
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2 10  nm i s  more d i ff i cu l t because  of the g reater presence of i nte rference 
s u b stances from the b l ood o r  from the reagents . 
The method descri bed for the quant i tat i on of t h i openta l 
offers many advantages . I t s  sens i t i v i ty permi ts  quanti tat i on i n  
s u b -therapeut i c  concentrat i ons  a s  wel l a s  i n  l a rger concentra t i o n s  ( 95 ) .  
No i nterferences from co-extracted dru g s  o r  endogenou s  products were 
detected . Moreover i t  permi tted the quant i tati on of th i openta l i n  
decomposed b l ood . 
I t  was somewhat s u rpri s i ng to f i nd that th i openta l was  
stab l e over a 2 month peri od both in  b l ood and  in  buffe r .  
N arbutt-Meri ng  a n d  Weg l ows kou  · ( 1 10 )  i dent i f i ed  t h e  decompo s i t i on 
products of th i opental i n  pharmaceut i ca l  preparat i ons . Speci f i ca l l y ,  
they a rti fi ca l l y  aged the prepa rat i ons  by heat i n g  a t  1 1 0 ° C  for 3 t o  24 
hours  and i denti f i ed the b rea kdown products by paper chromatography . 
The scheme wh i ch they deri ved i s  g i ven i n  F i g ure 22 . S i nce no changes  
i n  th i openta l concentrati on wa s found i n  e i ther med i um stud i ed , n o  
attempts were made to i dent i fy a ny  of t he se  products i n  t he  s pec i men s  
tested i n  th i s study . 
I I I .  L I DOCAINE  
Al though  numerous  gas  chromatograph i c  p rocedu res  for l i doca i ne 
us i n g  n i t rogen detect i on have been pub l i s hed ( 1 1 1 - 1 17 ) , several probl ems 
w i th  these methods were apparen t .  F o r  exampl e ,  s ome requ i re s uch  t i me 
consumi ng steps  a s  mu l t i p l e extract i ons  ( 1 14 , 1 1 5 ) o r  deri vat i zat i on  
( 1 10 ) . Prev i ou s  attempts at  l i doca i ne quant i f i cat i on re s u l ted i n  
i n s tab i li ty o f  the standard . The method deve l oped i l l u s trated the  
stab i l i ty of the standard c urve  and s peed of ana lys i s wi thout 
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FI GURE 22 . Decompos i ti on of t h i openta l  i n  p harmaceuti. c a 1  preparat i ons 
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s acr i f i c i ng the needed spec i f i c i ty ,  sens i ti v i ty ,  and  preci s i on .  N o  
card i oact i ve drug s  wh i ch mi ght  be  co-admi n i s tered wi th  l i doca i ne  were 
found to i nterfere wi th 1 i doca i ne  ana lyses  . F urthermore , i ts 
sen s i t i v i ty enab l es  the quant i tat i on  of s ub -therapeut i c concent ra t i o n s  
of  l i doca i ne .  I t s  prec i s i on i s  a l so  comparab l e t o  other pub l i s hed  g a s  
ch romatograph i c  methods for l i doca i ne .  
L i doca i ne h a s  been i mp l i cated i n  n umerous  acci denta l and  
homi c i dal  deaths  ( 1 18 ) . Becaus e  of  th i s ,  i ts chemi ca l  stab i l i ty in  body 
fl u i ds and t i s s ues  takes  on g reat s i gn i f i cance . Today , l i tt l e work h a s  
been publ i shed on  t h e  stab i l i ty of  l i doca i ne i n  b i o l og i ca l  matri ces . 
Howeve r ,  ethyl g l ycyl xyl i d i de and g l ycyl xyl i d i de ,  two metabo l i te s  of  
l i doca i ne ,  are known to  be  u n s tab l e i n  p l a sma and  u ri ne . Adj epon-Yamoah 
and  P rescott ( 1 1 9 )  found s i gn i fi cant  l os s e s  of each when stored for  one 
month  in neutra l or  a l ka l i ne so l ut i on  at  4°C to -20° C .  
I t  appears that from the data presented here , l i doca i ne i s  
rel at i ve ly  stab l e i n  serum , b l ood , and  l i ve r  when s tored at  e i ther  room 
temperatu re or  at  4° C .  I n  a l l spec i mens  ana l yzed , a t  l ea st  70% o f  the  
amount  ori g i na l l y  present  was recovered after 2 month s .  Th i s  s tab i l i ty 
i n  b i o l og i ca l  s ampl e s  i s  not too s u rpri s i ng s i n ce l i doca i ne i s  q u i te 
stab l e when stored i n  aqueou s so l ut i on . Extremes i n  pH are req u i red 
before l i doca i ne i s  hydro l yzed to 2 , 6 - d imethyl a n i l i ne and  N , N -d i ethyl ­
ami noaceti c aci d ( 120 ) . 
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I V .  D I SOPYRAI>1 I D E , NORTRYPTY L I N E , PROCAI NAM I D E  
T o  ga i n i nformat i on  a b o u t  t h e  stab i l i ty of other N -conta i n i ng 
structures , not i nc l uded i n  the s tudy of benzod i azep i nes , barb i tu ra te s , 
and  l i doca i ne , the fol l owi n g  dru g s  were a l s o  exami ned i n  b l ood : 
d i sopyrami de , nortryptyl i ne ,  and proca i nami de . Nortrypty l i ne conta i n s  a 
secondary ami ne , p roca i nami de conta i n s  a pr ima ry ami ne , and d i s opy rami de 
has an  ami de l i n kage  wi th a pr ima ry ami n e .  I t  w a s  found that each  drug  
was stabl e in  b l ood over  a two month  peri od , both a t  2 5 ° C and  4 ° C . Th i s  
wou l d  s u ggest that drugs  o r  chemi ca l s conta i n i ng these funct i on a l  g roups  
a re stab l e u nder  the experi mental  des i gn fol l owed . 
The stab i l i ty of d i sopyrami de i n  b l ood wa s a l s o  observed  i n  
aqueo u s  so l ut i on ( 12 1 ) . Howeve r , l i tt l e data i n  the l i teratu re were 
found concern i ng the aqueou s stab i l i ty of  proca i nami de and 
nortrypty l i ne .  Therefore , concu rrent wi th  the b l ood exper imen t , 
s o l ut i ons  of proca i nami de and  nortryptyl i ne i n  phosphate buffer ( pH 7 . 5 )  
were prepared and ana lyzed wi th the  b l ood sampl es . No s i gn i f i cant  
changes  i n  concentrat i on  i n  e i ther  drug  were found  over  the two month  
peri od . 
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CONCLUS ION  
Th l S research  c l earl y i nd i cated that dru g s  can vary l n  the i r � 
v i tro stabi l i ty i n  b l ood and i n  t i s sues  and  that numerous  factors can  
a l te r  stabi l i ty .  One approach to ana lyz i n g  a l l of  the data  presented 
here i n  i ts enti rety i s  to rev i ew the s tructu res of the drug s  i nv o l ved , 
p l a c i n g  speci fi c emphas i s  on the n i trogen contai n i n g  functi ona l  groups  
po s se s sed by  these chemi ca l s .  Tab l e  35 l i s t s  the drugs , p l ac i ng 
s pec i fi c emphas i s  on the n i t rogen-conta i n i n g functi ona l  groups and  the i r 
stab i l i ty o r  i nstabi l i ty i n  b l ood . From Tab l e  35 , a number of 
conc l u s i ons  can be  drawn . F i rst l y , the bas i c  s tructure of the 
barb i turate ring i s  s tab l e  in  b l ood , s i nce no changes  in  oxyb a rb i tu rates  
o r  th i opental were observed . The stab i l i ty of the benzodi azep i n e  r i n g  
requ i res  a more deta i l ed ana l ys i s ,  1 0  rev i ew ,  c h l ord i a zepox i de ( CO P ) , 
norchl ordi azepox i de ( NCOP ) , and  demoxepam ( O EM ) decomposed i n  b l ood  a t  
25 ° C .  C O P  a n d  NCOP b ro ke down t o  OEM wh i ch wa s then converted t o  
nord i azepam ; these changes  d o  not d i rectl y i n v o l v e  the b e n z o d i a z e p i n e  
ri n g .  T h e  convers i on of OEM t o  NO  i nvo l ves  t h e  l os s  of t h e  n i trone  
oxygen . Therefore , it  appears  from the  data that n i trones a re u n s tab l e  
l n  b l ood u nder the s to rage  condi t i ons  stud i ed . However ,  one other  
benzodi azep i ne  was found  to be  u n stab l e  ln  b l ood a t  2 5 ° C , n i trazepam . 
S i nce  no b reakdown products ot n i trazepam were i dent i t i ed and  
quantl tated , it  cannot be  sa i d wi th certa i nty whether  the n i tro g roup 
was be i ng changed o r  the  benzod i azepfne ri n g  structure was be i n g  b ro ken  
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TABLE 35 
N i trogen-Conta i n i ng Funct i on a l  G roup s  
of  Drug s  Exami ned 
Drug Stab l e /Un sta b l e 
i n  B l ood at 2 5 ° C  
d i azepam s tab l e 
fl u razepam stab l e 
nord i azepam ? 
n i trazepam unstab l e 
N- l -desa l kyl fl u razepam stab l e 
ch l ord i azepox i de u n stab l e 
norch l ordi azepoxi de u n s tab l e 
demoxepam unstab l e 
n i trazepam unstab l e 
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TABLE 35  ( cont i nued ) 
N i trogen-Conta i n i n g  Funct i ona l  Groups 
of Drugs Exami ned 
Drug  
b a rb i tu rates 
d i sopyrami de 
l i doca i ne 
proca i nami de 
proca i nami de 
nortryptyl  i ne 
d i  sopy rami de 
fl u razepam 
l i doca i ne 
Stab l e/Unstab l e  
i n  B l ood a t  2 5 ° C  
s tab l e 
stab l e 
stab l e  
stab l e 
stab l e 
s tab l e  
stab l e 
stab l e 
s ta b l e 
NOTES : R ,  Rl and  R2 a re a l kyl g roups  
Ar i s  an a ryl  g roup  
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down . I n  other  words , i t  i s  pos s i b l e  that the  n i tro g roup  i s  
contri b ut i n g  to  the i nstab i l i ty of  the ri n g , ma k i n g  i t  more s u s c e pt i b l e 
to b rea kdown . Of a l l the drugs  stud i ed , n i trazepam mos t  c l o s e l y  
resemb l e s  nord i azepam s tructu ra l l y , t h e  o n l y  d i fference be i n g  t h e  n i t ro 
group  on n i trazepam . S i nce confl i ct i ng data  ex i sts  on nordi azepam , no  
further  s tatement  about. the  s i te of  n i t razepam degradati o n  c an  be made . 
Other N-conta i n i ng functi ona l  g roups  appeared to be s tab l e 
accord i n g  to the  data p re-Sen ted : ami des , a n i l i des , ami nes , a n d  i m i n e s . 
I n  those chemi ca l s  unstab l e a t  25 ° C , thei r decompos i ti on can  be 
traced to  both chemi ca l  and mi croorga n i sm effects . For exampl e ,  the  
b rea kdown of  ch l ord i azepox i de to  demoxepam occurred in  bl ood a n d  aqueous 
buffer , suggest i n g  that  th i s i s  a n  effect seen  i n  a l l aqueous medi a ;  
however , the convers i on o f  demoxepam to nord i a zepam i s  not seen  i n  water  
and i s  g reatly del ayed  by  fl uor i de , a mi croorga n i sm  i n h i b i tor . The  
decompos i t i on of  n i t razepam at  25°C  was  not  studied  in  gre a t  detai l .  
Neverthe l e s s , n i trazepam b reakdown wa s seen  i n  both aqueous buffer a n d  
b l ood , suggest i n g  t h a t  i t  �/a s , a t  l ea s t  i n  p art .  a brea kdown i nvol v i ng 
aqueous  med i a .  
The l os s  of  the  n i trone oxygen a s  seen  i n  the breakdown o f  
chl ord i azepoxi de , norch 1 0rdi azepoxi de , and demoxepam ha s been reported 
prev i ous ly  ( 122 ) and can occur in  several  ways . For exampl e ,  n i trones  
can  react  wi th e1 ectroph i 1 es (E )  i n  aqueous  o r  al cohol i c  medi a t o  form 










The deoxygenat i on may a l s o  occur  upon mi l d  heat i n g  i n  v ari o u s  s o l vents  
o r  upon heati ng  more v i gorou s l y  e i ther a l one o r  i n  the presence  of  
vari o u s  so l i d  cata l ysts . ,  Therefore , n i trones a re unstab l e in  other  
so l ut i ons  bes i des b l ood . 
The work presented has  app l i cati ons  i n  the c l i n i ca l  and  foren s i c  
tox i col ogy l aboratori es . B i o l og i ca l  spec i mens  conta i n i ng 
c h l ord i azepox i de or  n i trazepam s hou l d  not be  exposed to L � u C  for l ong  
peri ods  of t ime to protect t he  i ntegri ty of  the spec i mens . Howeve r , 
these  f i ndi ngs  can be  app l i ed i n  a more general  sense . For  examp l e ,  a ny 
b i o l og i ca l spec i men conta i n i ng chemi ca l s  wi th  n i trones mus t  be  p re s e rved  
proper ly  to ensure proper and mean l ngful  a na l ys i s .  Speci t l ca l l y ,  b l ood  
and  ti s sues  s hou l d b e  frozen i mmed l ate l y  upon rece i pt and kept there  
unt i l the t i me for  ana l y s i s .  Al though  it  i s  unc l ear  to date  about  the  
stab i  l i ty of the n i tro functl ona l  g roup , it  too shou l d  be stored under  
these  ri gorou s s to rage condi t i ons  unti l more data  a re obta i ned . 
I n  concl u s i on , i t  s hou l d b e  stated that knowl edge concern i n g the  
sta b i l i ty of a l l chemi ca l s  requ i ri ng ana l ys i s  by c l i n i ca l  and  foren s i c 
toxi col og i sts  i s  i mportant for proper i nterpretati on of res u l ts . T h i s 
re sea rch  has  focused on drugs  wi th  n i trogen -conta i n i n g  functi ona l  
g roup s , but th i s g rou p , a l be i t a l a rge g rou p , i s  by  no means  th e  o n ly  
g roup  of i nterest  to the  toxi col o g i s t . M uch  more work of th i s type  i s  
requ i red i n  the future , s i nce there a re st i l l  l a rge  group s  of chemi c a l s 
wh i ch have not been s tud i ed  thorough l y .  
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APPEND I X  
The stati st i c s  used  t o  compare the s l opes  o f  the concentrat i o n  v s . 
t i me fi gures  and tab l e s  a re summari zed be l ow ( 94 ,  1 23 ) : 
y = a + SX 
a = y - i n tercept 
S = s l ope 
The method of l ea st  square s  ( LSQ ) i s  u sed to obta i n  the best  
stra i ght  l i ne through the  data  po i nts : 
y = a + SX 
a = y- i ntercept obtai ned from LSQ fi t 
S = s l ope obta i ned from LSQ fi t 
Once a and  B a re obta i ned , these v a l ues  a re u sed for hypothes i s  
test i ng : 
Ho : B 0 ,  that i s ,  there i s  no change i n  concentrati on 
a s  a funct i on of t i me .  
S � 0 ,  that i s ,  there i s  a change i n  concentrat i on  
a s  a funct i on of t ime . 
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The data from each f i g ure and tab l e can be u sed to obta i n  a 95% 
confi dence i nterva l  ( C I l for 6 .  S i nce th i s i s  a 2 -s i ded test , the 95%  
C I  can be  u sed for  hypothe s i s te st i ng . I f  0 fal l s  wi th i n  th i s 
confi dence i nterval , then Ho cannot be rej ected at  the 95% confi dence 
i nterva l and there i s  no stati st i ca l l y  s i gn i f i cant  d i fference between 0 
and  6 .  Th i s  wou l d then i nd i cate that there a re no changes i n  drug 
concentrati on a s  a funct i on of t i me .  
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